Sabra Health Care REIT (SBRA) 10-K 22 Feb 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2016	Feb. 13, 2017	Jun. 30, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Sabra Health Care REIT, Inc.
Entity Central Index Key	1,492,298
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		65,285,614
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 1.3

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Assets
Real estate investments, net of accumulated depreciation of $282,812 and $237,841 as of December 31, 2016 and 2015, respectively	$ 2,009,939	$ 2,039,616
Loans receivable and other investments, net	96,036	300,177
Cash and cash equivalents	25,663	7,434
Restricted cash	9,002	9,813
Prepaid expenses, deferred financing costs and other assets, net	125,279	111,797
Total assets	2,265,919	2,468,837
Liabilities
Mortgage notes, net	160,752	174,846
Revolving credit facility	26,000	255,000
Term loans, net	335,673	264,229
Senior unsecured notes, net	688,246	685,704
Accounts payable and accrued liabilities	39,639	35,182
Total liabilities	1,250,310	1,414,961
Commitments and contingencies
Equity
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of December 31, 2016 and 2015	58	58
Common stock, $.01 par value; 125,000,000 shares authorized, 65,285,614 and 65,182,335 shares issued and outstanding as of December 31, 2016 and 2015, respectively	653	652
Additional paid-in capital	1,208,862	1,202,541
Cumulative distributions in excess of net income	(192,201)	(142,148)
Accumulated other comprehensive loss	(1,798)	(7,333)
Total Sabra Health Care REIT, Inc. stockholders' equity	1,015,574	1,053,770
Noncontrolling interests	35	106
Total equity	1,015,609	1,053,876
Total liabilities and equity	$ 2,265,919	$ 2,468,837

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Assets
Accumulated depreciation	$ 282,812	$ 237,841
Equity
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	5,750,000	5,750,000
Preferred stock, shares outstanding	5,750,000	5,750,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	65,285,614	65,182,335
Common stock, shares outstanding	65,285,614	65,182,335

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues:
Rental income	$ 225,275,000	$ 209,851,000	$ 161,483,000
Interest and other income	27,463,000	25,505,000	19,367,000
Resident fees and services	7,788,000	3,508,000	2,668,000
Total revenues	260,526,000	238,864,000	183,518,000
Expenses:
Depreciation and amortization	68,472,000	63,079,000	43,332,000
Interest	64,873,000	59,218,000	46,958,000
Operating expenses	5,703,000	2,576,000	1,930,000
General and administrative	19,918,000	23,865,000	23,815,000
Provision for doubtful accounts and loan losses	5,543,000	12,842,000	3,594,000
Impairment of real estate	29,811,000	0	0
Total expenses	194,320,000	161,580,000	119,629,000
Other income (expense):
Loss on extinguishment of debt	(556,000)	0	(22,454,000)
Other income	10,677,000	2,260,000	1,560,000
Net (loss) gain on sales of real estate	(6,122,000)	(161,000)	3,914,000
Total other income (expense)	3,999,000	2,099,000	(16,980,000)
Net income	70,205,000	79,383,000	46,909,000
Net loss attributable to noncontrolling interests	71,000	30,000	43,000
Net income attributable to Sabra Health Care REIT, Inc.	70,276,000	79,413,000	46,952,000
Preferred stock dividends	(10,242,000)	(10,242,000)	(10,242,000)
Net income attributable to common stockholders	$ 60,034,000	$ 69,171,000	$ 36,710,000
Net income attributable to common stockholders, per:
Basic common share (in dollars per share)	$ 0.92	$ 1.11	$ 0.79
Diluted common share (in dollars per share)	$ 0.92	$ 1.11	$ 0.78
Weighted-average number of common shares outstanding, basic (in shares)	65,284,251	62,235,014	46,351,544
Weighted-average number of common shares outstanding, diluted (in shares)	65,520,672	62,460,239	46,889,531

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income	$ 70,205	$ 79,383	$ 46,909
Other comprehensive income (loss):
Foreign currency translation	(1,634)	(1,433)	0
Unrealized gain (loss) on cash flow hedge	7,169	(4,358)	(1,542)
Total other comprehensive income (loss)	5,535	(5,791)	(1,542)
Comprehensive income	75,740	73,592	45,367
Comprehensive loss attributable to noncontrolling interest	71	30	43
Comprehensive income attributable to Sabra Health Care REIT, Inc.	$ 75,811	$ 73,622	$ 45,410

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Total Stockholders' Equity [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Cumulated Distributions in Excess of Net Income [Member]	Accumulated Other Comprehensive Loss [Member]	Noncontrolling Interest [Member]
Beginning balance (in shares) at Dec. 31, 2013			5,750,000	38,788,745
Beginning balance at Dec. 31, 2013	$ 460,164	$ 460,164	$ 58	$ 388	$ 534,639	$ (74,921)	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	46,909	46,952				46,952		(43)
Other comprehensive income	(1,542)	(1,542)					(1,542)
Amortization of stock-based compensation	11,234	11,234			11,234
Common stock issuance, net (in shares)				20,258,256
Common stock issuance, net	507,930	507,930		$ 202	507,728
Preferred dividends	(10,242)	(10,242)				(10,242)
Common dividends	(72,630)	(72,630)				(72,630)
Beginning balance (in shares) at Dec. 31, 2014			5,750,000	59,047,001
Ending balance at Dec. 31, 2014	941,823	941,866	$ 58	$ 590	1,053,601	(110,841)	(1,542)	(43)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	79,383	79,413				79,413		(30)
Other comprehensive income	(5,791)	(5,791)					(5,791)
Amortization of stock-based compensation	6,946	6,946			6,946
Common stock issuance, net (in shares)				6,135,334
Common stock issuance, net	142,056	142,056		$ 62	141,994
Preferred dividends	(10,242)	(10,242)				(10,242)
Common dividends	(100,478)	(100,478)				(100,478)
Contribution from noncontrolling interest	179							179
Beginning balance (in shares) at Dec. 31, 2015			5,750,000	65,182,335
Ending balance at Dec. 31, 2015	1,053,876	1,053,770	$ 58	$ 652	1,202,541	(142,148)	(7,333)	106
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	70,205	70,276				70,276		(71)
Other comprehensive income	5,535	5,535					5,535
Amortization of stock-based compensation	8,559	8,559			8,559
Common stock issuance, net (in shares)				134,509
Common stock issuance, net	(1,512)	(1,512)		$ 1	(1,513)
Repurchase of common stock (in shares)				(31,230)
Repurchase of common stock	(725)	(725)			(725)
Preferred dividends	(10,242)	(10,242)				(10,242)
Common dividends	(110,087)	(110,087)				(110,087)
Beginning balance (in shares) at Dec. 31, 2016			5,750,000	65,285,614
Ending balance at Dec. 31, 2016	$ 1,015,609	$ 1,015,574	$ 58	$ 653	$ 1,208,862	$ (192,201)	$ (1,798)	$ 35

CONSOLIDATED STATEMENTS OF EQU7

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Stockholders' Equity [Abstract]
Common dividends (in dollars per share)	$ 1.67	$ 1.60	$ 1.51

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income	$ 70,205,000	$ 79,383,000	$ 46,909,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	68,472,000	63,079,000	43,332,000
Non-cash interest income adjustments	582,000	626,000	325,000
Amortization of deferred financing costs	5,040,000	5,143,000	4,045,000
Stock-based compensation expense	7,496,000	6,123,000	9,851,000
Amortization of debt discount (premium)	109,000	103,000	(10,000)
Loss on extinguishment of debt	556,000	0	1,576,000
Straight-line rental income adjustments	(21,984,000)	(24,320,000)	(19,821,000)
Provision for doubtful accounts and loan losses	5,543,000	12,842,000	3,594,000
Change in fair value of contingent consideration	(1,526,000)	(1,550,000)	(1,560,000)
Gain on consolidation	0	(710,000)	0
Net loss (gain) on sales of real estate	6,122,000	161,000	(3,914,000)
Impairment of real estate	29,811,000	0	0
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(1,452,000)	(22,794,000)	(7,993,000)
Accounts payable and accrued liabilities	11,462,000	6,977,000	12,635,000
Restricted cash	(3,697,000)	(3,962,000)	(3,632,000)
Net cash provided by operating activities	176,739,000	121,101,000	85,337,000
Cash flows from investing activities:
Acquisitions of real estate	(153,579,000)	(461,330,000)	(771,479,000)
Origination and fundings of loans receivable	(9,675,000)	(49,687,000)	(66,397,000)
Origination and fundings of preferred equity investments	(7,348,000)	(12,804,000)	(15,486,000)
Additions to real estate	(1,003,000)	(3,689,000)	(1,471,000)
Repayment of loans receivable	215,962,000	5,803,000	1,097,000
Release of contingent consideration held in escrow	0	5,240,000	0
Net proceeds from sale of real estate	98,006,000	27,241,000	27,264,000
Net cash (used in) provided by investing activities	142,363,000	(489,226,000)	(826,472,000)
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes	0	0	499,250,000
Principal payments on senior unsecured notes	0	0	(211,250,000)
Net (repayments of) proceeds from revolving credit facility	(229,000,000)	187,000,000	132,500,000
Proceeds from term loan	69,360,000	73,242,000	0
Proceeds from mortgage notes	0	28,735,000	57,703,000
Principal payments on mortgage notes	(14,768,000)	(3,132,000)	(89,110,000)
Payments of deferred financing costs	(5,937,000)	(1,452,000)	(19,131,000)
Contributions by noncontrolling interests	0	179,000	0
Issuance of common stock, net	(1,289,000)	139,403,000	510,147,000
Dividends paid on common and preferred stock	(119,264,000)	(109,897,000)	(81,489,000)
Net cash provided by (in used) financing activities	(300,898,000)	314,078,000	798,620,000
Net increase (decrease) in cash and cash equivalents	18,204,000	(54,047,000)	57,485,000
Effect of foreign currency translation on cash and cash equivalents	25,000	(312,000)	0
Cash and cash equivalents, beginning of period	7,434,000	61,793,000	4,308,000
Cash and cash equivalents, end of period	25,663,000	7,434,000	61,793,000
Supplemental disclosure of cash flow information:
Interest paid	59,234,000	53,875,000	34,468,000
Supplemental disclosure of non-cash investing and financing activities:
Assumption of mortgage indebtedness	0	30,456,000	14,102,000
Increase in real estate investments due to variable interest consolidation	0	10,700,000	0
Real estate acquired through loan receivable foreclosure	10,100,000	0	0
Decrease in loans receivable and preferred equity due to variable interest consolidation	0	(8,615,000)	0
Repayment of preferred equity investments	0	0	6,949,000
Decrease in loans receivables/increase in real estate	$ 0	$ 0	$ 16,832,000

BUSINESS

BUSINESS	12 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BUSINESS	BUSINESS Overview Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Sun”) and commenced operations on November 15, 2010 following Sabra's separation from Sun (the “Separation Date”). Sabra elected to be treated as a real estate investment trust (“REIT”) with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. Sabra believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. Sabra’s primary business consists of acquiring, financing and owning real estate property to be leased to third party tenants in the healthcare sector. Sabra primarily generates revenues by leasing properties to tenants and operators throughout the United States and Canada. Sabra owns substantially all of its assets and properties and conducts its operations through Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which Sabra is the sole general partner and Sabra's wholly owned subsidiaries are currently the only limited partners, or by subsidiaries of the Operating Partnership. The Company’s investment portfolio is primarily comprised of skilled nursing/transitional care facilities, senior housing facilities, an acute care hospital, investments in loans receivable and preferred equity investments.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation and Basis of Presentation The accompanying consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries as of December 31, 2016 and 2015 and for the years ended December 31, 2016 , 2015 and 2014 . All material intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). GAAP requires the Company to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity's equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary. The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. As of December 31, 2016 , the Company determined it was the primary beneficiary of two variable interest entities–a senior housing facility and an exchange accommodation titleholder variable interest entity–and has consolidated the operations of these entities in the accompanying consolidated financial statements. As of December 31, 2016 , the Company determined that operations of the entities were not material to the Company’s results of operations, financial condition or cash flows. As it relates to investments in loans, in addition to the Company's assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine if the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower's expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2016 and 2015 , none of the Company's investments in loans are accounted for as real estate joint ventures. As it relates to investments in joint ventures, based on the type of rights held by the limited partner(s), GAAP may preclude consolidation by the sole general partner in certain circumstances in which the general partner would otherwise consolidate the joint venture. The Company assesses limited partners' rights and their impact on the presumption of control of the limited partnership by the sole general partner when an investor becomes the sole general partner, and the Company reassesses if: there is a change to the terms or in the exercisability of the rights of the limited partners; the sole general partner increases or decreases its ownership of limited partnership interests; or there is an increase or decrease in the number of outstanding limited partnership interests. The Company also applies this guidance to managing member interests in limited liability companies. Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. Reclassifications Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods. As a result, certain reclassifications were made to the consolidated balance sheets and consolidated statements of income. As of December 31, 2015, there was $17.3 million of deferred financing costs related to the Company's mortgage notes, term loans and senior unsecured notes that was previously reported within “prepaid expenses, deferred financing costs and other assets, net” that was reclassified in accordance with Accounting Standards Update ("ASU") 2015-03 to their respective debt liability financial statement line items on the Company’s consolidated balance sheets. Real Estate Investments and Rental Revenue Recognition Real Estate Acquisition Valuation All assets acquired and liabilities assumed in an acquisition of real estate are measured at their acquisition date fair values. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of tenant relationship and origination and absorption intangible assets are included in prepaid expenses, deferred financing costs and other assets in the accompanying consolidated balance sheets. Acquisition pursuit costs associated with business combinations are expensed as incurred and costs associated with asset acquisitions are capitalized. On October 1, 2016, the Company early adopted ASU 2017-01, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as businesses acquisitions. (See “Recently Issued Accounting Standards Update” below for further information). As a result of early adopting ASU 2017-01, real estate acquisitions completed subsequent to October 1, 2016 did not meet the definition of a business combination and were deemed asset acquisitions, and the Company capitalized $0.3 million of acquisition pursuit costs associated with these acquisitions. Real estate acquisitions completed prior to October 1, 2016 were deemed business combinations and the related acquisition pursuit costs were expensed as incurred. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the years ended December 31, 2016 , 2015 and 2014 , the Company acquired seven , 24 , and 42 real estate properties, respectively, and expensed $1.2 million , $7.0 million and $3.1 million of acquisition pursuit costs, respectively, which is included in general and administrative expense on the accompanying consolidated statements of income. Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the evaluation of the specific characteristics of each tenant's lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income. Depreciation and Amortization Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of lease intangibles are included in depreciation and amortization in the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, 3 to 40 years; buildings and building improvements, 3 to 40 years; and furniture and equipment, 1 to 20 years. Impairment of Real Estate Investments The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through its undiscounted future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential future cash flows. In these instances, the undiscounted future cash flows used to assess recoverability are probability-weighted based on the Company's best estimates as of the date of evaluation. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments. During the year ended December 31, 2016 , the Company recorded an impairment loss of $29.8 million related to the Company's Forest Park - Frisco real estate investment. This facility was subsequently disposed of during the year ended December 31, 2016 . The Company did not record any impairment losses on its real estate investments during the years ended December 31, 2015 or 2014. Rental Revenue Recognition The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when collectability is reasonably assured. The Company makes estimates of the collectability of its tenant receivables related to base rents, straight-line rent and other revenues. When the Company analyzes accounts receivable and evaluates the adequacy of the allowance for doubtful accounts, it considers such things as historical bad debts, tenant creditworthiness, current economic trends, facility operating performance, lease structure, credit enhancements (including guarantees), current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. Specifically for straight-line rent receivables, the Company's assessment includes an estimation of a tenant's ability to fulfill its rental obligations over the remaining lease term. In addition, with respect to tenants in bankruptcy, management makes estimates of the expected recovery of pre-petition and post-petition claims in assessing the estimated collectability of the related receivable. When a tenant is in bankruptcy, the Company records a provision for doubtful accounts for management’s estimate of the tenant’s receivable balance that is uncollectible and generally will not recognize subsequent rental revenue until cash is received or until the tenant is no longer in bankruptcy and has the ability to make rental payments. The Company's collectability estimates for straight-line rent receivables include an assessment at the individual or master lease level as well as at an overall portfolio level. Assets Held for Sale and Discontinued Operations The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as “assets held for sale” for all periods presented in the accompanying consolidated financial statements. Mortgage notes payable and other liabilities related to real estate held for sale are classified as “liabilities related to assets held for sale” for all periods presented in the accompanying consolidated financial statements. Real estate classified as held for sale is no longer depreciated and is reported at the lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2016 and 2015, the Company did no t have any assets held for sale. Additionally, the Company records the operating results related to real estate that has been disposed of or classified as held for sale as discontinued operations for all periods presented if it represents a strategic shift that has or will have a major effect on the Company’s operations and financial results. Loans Receivable and Interest Income Loans Receivable The Company’s loans receivable are recorded at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a loan receivable is the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. On a quarterly basis the Company evaluates the collectability of its loan portfolio, including related interest income receivable, and establishes a reserve for loan losses. The Company's evaluation includes reviewing credit quality indicators such as payment status, changes affecting the underlying real estate collateral (for collateral dependent loans), changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The reserve for loan losses is a valuation allowance that reflects management’s estimate of loan losses inherent in the loan portfolio as of the balance sheet date. The reserve is adjusted through “Provision for doubtful accounts and loan losses” on the Company's consolidated statements of income and is decreased by charge-offs to specific loans when losses are confirmed. The reserve for loan losses includes an asset-specific component and a portfolio-based component. An asset-specific reserve relates to reserves for losses on loans considered impaired and interest income receivable that is deemed uncollectible. The Company considers a loan to be impaired when, based upon current information and events, management believes that it is probable that the Company will be unable to collect all amounts due under the contractual terms of the loan agreement resulting from the borrower’s failure to repay contractual amounts due, the granting of a concession by the Company or the expectation that the Company will receive assets with fair values less than the carrying value of the loan in satisfaction of the loan. If a loan is considered to be impaired, a reserve is established when the carrying value of that loan is greater than the present value of payments expected to be received, the observable market prices for similar instruments, the estimated fair value of the collateral (for loans that are dependent on the collateral for repayment) or other amounts expected to be received in satisfaction of the loan. A portfolio-based reserve covers the pool of loans that do not have asset-specific reserves. A provision for loan losses is recorded when available information as of each balance sheet date indicates that it is probable that a loss occurred in the pool of loans and the amount of the loss can be reasonably estimated, but the Company does not know which specific loans within the pool will ultimately result in losses. The required reserve balances for this pool of loans is derived based on estimated probabilities of default and estimated loss severities assuming a default occurs. Interest Income Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan or through the receipts of assets in satisfaction of contractual amounts due is probable, the Company will resume the accrual of interest. In instances where borrowers are in default under the terms of their loans, the Company may continue recognizing interest income provided that all amounts owed under the contractual terms of the loan, including accrued and unpaid interest, do not exceed the estimated fair value of the collateral, less costs to sell. Preferred Equity Investments and Preferred Return Preferred equity investments are accounted for at unreturned capital contributions, plus accrued and unpaid preferred returns. The Company recognizes preferred return income on a monthly basis based on the outstanding investment including any previously accrued and unpaid return. As a preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to currently pay the accrued preferred return. Cash and Cash Equivalents The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value. The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2016 . To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits the majority of all funds. Restricted Cash Restricted cash primarily consists of amounts held by mortgage lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts to the tenants and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets. As of December 31, 2016 and 2015 , restricted cash totaled $9.0 million and $9.8 million , respectively, and restricted cash obligations totaled $6.8 million and $5.0 million , respectively. Stock-Based Compensation Stock-based compensation expense for stock-based awards granted to Sabra’s employees and its non-employee directors are recognized in the statements of income based on their estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the employee providing additional services. Compensation expense for awards with performance-based vesting conditions is recognized based on the Company's estimate of the ultimate value of such award after considering the Company's expectations of future performance. Deferred Financing Costs Deferred financing costs representing fees paid to third parties to obtain financing are amortized over the terms of the respective financing agreements using the interest method. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close. Income Taxes The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT. As a result of certain acquisitions, the Company now records income tax expense or benefit with respect to certain of its entities that are taxed as taxable REIT subsidiaries under provisions similar to those applicable to regular corporations and not under the REIT provisions. The Company accounts for deferred income taxes using the asset and liability method and recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the Company's financial statements or tax returns. Under this method, the Company determines deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes a change in the Company's judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if the Company believes it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes a change in the Company's judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. The Company evaluates its tax positions using a two step approach: step one (recognition) occurs when a company concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination and step two (measurement) is only addressed if step one has been satisfied (i.e., the position is more likely than not to be sustained). Under step two, the tax benefit is measured as the largest amount of benefit (determined on a cumulative probability basis) that is more likely than not to be realized upon ultimate settlement. The Company will recognize tax penalties relating to unrecognized tax benefits as additional tax expense. Foreign Currency Certain of the Company's subsidiaries’ functional currencies are the local currencies of their respective foreign jurisdictions. The Company translates the results of operations of its foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period presented, and it translates balance sheet accounts using exchange rates in effect at the end of the period presented. The Company records resulting currency translation adjustments in accumulated other comprehensive income, a component of stockholders’ equity, on its consolidated balance sheets, and it records foreign currency transaction gains and losses as a component of interest and other income on its consolidated statements of income. Derivative Instruments The Company uses certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception the Company must make an assessment that the transaction that the Company intends to hedge is probable of occurring and this assessment must be updated each reporting period. The Company recognizes all derivative instruments as assets or liabilities in the consolidated balance sheets at their fair value. For derivatives designated and qualified as a hedge, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive income (loss), whereas the change in fair value of the ineffective portion is recognized in earnings. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria for hedge accounting would be recognized in earnings. As of December 31, 2016 , all of the Company's derivative instruments met the criteria for hedge accounting. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific transactions as well as recognizing obligations or assets in the consolidated balance sheets. The Company also assesses and documents, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying transaction will not occur, the Company would discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the then-current fair value of the derivative. Fair Value Measurements Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired real estate loans receivable and long-lived assets). Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories: • Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities; • Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable. When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items in Level 1 or Level 2. In instances where the market for a financial instrument is not active, regardless of the availability of a nonbinding quoted market price, observable inputs might not be relevant and could require the Company to make a significant adjustment to derive a fair value measurement. Additionally, in an inactive market, a market price quoted from an independent third party may rely more on models with inputs based on information available only to that independent third party. When the Company determines the market for a financial instrument owned by the Company to be illiquid or when market transactions for similar instruments do not appear orderly, the Company may use several valuation sources (including internal valuations, discounted cash flow analysis and quoted market prices) to establish a fair value. If more than one valuation source is used, the Company will assign weights to the various valuation sources. Additionally, when determining the fair value of liabilities in circumstances in which a quoted price in an active market for an identical liability is not available, the Company measures fair value using (i) a valuation technique that uses the quoted price of the identical liability when traded as an asset or quoted prices for similar liabilities or similar liabilities when traded as assets or (ii) another valuation technique that is consistent with the principles of fair value measurement, such as the income approach or the market approach. Changes in assumptions or estimation methodologies can have a material effect on these estimated fair values. In this regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, may not be realized in an immediate settlement of the instrument. The Company considers the following factors to be indicators of an inactive market: (i) there are few recent transactions, (ii) price quotations are not based on current information, (iii) price quotations vary substantially either over time or among market makers (for example, some brokered markets), (iv) indexes that previously were highly correlated with the fair values of the asset or liability are demonstrably uncorrelated with recent indications of fair value for that asset or liability, (v) there is a significant increase in implied liquidity risk premiums, yields, or performance indicators (such as delinquency rates or loss severities) for observed transactions or quoted prices when compared with the Company’s estimate of expected cash flows, considering all available market data about credit and other nonperformance risk for the asset or liability, (vi) there is a wide bid-ask spread or significant increase in the bid-ask spread, (vii) there is a significant decline or absence

RECENT REAL ESTATE ACQUISITIONS

RECENT REAL ESTATE ACQUISITIONS	12 Months Ended
	Dec. 31, 2016
Business Combinations [Abstract]
RECENT REAL ESTATE ACQUISITIONS	RECENT REAL ESTATE ACQUISITIONS During the year ended December 31, 2016 , the Company acquired one skilled nursing/transitional care facility and six senior housing facilities. During the year ended December 31, 2015 , the Company acquired four skilled nursing/transitional care facilities and 20 senior housing facilities. The consideration was allocated as follows (in thousands): Year Ended December 31, 2016 2015 Land $ 7,755 $ 32,336 Building and Improvements 143,027 449,789 Tenant Origination and Absorption Costs 2,202 7,556 Tenant Relationship 642 2,106 Total Consideration $ 153,626 $ 491,787 The tenant origination and absorption costs intangible assets and tenant relationship intangible assets acquired in connection with these acquisitions have weighted-average amortization periods as of the date of acquisition of 15 years and 25 years, respectively. For the year ended December 31, 2016 , the Company recognized $4.6 million and $2.2 million of total revenues and net income attributable to common stockholders, respectively, from the properties acquired during the year ended December 31, 2016 . Net income attributable to common stockholders for the year ended December 31, 2016 includes expensed acquisition pursuit costs of $1.1 million related to acquisitions accounted for as business combinations. For the year ended December 31, 2015, the Company recognized $17.6 million and $5.3 million of total revenues and net income attributable to common stockholders, respectively, from the properties acquired during the year ended December 31, 2015. Net income attributable to common stockholders for the year ended December 31, 2015 includes expensed acquisition pursuit costs of $6.7 million . On June 11, 2015, the Company acquired nine senior housing facilities with a total of 865 units located in British Columbia and Ontario, Canada (the “Canadian Portfolio”) for a purchase price of CAD $170.5 million (U.S. $138.8 million ). Concurrently with the acquisition, the Company entered into a triple-net master lease agreement with an affiliate of Senior Lifestyle Corporation. The master lease has an initial term of 10 years with two five -year renewal options with annual rent increases of 4.0% in years two and three and the greater of 3.0% or the Canadian Consumer Price Index ("CPI") during the remainder of the lease term. The master lease is expected to generate annual lease revenues determined in accordance with GAAP of CAD $11.9 million . In connection with the acquisition of the Canadian Portfolio, the Company assumed three existing mortgage loans with then outstanding principal amounts totaling CAD $24.2 million . On June 30, 2015, the Company acquired three skilled nursing facilities for a purchase price of $175.5 million . On November 25, 2015, the Company acquired another skilled nursing facility for a purchase price of $58.9 million . Each of these facilities specializes in transitional care and medically complex post-surgical, ventilator and dialysis patients, and the facilities have a total of 678 licensed beds located in Maryland. Each of these facilities is operated by the same operator. Concurrently with the acquisition of the three skilled nursing facilities on June 30, 2015, the Company entered into a triple-net master lease agreement with the operator of these facilities. This master lease has an initial term of 15 years with two 10 -year renewal options and annual rent escalators equal to the greater of 2.50% or CPI, but not to exceed 2.75% . In connection with its November 25, 2015 acquisition of the skilled nursing facility for $58.9 million , the Company assumed one U.S. Department of Housing and Urban Development ("HUD") insured mortgage with an outstanding principal balance of $10.8 million , having an annual interest rate of 5.60% . The mortgage note was subsequently repaid during the twelve months ended December 31, 2016 . This skilled nursing facility is also being operated by the same operator that operates the three skilled nursing facilities acquired by the Company on June 30, 2015. The Company has been advised by the sellers of each of these four skilled nursing facilities that prior to the sales of these facilities to the Company, no entity or group of entities, or individual or group of individuals, controlled or jointly controlled all four facilities, and no individual or group managed all four facilities.

REAL ESTATE PROPERTIES HELD FOR

REAL ESTATE PROPERTIES HELD FOR INVESTMENT	12 Months Ended
	Dec. 31, 2016
Real Estate Investments, Net [Abstract]
REAL ESTATE PROPERTIES HELD FOR INVESTMENT	REAL ESTATE PROPERTIES HELD FOR INVESTMENT The Company’s real estate properties held for investment consisted of the following (dollars in thousands): As of December 31, 2016 Property Type Number of Properties Number of Beds/Units Total Real Estate at Cost Accumulated Depreciation Total Real Estate Investments, Net Skilled Nursing/Transitional Care 97 10,819 $ 1,042,754 $ (190,038 ) $ 852,716 Senior Housing 85 7,989 1,187,951 (82,131 ) 1,105,820 Acute Care Hospital 1 70 61,640 (10,387 ) 51,253 183 18,878 2,292,345 (282,556 ) 2,009,789 Corporate Level 406 (256 ) 150 $ 2,292,751 $ (282,812 ) $ 2,009,939 As of December 31, 2015 Property Type Number of Properties Number of Beds/Units Total Real Estate at Cost Accumulated Depreciation Total Real Estate Investments, Net Skilled Nursing/Transitional Care 100 11,012 $ 1,029,291 $ (167,968 ) $ 861,323 Senior Housing 78 7,213 1,072,060 (52,494 ) 1,019,566 Acute Care Hospitals 2 124 175,807 (17,127 ) 158,680 180 18,349 2,277,158 (237,589 ) 2,039,569 Corporate Level 299 (252 ) 47 $ 2,277,457 $ (237,841 ) $ 2,039,616 December 31, 2016 December 31, 2015 Building and improvements $ 1,983,769 $ 1,954,129 Furniture and equipment 85,196 97,840 Land improvements 3,744 3,594 Land 220,042 221,894 2,292,751 2,277,457 Accumulated depreciation (282,812 ) (237,841 ) $ 2,009,939 $ 2,039,616 Contingent Consideration Arrangements In connection with four of its real estate acquisitions, the Company entered into contingent consideration arrangements. Under the contingent consideration arrangements, the Company may pay out additional amounts based on incremental value created through the improvement of operations of the acquired facility (a contingent consideration liability) or may be entitled to receive a portion of the original purchase price of the acquired facility if the facility does not meet certain performance hurdles (a contingent consideration asset). The estimated value of the contingent consideration liabilities at the time of purchase was $3.2 million . The estimated value of the contingent consideration asset at the time of purchase was $0 . The contingent consideration amounts would be determined based on facility performance and the facilities achieving certain performance hurdles during 2016 through 2018. To determine the value of the contingent consideration, the Company used significant inputs not observable in the market to estimate the contingent consideration, made assumptions regarding the probability of the facilities achieving the incremental value and then applied an appropriate discount rate. As of December 31, 2016 , based on the potential future performance of these facilities, the contingent consideration liabilities had an estimated value of $0.8 million , which amount is included in accounts payable in the accompanying consolidated balance sheets, and the contingent consideration asset was determined to have a value of $0 . During the year ended December 31, 2016 , the Company recorded an adjustment to decrease the contingent consideration arrangements by $1.5 million and included this amount in other income (expense) on the accompanying consolidated statements of income. Operating Leases As of December 31, 2016 , nearly all of the Company’s real estate properties held for investment were leased under triple-net operating leases with expirations ranging from four to 16 years. As of December 31, 2016 , the leases had a weighted-average remaining term of over nine years. The leases include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. In addition, the Company may receive additional security under these operating leases in the form of letters of credit and security deposits from the lessee or guarantees from the parent of the lessee. Security deposits received in cash related to tenant leases are included in accounts payable and accrued liabilities in the accompanying consolidated balance sheets and totaled $2.7 million and $1.3 million as of December 31, 2016 and 2015 , respectively. As of December 31, 2016 , the Company had a $3.2 million reserve for unpaid cash rents and a $3.7 million reserve associated with accumulated straight-line rental income. As of December 31, 2015 , the Company had a $3.5 million reserve for unpaid cash rents and a $5.3 million reserve associated with accumulated straight-line rental income. As of December 31, 2016 , the Company's three largest tenants, Genesis Healthcare, Inc. ("Genesis"), certain wholly owned subsidiaries of Holiday AL Holdings LP (collectively, "Holiday") and NMS Healthcare, represented 32.3% , 16.2% , and 12.4% , respectively, of the Company's annualized revenues. Other than these three tenants, none of the Company's tenants individually represented 10% or more of the Company's annualized revenues as of December 31, 2016 . The Company has entered into memoranda of understanding with Genesis to market for sale 35 skilled nursing facilities and make certain other lease and corporate guarantee amendments for the remaining 43 facilities leased to Genesis. Marketing of these 35 facilities is ongoing and is expected to be completed over the next several quarters; provided, however that there can be no assurances that the Company will successfully complete these sales on the terms or timing contemplated by the memoranda or understanding, or at all. The Company monitors the creditworthiness of its tenants by reviewing credit ratings (if available) and evaluating the ability of the tenants to meet their lease obligations to the Company based on the tenants’ financial performance, including the evaluation of any parent guarantees (or the guarantees of other related parties) of tenant lease obligations. Because formal credit ratings may not be available for most of the Company’s tenants, the primary basis for the Company’s evaluation of the credit quality of its tenants (and more specifically the tenants’ ability to pay their rent obligations to the Company) is the tenants’ lease coverage ratios. These coverage ratios include earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) to rent coverage and earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) to rent coverage at the lease level and consolidated EBITDAR to total fixed charge coverage at the parent guarantor level when such a guarantee exists. The Company obtains various financial and operational information from its tenants each month and reviews this information in conjunction with the above-described coverage metrics to identify financial and operational trends, evaluate the impact of the industry's operational and financial environment (including the impact of government reimbursement), and evaluate the management of the tenant’s operations. These metrics help the Company identify potential areas of concern relative to its tenants’ credit quality and ultimately the tenants’ ability to generate sufficient liquidity to meet its obligations, including its obligation to continue to pay the rent due to the Company. As of December 31, 2016 , the future minimum rental payments from the Company’s properties under non-cancelable operating leases was as follows (in thousands): 2017 $ 214,701 2018 220,677 2019 227,049 2020 233,275 2021 203,442 Thereafter 1,145,204 $ 2,244,348

DISPOSITIONS

DISPOSITIONS	12 Months Ended
	Dec. 31, 2016
Discontinued Operations and Disposal Groups [Abstract]
DISPOSITIONS	DISPOSITIONS 2016 Dispositions During the year ended December 31, 2016 , the Company completed the sale of four skilled nursing/transitional care facilities, one acute care hospital, and one parcel of land for aggregate consideration of $98.0 million after selling expenses of $2.7 million . The net carrying value of the assets and liabilities of these facilities, after the impairment loss of $29.8 million recognized in relation to the acute care hospital, was $104.1 million , resulting in an aggregate $6.1 million loss on sale. Excluding the net loss on sale and real estate impairment, the Company recognized $0.7 million of net income, $2.3 million of net loss and $13.3 million of net income from these facilities during the years ended December 31, 2016 , 2015 and 2014 , respectively. The sales of these facilities do not represent a strategic shift that has or will have a major effect on the Company's operations and financial results and therefore the results of operations attributable to these facilities have remained in continuing operations. 2015 Dispositions During the year ended December 31, 2015 , the Company completed the sale of five skilled nursing/transitional care facilities for aggregate consideration of $27.2 million after selling expenses of $0.5 million . The carrying values of the assets and liabilities of these facilities was $27.4 million , which resulted in a $0.2 million loss. During the years ended December 31, 2015 and 2014 the Company recognized $1.8 million (excluding the net loss on sale) and $2.3 million of net income, respectively, from these facilities.

TENANT ORIGINATION AND ABSORPTI

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP ASSETS	12 Months Ended
	Dec. 31, 2016
TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP [Abstract]
TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP ASSETS	TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP ASSETS As of December 31, 2016 and 2015 , the Company’s tenant origination and absorption costs and tenant relationship assets were as follows (in thousands): Tenant Origination and Absorption Costs Tenant Relationship December 31, 2016 2015 2016 2015 Cost $ 23,987 $ 24,492 $ 7,430 $ 7,269 Accumulated amortization (4,432 ) (4,215 ) (735 ) (679 ) Net amount $ 19,555 $ 20,277 $ 6,695 $ 6,590 Decreases in net income as a result of amortization of the Company’s tenant origination and absorption costs and tenant relationship assets for the years ended December 31, 2016 , 2015 and 2014 are as follows (in thousands): Tenant Origination and Absorption Costs Tenant Relationship For the Year Ended December 31, 2016 2015 2014 2016 2015 2014 Amortization $ (2,705 ) $ (2,729 ) $ (1,109 ) $ (477 ) $ (466 ) $ (192 ) The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2016 will be amortized for the years ending December 31 as follows (dollars in thousands): Tenant Origination and Absorption Costs Tenant Relationship 2017 $ 1,868 $ 326 2018 1,868 326 2019 1,868 326 2020 1,868 326 2021 1,868 326 Thereafter 10,215 5,065 $ 19,555 $ 6,695 Weighted-Average Remaining Amortization Period 13.4 years 23.1 years

LOANS RECEIVABLE AND OTHER INVE

LOANS RECEIVABLE AND OTHER INVESTMENTS	12 Months Ended
	Dec. 31, 2016
REAL ESTATE LOANS RECEIVABLE [Abstract]
LOANS RECEIVABLE AND OTHER INVESTMENTS	LOANS RECEIVABLE AND OTHER INVESTMENTS As of December 31, 2016 and 2015 , the Company’s loans receivable and other investments consisted of the following (dollars in thousands): December 31, 2016 Investment Quantity as of December 31, 2016 Facility Type Principal Balance as of December 31, 2016 (1) Book Value as of December 31, 2016 Book Value as of December 31, 2015 Weighted Average Contractual Interest Rate / Rate of Return Weighted Average Annualized Effective Interest Rate / Rate of Return Maturity Date as of December 31, 2016 Loans Receivable: Mortgage 4 Skilled Nursing / Senior Housing $ 38,231 $ 38,262 $ 166,277 9.1 % 8.9 % 11/07/16 - 04/30/18 Construction 1 Senior Housing 795 842 75,201 8.0 % 7.7 % 03/31/21 Mezzanine 1 Senior Housing 9,640 9,656 15,613 11.0 % 10.8 % 08/31/17 Pre-development 3 Senior Housing 4,005 4,023 3,768 9.0 % 7.7 % 01/28/17 - 09/09/17 Debtor-in-possession 1 Acute Care Hospital 813 813 13,625 5.0 % 5.0 % N/A 10 53,484 53,596 274,484 9.3 % 9.1 % Loan loss reserve — (2,750 ) (4,300 ) 53,484 50,846 270,184 Other Investments: Preferred Equity 12 Skilled Nursing/Senior Housing 44,882 45,190 29,993 12.9 % 12.9 % N/A Total 22 $ 98,366 $ 96,036 $ 300,177 10.9 % 10.8 % (1) Principal balance includes amounts funded and accrued but unpaid interest / preferred return and excludes capitalizable fees. During the year ended December 31, 2016 , the Company received aggregate proceeds of $196.1 million , consisting of outstanding principal balance of $170.8 million and $25.3 million of accrued and unpaid interest and fees, in final repayments of the Forest Park - Fort Worth construction loan and the Forest Park - Dallas mortgage loan. As of December 31, 2016 , the Company considered three loan receivable investments to be impaired. The principal balances of the impaired loans were $17.4 million and $30.0 million as of December 31, 2016 and December 31, 2015, respectively. The Company recorded a provision for loan losses of $3.1 million related to four loan receivable investments during the year ended December 31, 2016 , one of which was partially repaid prior to December 31, 2016 through the foreclosure of the real estate asset. As of December 31, 2016 , four investments in loans receivable totaling $31.2 million were on nonaccrual status. During the year ended December 31, 2016 , the Company decreased its provision for portfolio-based loan losses by $1.3 million . The Company's specific loan loss reserve and portfolio-based loan loss reserve were $2.3 million and $0.4 million , respectively, as of December 31, 2016 . The Company recorded a $2.6 million specific loan loss reserve and a $1.8 million portfolio-based loan loss reserve during the year ended December 31, 2015.

DEBT

DEBT	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
DEBT	DEBT Mortgage Indebtedness The Company’s mortgage notes payable consist of the following (dollars in thousands): Interest Rate Type Book Value as of (1) Book Value as of (1) Weighted Average Effective Interest Rate at (2) Maturity Date Fixed Rate $ 163,638 $ 177,850 3.87 % December 2021 - (1) Principal balance does not include deferred financing costs of $2.9 million and $3.0 million as of December 31, 2016 and 2015 , respectively. (2) Weighted average effective interest rate includes private mortgage insurance. Senior Unsecured Notes The Company’s senior unsecured notes consist of the following (dollars in thousands): Principal Balance as of Title Maturity Date December 31, 2016 (1) December 31, 2015 (1) 5.5% senior unsecured notes due 2021 (“2021 Notes”) February 1, 2021 $ 500,000 $ 500,000 5.375% senior unsecured notes due 2023 (“2023 Notes”) June 1, 2023 200,000 200,000 $ 700,000 $ 700,000 (1) Principal balance does not include discount of $0.5 million and $0.6 million as of December 31, 2016 and 2015 , respectively, and also excludes deferred financing costs of $11.2 million and $13.7 million as of December 31, 2016 and 2015 , respectively. 5.5% Notes due 2021 . On January 23, 2014, the Operating Partnership and Sabra Capital Corporation, wholly owned subsidiaries of the Company (the “Issuers”), completed an underwritten offering of $350.0 million aggregate principal amount of 5.5% senior unsecured notes (the “Existing 2021 Notes”). The 2021 Notes were sold at par, resulting in gross proceeds of $350.0 million and net proceeds of approximately $340.8 million after deducting underwriting discounts and other offering expenses. On October 10, 2014, the Issuers issued an additional $150.0 million aggregate principal amount of 5.5% senior unsecured notes, which are treated as a single class with, and have the same terms as, the Existing 2021 Notes (the additional notes and the Existing 2021 Notes, together, the “2021 Notes”). The notes were issued at 99.5% providing net proceeds of approximately $145.6 million (not including pre-issuance accrued interest), after deducting underwriting discounts and other offering expenses and a yield-to-maturity of 5.593% . The 2021 Notes accrue interest at a rate of 5.5% per annum payable semiannually on February 1 and August 1 of each year. The 2021 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after February 1, 2017, at the redemption prices set forth in the 2021 Notes indenture, plus accrued and unpaid interest to the applicable redemption date. Assuming the 2021 Notes are not redeemed, the 2021 Note mature on February 1, 2021. 5.375% Notes Due 2023. On May 23, 2013, the Issuers completed an underwritten public offering of $200.0 million aggregate principal amount of 5.375% senior unsecured notes (the “2023 Notes”). The 2023 Notes were sold at par, resulting in gross proceeds of $200.0 million and net proceeds of approximately $194.6 million after deducting underwriting discounts and other offering expenses. The 2023 Notes accrue interest at a rate of 5.375% per annum payable semiannually on June 1 and December 1 of each year. The 2023 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after June 1, 2018, at the redemption prices set forth in the indenture governing the 2023 Notes (the “2023 Notes Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to June 1, 2018, the Issuers may redeem all or a portion of the 2023 Notes at a redemption price equal to 100% of the principal amount of the 2023 Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to June 1, 2016, the Issuers may redeem up to 35% of the principal amount of the 2023 Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 105.375% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the 2023 Notes are not redeemed, the 2023 Notes mature on June 1, 2023. The obligations under the 2021 Notes and 2023 Notes (collectively, the “Senior Notes”) are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and certain of Sabra’s other existing and, subject to certain exceptions, future material subsidiaries; provided, however, that such guarantees are subject to release under certain customary circumstances. See Note 15, “Summarized Consolidating Information”, for additional information concerning the circumstances pursuant to which the guarantors will be automatically and unconditionally released from their obligations under the guarantees. The indentures governing the Senior Notes (the “Senior Notes Indentures”) contain restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their restricted subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; (iii) pay dividends or distributions on, or redeem or repurchase, their capital stock; (iv) make certain investments or other restricted payments; (v) sell assets; (vi) create liens on their assets; (vii) enter into transactions with affiliates; (viii) merge or consolidate or sell all or substantially all of their assets; and (ix) create restrictions on the ability of Sabra’s restricted subsidiaries to pay dividends or other amounts to Sabra. Such limitations on distributions also include a limitation on the extent of allowable cumulative distributions made not to exceed the greater of (a) the sum of (x) 95% of cumulative Adjusted Funds from Operations and (y) the net proceeds from the issuance of common and preferred equity and (b) the minimum amount of distributions required for the Company to maintain its REIT status. The Senior Notes Indentures also provide for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the Senior Notes, the failure to comply with certain covenants and agreements specified in the Senior Notes Indentures for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then-outstanding Senior Notes may become due and payable immediately. The Company was in compliance with all applicable financial covenants under the Senior Notes Indentures related to the Senior Notes outstanding as of December 31, 2016 . Revolving Credit Facility and Term Loans On September 10, 2014, the Operating Partnership entered into an unsecured revolving credit facility (the “Prior Revolving Credit Facility”) that provided for a borrowing capacity of $650.0 million and provided an accordion feature allowing for an additional $100.0 million of capacity, subject to terms and conditions. On October 10, 2014, the Operating Partnership converted $200.0 million of the outstanding borrowings under the Prior Revolving Credit Facility to a term loan. Concurrent with the term loan conversion, the Company entered into a five -year interest rate cap contract that caps LIBOR at 2.0% . Borrowings under the Prior Revolving Credit Facility bore interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Operating Partnership's option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5% , (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (referred to as the “Base Rate”). The applicable percentage for borrowings varied based on the Consolidated Leverage Ratio, as defined in the credit agreement for the Prior Revolving Credit Facility, and ranged from 2.00% to 2.60% per annum for LIBOR based borrowings and 1.00% to 1.60% per annum for borrowings at the Base Rate. In addition, the Operating Partnership was required to pay an unused fee to the lenders equal to 0.25% or 0.35% per annum based on the amount of unused borrowings under the Prior Revolving Credit Facility. On June 10, 2015, Sabra Canadian Holdings, LLC, a wholly-owned subsidiary of the Company, entered into a new Canadian dollar denominated term loan of CAD $90.0 million (U.S. $73.2 million ) (the "Prior Canadian Term Loan") that bore a variable interest rate of the Canadian Dollar Offer Rate (“CDOR”) plus 2.00% - 2.60% depending on the Company's consolidated leverage ratio. On January 14, 2016, the Operating Partnership and Sabra Canadian Holdings, LLC, also a wholly owned subsidiary of the Company (together, the “Borrowers”), entered into a third amended and restated unsecured credit facility (the “Credit Facility”). The Credit Facility amends and restates the a Prior Revolving Credit Facility and replaces the Prior Canadian Term Loan. The Credit Facility includes a revolving credit facility (the “Revolving Credit Facility”) and U.S. dollar and Canadian dollar term loans (collectively, the “Term Loans”). The Revolving Credit Facility provides for a borrowing capacity of $500.0 million and, in addition, increases the Company's U.S. dollar and Canadian dollar term loans to $245.0 million and CAD $125.0 million , respectively. Further, up to $125.0 million of the Revolving Credit Facility may be used for borrowings in certain foreign currencies. The Credit Facility also contains an accordion feature that can increase the total available borrowings to $1.25 billion , subject to terms and conditions. In addition, the Canadian dollar term loan was re-designated as a net investment hedge (see Note 9, “Derivative and Hedging Instruments,” for further information). The Revolving Credit Facility has a maturity date of January 14, 2020, and includes two six -month extension options. The Term Loans have a maturity date of January 14, 2021. As of December 31, 2016 , there was $26.0 million outstanding under the Revolving Credit Facility and $474.0 million available for borrowing. Borrowings under the Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Operating Partnership’s option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5% , (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (the “Base Rate”). The applicable percentage for borrowings will vary based on the Consolidated Leverage Ratio, as defined in the credit agreement, and will range from 1.80% to 2.40% per annum for LIBOR based borrowings and 0.80% to 1.40% per annum for borrowings at the Base Rate. As of December 31, 2016 , the interest rate on the Revolving Credit Facility was 2.77% . In addition, the Operating Partnership pays an unused fee to the lenders equal to 0.25% or 0.30% per annum, which is determined by usage under the Revolving Credit Facility. The U.S. dollar term loan bears interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Operating Partnership’s option, either (a) LIBOR or (b) the Base Rate. The applicable percentage for borrowings will vary based on the Consolidated Leverage Ratio, as defined in the credit agreement, and will range from 1.75% to 2.35% per annum for LIBOR based borrowings and 0.75% to 1.35% per annum for borrowings at the Base Rate. The Canadian dollar term loan bears interest on the outstanding principal amount at a rate equal to the Canadian Dollar Offer Rate (“CDOR”) plus 1.75% to 2.35% depending on the Consolidated Leverage Ratio. On June 10, 2015, concurrently with entering into the Prior Canadian Term Loan, the Company entered into an interest rate swap agreement to fix the CDOR portion of the interest rate for this CAD $90.0 million term loan at 1.59% . In addition, the Prior Canadian Term Loan was designated as a net investment hedge (see Note 9, “Derivative and Hedging Instruments,” for further information). On August 10, 2016, the Company entered into two interest rate swap agreements to fix the LIBOR portion of the interest rate for its $245.0 million U.S. dollar term loan at 0.90% and one interest rate swap agreement to fix the CDOR portion on CAD $35.0 million of its Canadian dollar term loan at 0.93% . In addition, the Company terminated the five -year interest rate cap contract that capped LIBOR at 2.0% . In the event that Sabra achieves investment grade ratings from at least two of S&P, Moody’s and/or Fitch, the Operating Partnership can elect to reduce the applicable percentage for LIBOR or Base Rate borrowings. If the Operating Partnership makes this election, the applicable percentage for borrowings will vary based on the Debt Ratings at each Pricing Level, as defined in the credit agreement, and will range from 0.90% to 1.70% per annum for LIBOR based borrowings under the Revolving Credit Facility, 1.00% to 1.95% per annum for LIBOR or CDOR based borrowings under the Term Loans, 0.00% to 0.70% per annum for borrowings at the Base Rate under the Revolving Credit Facility, and 0.00% to 0.95% per annum for borrowings at the Base Rate under the U.S. dollar term loan. In addition, should the Operating Partnership elect this option, the unused fee will no longer apply and a facility fee ranging between 0.125% and 0.300% per annum will take effect based on the borrowing capacity regardless of amounts outstanding under the Revolving Credit Facility. The obligations of the Borrowers under the Credit Facility are guaranteed by Sabra and certain subsidiaries of Sabra. The Credit Facility contains customary covenants that include restrictions or limitations on the ability to make acquisitions and other investments, pay dividends, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. The Credit Facility also requires Sabra, through the Operating Partnership, to comply with specified financial covenants, which include a maximum leverage ratio, a minimum fixed charge coverage ratio and a minimum tangible net worth requirement. As of December 31, 2016 , the Company was in compliance with all applicable financial covenants under the Prior Revolving Credit Facility and the Prior Canadian Term Loan. Interest Expense During the years ended December 31, 2016 , 2015 and 2014 , the Company incurred interest expense of $64.9 million , $ 59.2 million and $47.0 million , respectively. Included in interest expense for the years ended December 31, 2016 , 2015 and 2014 , was $5.0 million , $5.1 million and $4.0 million , respectively, of deferred financing costs amortization. As of December 31, 2016 and 2015 , the Company had $ 13.8 million and $ 13.3 million , respectively, of accrued interest included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Maturities The following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2016 (in thousands): Mortgage Indebtedness Revolving Credit Facility (1) Terms Loans Senior Notes Total 2017 $ 4,128 $ — $ — $ — $ 4,128 2018 4,265 — — — 4,265 2019 4,408 — — — 4,408 2020 4,555 26,000 — — 30,555 2021 19,402 — 338,000 500,000 857,402 Thereafter 126,880 — — 200,000 326,880 Total Principal Balance 163,638 26,000 338,000 700,000 1,227,638 Discount — — — (515 ) (515 ) Deferred Financing Costs (2,886 ) — (2,327 ) (11,239 ) (16,452 ) Total Debt, net 160,752 26,000 335,673 688,246 1,210,671 (1) Revolving Credit Facility is subject to two six -month extension options.

DERIVATIVE AND HEDGING INSTRUME

DERIVATIVE AND HEDGING INSTRUMENTS	12 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE AND HEDGING INSTRUMENTS	DERIVATIVE AND HEDGING INSTRUMENTS The Company is exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign exchange rates. The Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates and foreign exchange rates. The Company’s derivative financial instruments are used to manage differences in the amount of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s investments and borrowings. Certain of the Company’s foreign operations expose the Company to fluctuations of foreign interest rates and exchange rates. These fluctuations may impact the value in the Company’s functional currency, the U.S. dollar, of the Company’s investment in foreign operations, the cash receipts and payments related to these foreign operations and payments of interest and principal under Canadian dollar denominated debt. The Company enters into derivative financial instruments to protect the value of its foreign investments and fix a portion of the interest payments for certain debt obligations. The Company does not enter into derivatives for speculative purposes. Cash Flow Hedges The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Approximately $3.3 million of losses, which are included in accumulated other comprehensive loss, as of December 31, 2016 , are expected to be reclassified into earnings in the next 12 months. During the year ended December 31, 2016 , the Company terminated its interest rate cap, generating cash proceeds of $0.3 million . The balance of the loss in other comprehensive income will be reclassified to earnings through 2019. Net Investment Hedges The Company is exposed to fluctuations in foreign exchange rates on investments it holds in Canada. The Company uses cross currency interest rate swaps to hedge its exposure to changes in foreign exchange rates on these foreign investments. The following presents the notional amount of derivatives instruments as of the dates indicated (in thousands): December 31, 2016 December 31, 2015 Derivatives designated as cash flow hedges: Denominated in U.S. Dollars $ 245,000 $ 200,000 Denominated in Canadian Dollars $ 125,000 $ 90,000 Derivatives designated as net investment hedges: Denominated in Canadian Dollars $ 56,300 $ 56,300 Financial instrument designated as net investment hedge: Denominated in Canadian Dollars $ 125,000 $ 90,000 The following is a summary of the derivative and financial instruments designated as hedging instruments held by the Company at December 31, 2016 and 2015 (in thousands): Fair Value Maturity Dates December 31, Type Designation Count 2016 2015 Balance Sheet Location Assets: Interest rate cap Cash Flow — $ — $ 1,695 2019 Prepaid expenses, deferred financing costs and other assets, net Interest rate swap Cash Flow 3 8,083 — 2021 Prepaid expenses, deferred financing costs and other assets, net Cross currency interest rate swaps Net Investment 2 3,157 5,392 2025 Prepaid expenses, deferred financing costs and other assets, net $ 11,240 $ 7,087 Liabilities: Interest rate swap Cash Flow 1 $ 716 $ 1,468 2020 - 2021 Accounts payable and accrued liabilities CAD Term Loan Net Investment 1 93,000 64,890 2020 Term loans, net $ 93,716 $ 66,358 The following presents the effect of the Company’s hedging instruments on the consolidated statements of income and the consolidated statements of equity for years ended December 31, 2016 , 2015 and 2014 : Gain (Loss) Recognized in Other Comprehensive Income (Effective Portion) Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income (Effective Portion) Income Statement Location For the year ended December 31, 2016 2015 2014 2016 2015 2014 Cash Flow Hedges: Interest Rate Products $ 5,879 $ (4,764 ) $ (1,542 ) $ (1,360 ) $ (319 ) $ — Interest Expense Net Investment Hedges: Foreign Currency Products (2,085 ) 5,476 — — — — N/A CAD Term Loan (3,750 ) (8,352 ) — — — — N/A $ 44 $ (7,640 ) $ (1,542 ) $ (1,360 ) $ (319 ) $ — During the year ended December 31, 2016 , the Company determined that a portion of a cash flow hedge was ineffective and recognized $0.8 million of unrealized gains related to its interest rate swaps to other income (expense) in the consolidated statements of income. During the years ended December 31, 2015 and 2014 , the Company recorded no hedge ineffectiveness in earnings. Offsetting Derivatives The Company enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with the same counterparty. The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2016 and 2015 : As of December 31, 2016 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 11,240 $ — $ 11,240 $ (716 ) $ — $ 10,524 Offsetting Liabilities: Derivatives $ 716 $ — $ 716 $ (716 ) $ — $ — As of December 31, 2015 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 7,087 $ — $ 7,087 $ (1,468 ) $ — $ 5,619 Offsetting Liabilities: Derivatives $ 1,468 $ — $ 1,468 $ (1,468 ) $ — $ — Credit-risk-related Contingent Features The Company has agreements with each of its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, including a default where repayment of the indebtedness has not been accelerated by the lender, then the Company could also be declared in default on its derivative obligations. As of December 31, 2016 , the Company had no derivatives with a fair value in a net liability position.

FAIR VALUE DISCLOSURES

FAIR VALUE DISCLOSURES	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
FAIR VALUE DISCLOSURES	FAIR VALUE DISCLOSURES Financial Instruments The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments. Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable, accrued liabilities, the Credit Facility are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows: Loans receivable: These instruments are presented in the accompanying consolidated balance sheets at their amortized cost and not at fair value. The fair value of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, the underlying collateral value and other credit enhancements. As such, the Company classifies these instruments as Level 3. Preferred equity investments: These instruments are presented in the accompanying consolidated balance sheets at their cost and not at fair value. The fair value of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investment, the underlying collateral value and other credit enhancements. As such, the Company classifies these instruments as Level 3. Derivative instruments: The Company’s derivative instruments are presented at fair value on the accompanying consolidated balance sheets. The Company estimates the fair value of derivative instruments, including its interest rate cap, interest rate swap and cross currency swaps, using the assistance of a third party using inputs that are observable in the market, which includes forward yield curves and other relevant information. Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivative financial instruments utilize level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by itself and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company has determined that its derivative financial instruments valuations in their entirety are classified in level 2 of the fair value hierarchy. Senior Notes: These instruments are presented in the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums (discounts) and not at fair value. The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades. As such, the Company classifies these instruments as Level 2. Mortgage indebtedness: These instruments are presented in the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums (discounts) and not at fair value. The fair values of the Company’s mortgage notes payable were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements. As such, the Company classifies these instruments as Level 3. The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2016 and 2015 whose carrying amounts do not approximate their fair value (in thousands): December 31, 2016 December 31, 2015 Carrying Amount (1) Face Value (2) Fair Value Carrying (1) Face Value (2) Fair Value Financial assets: Loans receivable $ 53,596 $ 53,484 $ 51,914 $ 270,184 $ 273,811 $ 274,628 Preferred equity investments 45,190 44,882 48,332 29,993 29,643 30,838 Financial liabilities: Senior Notes 688,246 700,000 709,500 685,704 700,000 718,500 Mortgage indebtedness 160,752 163,638 150,091 174,846 177,850 165,296 (1) Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts). (2) Face value represents amounts contractually due under the terms of the respective agreements. The Company determined the fair value of financial instruments as of December 31, 2016 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands): Fair Value Measurements Using Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Total (Level 1) (Level 2) (Level 3) Financial assets: Loans receivable $ 51,914 $ — $ — $ 51,914 Preferred equity investments 48,332 — — 48,332 Financial liabilities: Senior Notes 709,500 — 709,500 — Mortgage indebtedness 150,091 — — 150,091 Disclosure of the fair value of financial instruments is based on pertinent information available to the Company at the applicable dates and requires a significant amount of judgment. Despite increased capital market and credit market activity, transaction volume for certain financial instruments remains relatively low. This has made the estimation of fair values difficult and, therefore, both the actual results and the Company’s estimate of fair value at a future date could be materially different. Items Measured at Fair Value on a Recurring Basis During the year ended December 31, 2016 , the Company recorded the following amounts measured at fair value (in thousands): Fair Value Measurements Using Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Total (Level 1) (Level 2) (Level 3) Recurring Basis: Financial assets: Interest rate swap $ 8,083 $ — $ 8,083 $ — Cross currency swap 3,157 — 3,157 — Financial liabilities: Contingent consideration liability 818 — — 818 Interest rate swap 716 — 716 — The Company’s contingent consideration arrangements are the result of four acquisitions of real estate (see Note 4, “Real Estate Properties Held for Investment”). In order to determine the fair value of the Company’s contingent consideration arrangements, the Company used significant inputs not observable in the market to estimate the contingent consideration. In addition to using an appropriate discount rate, the Company used projections provided by the facilities to estimate future earnings at the facilities, then developed probability-weighted scenarios of the potential future performance of the facilities and the resulting payout from these scenarios. As of December 31, 2016 , the contingent consideration liability was valued at $0.8 million and the contingent consideration asset was determined to have a value of $ 0 . The following reconciliation provides the details of activity for contingent consideration liability recorded at fair value using Level 3 inputs (in thousands): Balance as of December 31, 2014 $ 3,900 Decrease in contingent liability (1,200 ) Balance as of December 31, 2015 $ 2,700 Decrease in contingent liability (1,876 ) Foreign currency translation (6 ) Balance as of December 31, 2016 $ 818 The following reconciliation provides the details of activity for contingent consideration asset recorded at fair value using Level 3 inputs (in thousands): Balance as of December 31, 2014 $ — Increase in contingent asset 350 Balance as of December 31, 2015 $ 350 Decrease in contingent asset (350 ) Balance as of December 31, 2016 — A corresponding amount equal to the decreases in the contingent consideration liability and contingent consideration asset were included as other income on the accompanying consolidated statements of income for the year ended December 31, 2016 .

EQUITY

EQUITY	12 Months Ended
	Dec. 31, 2016
Equity [Abstract]
EQUITY	EQUITY Preferred Stock On March 21, 2013, the Company completed an underwritten public offering of 5.8 million shares of 7.125% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) at a price of $25.00 per share, pursuant to an effective registration statement. The Company received net proceeds of $138.3 million from the offering, after deducting underwriting discounts and other offering expenses. The Company classified the par value as preferred equity on its consolidated balance sheets with the balance of the liquidation preference, net of any issuance costs, recorded as an increase in paid-in capital. The holders of the Company’s Series A Preferred Stock rank senior to the Company’s common stock with respect to dividend rights and rights upon the Company’s liquidation, dissolution or winding up of its affairs. At December 31, 2016 , there were no dividends in arrears. The Series A Preferred Stock does not have a stated maturity date, but the Company may redeem the Series A Preferred Stock on or after March 21, 2018, for $25.00 per share, plus any accrued and unpaid dividends. The Company may redeem the Series A Preferred Stock prior to March 21, 2018, in limited circumstances to preserve its status as a REIT or pursuant to a specified change of control. Upon the occurrence of a specified change of control, each holder of Series A Preferred Stock will have the right to convert some or all of the shares of Series A Preferred Stock held by such holder into a number of shares of the Company’s common stock equivalent to $25.00 plus accrued and unpaid dividends, but not to exceed a cap of 1.7864 shares of common stock per share of Series A Preferred Stock (subject to certain adjustments). Common Stock On June 30, 2015, the Company completed an underwritten public offering of 5.9 million newly issued shares of its common stock pursuant to an effective registration statement. The Company received net proceeds, before expenses, of $147.9 million from the offering, after giving effect to the issuance and sale of all 5.9 million shares of common stock, at a price of $25.06 per share. These proceeds were primarily used to repay borrowings outstanding under the Prior Revolving Credit Facility. Other Common Stock Issuances The following is a summary of the Company’s other common stock issuances during the years ended December 31, 2016 and 2015 : Year Ended December 31, 2016 2015 Vesting of common stock units 103,279 235,334 Upon any payment of shares as a result of restricted stock unit vestings, the participant is required to satisfy the related tax withholding obligation. The 2009 Performance Incentive Plan provides that the Company has the right, at its option, to (a) require the participant to pay such tax withholding or (b) reduce the number of shares to be delivered by a number of shares necessary to satisfy the related minimum applicable statutory tax withholding obligation. During the years ended December 31, 2016 and 2015, pursuant to advance elections made by certain participants, the Company incurred $1.5 million and $5.0 million , respectively, in tax withholding obligations that were satisfied through a reduction in the number of shares delivered to those participants. Accumulated Other Comprehensive Loss The following is a summary of the Company’s accumulated other comprehensive loss (in thousands): Year Ended December 31, 2016 2015 Foreign currency translation $ (3,067 ) $ (1,433 ) Unrealized gains (losses) on cash flow hedges 1,269 (5,900 ) Total accumulated other comprehensive loss $ (1,798 ) $ (7,333 )

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Dec. 31, 2016
STOCK-BASED COMPENSATION [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION All stock-based awards are subject to the terms of the 2009 Performance Incentive Plan, which was assumed by the Company effective as of November 15, 2010 in connection with the Company's separation from Sun and amended and restated in June 2013. The 2009 Performance Incentive Plan provides for the granting of stock-based compensation, including stock options, time-based stock units, funds from operations-based stock units ("FFO Units"), relative total stockholder return-based stock units ("TSR Units") and performance based restricted stock units to officers, employees and directors in connection with their employment with or services provided to the Company. Stock Options The total intrinsic value of stock options exercised was $0.7 million during the year ended December 31, 2014 . The exercise price for the stock options exercised during the year ended December 31, 2014 was paid through the withholding of shares. The total fair value of stock options that vested during the year ended December 31, 2014 was $0.2 million . The Company had no stock options outstanding during the years ended December 31, 2016 and 2015 . Restricted Stock Units and Performance-Based Restricted Stock Units Under the 2009 Performance Incentive Plan, restricted stock units and performance-based restricted stock units generally have a contractual life or vest over a three - to five -year period. The vesting of certain restricted stock units may accelerate, as defined in the grant, upon retirement, a change in control and other events. When vested (and subject to any applicable deferral or holdback period), each performance-based restricted stock unit is convertible into one share of common stock, subject to any deferrals in issuance pursuant to the grant. The restricted stock units are valued on the grant date based on the market price of the Company's common stock on that date. Generally, the Company recognizes the fair value of the awards over the applicable vesting period as compensation expense. In addition, since the shares to be issued may vary based on the performance of the Company, the Company must make assumptions regarding the projected performance criteria and the shares that will ultimately be issued. The amount of FFO Units that will ultimately vest is dependent on the amount by which the Company's funds from operation ("FFO") differs from a target FFO amount for a period specified in each grant and will range from 0% to 250% of the FFO Units initially granted. Similarly, the amount of TSR Units that will ultimately vest is dependent on the amount by which the total shareholder return ("TSR") of the Company's common stock differs from a predefined peer group for a period specified in each grant and will range from 0% to 200% of the TSR Units initially granted. Upon any payment of restricted stock units, the participant is required to pay the related tax withholding obligation. The 2009 Performance Incentive Plan provides that unless otherwise elected in advance by the participant, the Company will reduce the number of shares to be delivered to pay the related statutory tax withholding obligation. The value of the shares withheld is dependent on the closing price of the Company's common stock on the date the relevant transaction occurs. The following table summarizes additional information concerning restricted stock units at December 31, 2016 : Restricted Stock Units Weighted Average Grant Date Fair Value Per Unit Unvested as of December 31, 2015 732,756 $ 21.37 Granted 393,532 22.05 Vested (214,671 ) 22.01 Dividends reinvested 73,888 22.07 Cancelled/Forfeited (81,538 ) 21.13 Unvested as of December 31, 2016 903,967 $ 21.58 As of December 31, 2016 , the weighted average remaining vesting period of restricted stock units was 2.2 years. The weighted average fair value per share at the date of grant for restricted stock units for the years ended December 31, 2016 , 2015 and 2014 was $22.05 , $21.11 and $25.88 , respectively. The total fair value of units vested during the years ended December 31, 2016 , 2015 and 2014 was $4.7 million , $8.5 million and $9.6 million , respectively. The fair value of the TSR Units are estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the table below. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility was based on historical volatility for the most recent 3 -year period ending on the grant date for the Company and the selected peer companies, and calculated on a daily basis. The following are the key assumptions used in this valuation: 2016 2015 2014 Risk Free Interest Rate 0.78% - 1.60% 0.87% - 1.31% 1.07% - 1.09% Expected Stock Price Volatility 27.40% - 28.42% 23.55% - 27.02% 24.14% - 24.22% Expected Service Period 2.3 - 3.0 years 2.5 - 3.0 years 3.0 years Expected Dividend Yield (assuming full reinvestment) — % — % — % During the years ended December 31, 2016 , 2015 and 2014 , the Company recognized $7.5 million , $6.1 million and $9.9 million , respectively, of stock-based compensation expense. As of December 31, 2016 , there was $10.4 million of total unrecognized stock-based compensation expense related to unvested awards, which is expected to be recognized over a weighted average period of 2.6 years. Employee Benefit Plan The Company maintains a 401(k) plan that allows for eligible participants to defer compensation, subject to certain limitations imposed by the Internal Revenue Code of 1986, as amended (the “Code”). The Company provides a discretionary matching contribution of up to 3% of each participant's eligible compensation. During the years ended December 31, 2016 , 2015 and 2014 , the Company's matching contributions were approximately $73,000 , $35,000 and $51,000 , respectively.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement to distribute at least 90% of our taxable ordinary income. In addition, the Company is required to meet certain asset and income tests. As a REIT, the Company generally will not be subject to corporate level federal income tax on taxable income that it distributes to its stockholders. The Company also elected to treat certain of its consolidated subsidiaries as taxable REIT subsidiaries, which are subject to federal, state and foreign income taxes. The Company is subject to corporate income tax on built-in gains (the excess of fair market value over tax basis on properties held by Sabra as of the date Sabra elected to be taxed as a REIT, or January 1, 2011) on taxable dispositions of properties acquired in the Company's separation from Sun occurring within a specified period (generally five years) following the election to be taxed as a REIT. As of January 1, 2011, the built-in-gains tax associated with the Company’s properties totaled approximately $145.8 million assuming a 40% corporate tax rate. This built-in gains tax is generally not payable on dispositions of property to the extent the proceeds from such dispositions are reinvested in qualifying like-kind replacement property as defined under various provisions of the Code. The Company does not expect to dispose of any properties held by Sabra at the Separation Date if such a disposition would result in the imposition of a material tax liability. Gains from asset dispositions occurring more than five years after the acquisition will not be subject to this corporate-level tax. As a result, the Company has not recorded a deferred tax liability associated with this corporate-level tax. As a result of acquisitions in Canada during 2015, the Company was subject to income taxes under the laws of Canada. The Company recorded a $0.7 million income tax benefit during each of the years ended December 31, 2016 and 2015, with respect to its Canadian operations. Due to uncertainty over the Company's ability to utilize this income tax benefit in future periods, the Company recorded a valuation allowance of $0.7 million against the deferred tax benefit during each of the years ended December 31, 2016 and 2015. The following is a reconciliation of the Company’s beginning and ending unrecognized tax benefits (in thousands): Balance at December 31, 2014 $ 24,212 Additions (reductions) based on prior years’ tax positions — Additions (reductions) based on 2015 tax positions — Balance at December 31, 2015 $ 24,212 Additions (reductions) based on prior years’ tax positions (24,212 ) Additions (reductions) based on 2016 tax positions — Balance at December 31, 2016 $ — During the 2016 fiscal year the full amount of unrecognized tax benefits were released due to the lapse of applicable statute of limitations. The Company does not anticipate that the balance in unrecognized tax benefits will change materially in fiscal year 2017. We classify interest and penalties from significant uncertain tax positions as interest expense and operating expenses, respectively, in our consolidated financial statements. For the years ended December 31, 2016, 2015, and 2014, we had no such interest or penalties. With certain exceptions, the tax year 2013 and thereafter remain open to examination by the major taxing jurisdictions with which the Company files tax returns.

EARNINGS PER COMMON SHARE

EARNINGS PER COMMON SHARE	12 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
EARNINGS PER COMMON SHARE	EARNINGS PER COMMON SHARE The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts): Year Ended December 31, 2016 2015 2014 Numerator Net income attributable to common stockholders $ 60,034 $ 69,171 $ 36,710 Denominator Basic weighted average common shares and common equivalents 65,284,251 62,235,014 46,351,544 Dilutive stock options and restricted stock units 236,421 225,225 537,987 Diluted weighted average common shares 65,520,672 62,460,239 46,889,531 Net income attributable to common stockholders, per: Basic common share $ 0.92 $ 1.11 $ 0.79 Diluted common share $ 0.92 $ 1.11 $ 0.78 During the years ended December 31, 2016 , 2015 and 2014 , approximately 128,000 , 76,000 and 54,000 restricted stock units, respectively, were not included because they were anti-dilutive. No stock options were outstanding during the years ended December 31, 2016 and 2015 and no stock options were considered anti-dilutive during the year ended December 31, 2014 .

SUMMARIZED CONSOLIDATING INFORM

SUMMARIZED CONSOLIDATING INFORMATION	12 Months Ended
	Dec. 31, 2016
SUMMARIZED CONDENSED CONSOLIDATING INFORMATION [Abstract]
SUMMARIZED CONSOLIDATING INFORMATION	SUMMARIZED CONSOLIDATING INFORMATION In connection with the offerings of the Senior Notes by the Issuers, the Company and certain 100% owned subsidiaries of the Company (the “Guarantors”) have, jointly and severally, fully and unconditionally guaranteed the Senior Notes, subject to release under certain customary circumstances as described below. These guarantees are subordinated to all existing and future senior debt and senior guarantees of the Guarantors and are unsecured. The Company conducts all of its business through and derives virtually all of its income from its subsidiaries. Therefore, the Company’s ability to make required payments with respect to its indebtedness (including the Senior Notes) and other obligations depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries. A Guarantor will be automatically and unconditionally released from its obligations under the guarantees with respect to the Senior Notes in the event of: • Any sale of the subsidiary Guarantor or of all or substantially all of its assets; • A merger or consolidation of a subsidiary Guarantor with an issuer of the Senior Notes or another Guarantor, provided that the surviving entity remains a Guarantor; • A subsidiary Guarantor is declared “unrestricted” for covenant purposes under the Senior Notes Indentures; • The requirements for legal defeasance or covenant defeasance or to discharge the Senior Notes Indentures have been satisfied; • A liquidation or dissolution, to the extent permitted under the Senior Notes Indentures, of a subsidiary Guarantor; and • The release or discharge of the guaranty that resulted in the creation of the subsidiary guaranty, except a discharge or release by or as a result of payment under such guaranty. Pursuant to Rule 3-10 of Regulation S-X, the following summarized consolidating information is provided for the Company (the “Parent Company”), the Issuers, the Guarantors, and the Company’s non-Guarantor subsidiaries with respect to the Senior Notes. This summarized financial information has been prepared from the books and records maintained by the Company, the Issuers, the Guarantors and the non-Guarantor subsidiaries. The summarized financial information may not necessarily be indicative of the results of operations or financial position had the Issuers, the Guarantors or non-Guarantor subsidiaries operated as independent entities. Sabra’s investments in its consolidated subsidiaries are presented based upon Sabra’s proportionate share of each subsidiary’s net assets. The Guarantor subsidiaries’ investments in the non-Guarantor subsidiaries and non-Guarantor subsidiaries’ investments in Guarantor subsidiaries are presented under the equity method of accounting. Intercompany activities between subsidiaries and the Parent Company are presented within operating activities on the consolidating statement of cash flows. Consolidating financial statements for the Company and its subsidiaries, including the Parent Company only, the Issuers, the combined Guarantor subsidiaries and the combined non-Guarantor subsidiaries, are as follows: CONSOLIDATING BALANCE SHEET December 31, 2016 (in thousands, except share and per share amounts) Parent Company Issuers Combined Guarantor Subsidiaries Combined Non- Guarantor Subsidiaries Elimination Consolidated Assets Real estate investments, net of accumulated depreciation $ 150 $ — $ 1,828,629 $ 181,160 $ — $ 2,009,939 Loans receivable and other investments, net (410 ) — 96,446 — — 96,036 Cash and cash equivalents 18,168 — 2,675 4,820 — 25,663 Restricted cash — — 57 8,945 — 9,002 Prepaid expenses, deferred financing costs and other assets, net 2,859 18,023 95,740 10,566 (1,909 ) 125,279 Intercompany 368,281 686,376 — — (1,054,657 ) — Investment in subsidiaries 640,238 908,253 12,364 — (1,560,855 ) — Total assets $ 1,029,286 $ 1,612,652 $ 2,035,911 $ 205,491 $ (2,617,421 ) $ 2,265,919 Liabilities Mortgage notes, net $ — $ — $ — $ 160,752 $ — $ 160,752 Revolving credit facility — 26,000 — — — 26,000 Term loans, net — 243,626 92,047 — — 335,673 Senior unsecured notes, net — 688,246 — — — 688,246 Accounts payable and accrued liabilities 13,712 14,542 11,333 1,961 (1,909 ) 39,639 Intercompany — — 1,048,309 6,348 (1,054,657 ) — Total liabilities 13,712 972,414 1,151,689 169,061 (1,056,566 ) 1,250,310 Total Sabra Health Care REIT, Inc. stockholders’ equity: 1,015,574 640,238 884,222 36,395 (1,560,855 ) 1,015,574 Noncontrolling interests — — — 35 — 35 Total equity 1,015,574 640,238 884,222 36,430 (1,560,855 ) 1,015,609 Total liabilities and equity $ 1,029,286 $ 1,612,652 $ 2,035,911 $ 205,491 $ (2,617,421 ) $ 2,265,919 CONSOLIDATING BALANCE SHEET December 31, 2015 (in thousands, except share and per share amounts) Parent Company Issuers Combined Guarantor Subsidiaries Combined Non- Guarantor Subsidiaries Elimination Consolidated Assets Real estate investments, net of accumulated depreciation $ 48 $ — $ 1,874,394 $ 165,174 $ — $ 2,039,616 Loans receivable and other investments, net — — 302,282 — (2,105 ) 300,177 Cash and cash equivalents 2,548 — 456 4,430 — 7,434 Restricted cash — — 1,788 8,025 — 9,813 Prepaid expenses, deferred financing costs and other assets, net 2,047 13,384 91,225 7,996 (2,855 ) 111,797 Intercompany 489,763 918,209 — — (1,407,972 ) — Investment in subsidiaries 568,841 792,065 8,855 — (1,369,761 ) — Total assets $ 1,063,247 $ 1,723,658 $ 2,279,000 $ 185,625 $ (2,782,693 ) $ 2,468,837 Liabilities Mortgage notes $ — $ — $ 10,766 $ 164,080 $ — $ 174,846 Revolving credit facility — 255,000 — — — 255,000 Term loans, net — 200,000 64,229 — — 264,229 Senior unsecured notes, net — 685,704 — — — 685,704 Accounts payable and accrued liabilities 9,477 14,113 11,392 2,056 (1,856 ) 35,182 Intercompany — — 1,399,041 8,931 (1,407,972 ) — Total liabilities 9,477 1,154,817 1,485,428 175,067 (1,409,828 ) 1,414,961 Total Sabra Health Care REIT, Inc. stockholders' equity 1,053,770 568,841 793,572 10,452 (1,372,865 ) 1,053,770 Noncontrolling interests — — — 106 — 106 Total equity 1,053,770 568,841 793,572 10,558 (1,372,865 ) 1,053,876 Total liabilities and equity $ 1,063,247 $ 1,723,658 $ 2,279,000 $ 185,625 $ (2,782,693 ) $ 2,468,837 CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2016 (in thousands, except share and per share amounts) Parent Company Issuers Combined Guarantor Subsidiaries Combined Non- Guarantor Subsidiaries Elimination Consolidated Revenues: Rental income $ — $ — $ 206,406 $ 21,197 $ (2,328 ) $ 225,275 Interest and other income 3 — 27,712 1 (253 ) 27,463 Resident fees and services — — — 7,788 — 7,788 Total revenues 3 — 234,118 28,986 (2,581 ) 260,526 Expenses: Depreciation and amortization 816 — 60,910 6,746 — 68,472 Interest — 54,589 3,497 6,787 — 64,873 Operating expenses — — — 8,066 (2,363 ) 5,703 General and administrative 16,218 57 3,284 359 — 19,918 Provision for doubtful accounts and loan losses (1,376 ) — 6,498 421 — 5,543 Impairment of real estate — — 29,811 — — 29,811 Total expenses 15,658 54,646 104,000 22,379 (2,363 ) 194,320 Other income (expense): Loss on extinguishment of debt — (468 ) (88 ) — — (556 ) Other income (expense) 7,366 (196 ) 3,507 — — 10,677 Net (loss) gain on sales of real estate — — (6,143 ) 21 — (6,122 ) Total other income (expense) 7,366 (664 ) (2,724 ) 21 — 3,999 Income in subsidiary 78,783 134,093 6,840 — (219,716 ) — Net income 70,494 78,783 134,234 6,628 (219,934 ) 70,205 Net loss attributable to noncontrolling interest — — — 71 — 71 Net income attributable to Sabra Health Care REIT, Inc. 70,494 78,783 134,234 6,699 (219,934 ) 70,276 Preferred stock dividends (10,242 ) — — — — (10,242 ) Net income attributable to common stockholders $ 60,252 $ 78,783 $ 134,234 $ 6,699 $ (219,934 ) $ 60,034 Net income attributable to common stockholders, per: Basic common share $ 0.92 Diluted common share $ 0.92 Weighted-average number of common shares outstanding, basic 65,284,251 Weighted-average number of common shares outstanding, diluted 65,520,672 CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2015 (in thousands, except share and per share amounts) Parent Company Issuers Combined Combined Non- Elimination Consolidated Revenues: Rental income $ — $ — $ 190,582 $ 20,470 $ (1,201 ) $ 209,851 Interest and other income 2 334 25,472 1 (304 ) 25,505 Resident fees and services — — — 3,508 — 3,508 Total revenues 2 334 216,054 23,979 (1,505 ) 238,864 Expenses: Depreciation and amortization 47 — 57,141 5,891 — 63,079 Interest — 52,208 1,536 5,735 (261 ) 59,218 Operating expenses — — — 3,789 (1,213 ) 2,576 General and administrative 14,910 30 8,566 359 — 23,865 Provision for doubtful accounts and loan losses 1,291 — 11,551 — — 12,842 Total expenses 16,248 52,238 78,794 15,774 (1,474 ) 161,580 Other income (expense): Other income (expense) — 1,651 (101 ) 710 — 2,260 Net loss on sales of real estate — — (161 ) — — (161 ) Total other income (expense) — 1,651 (262 ) 710 — 2,099 Income in subsidiary 95,690 145,943 8,368 — (250,001 ) — Net income 79,444 95,690 145,366 8,915 (250,032 ) 79,383 Net loss attributable to noncontrolling interest — — — 30 — 30 Net income attributable to Sabra Health Care REIT, Inc. 79,444 95,690 145,366 8,945 (250,032 ) 79,413 Preferred stock dividends (10,242 ) — — — — (10,242 ) Net income attributable to common stockholders $ 69,202 $ 95,690 $ 145,366 $ 8,945 $ (250,032 ) $ 69,171 Net income attributable to common stockholders, per: Basic common share $ 1.11 Diluted common share $ 1.11 Weighted-average number of common shares outstanding, basic 62,235,014 Weighted-average number of common shares outstanding, diluted 62,460,239 CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2014 (in thousands, except share and per share amounts) Parent Company Issuers Combined Combined Non- Elimination Consolidated Revenues: Rental income $ — $ — $ 142,249 $ 19,234 $ — $ 161,483 Interest and other income 9 — 19,357 1 — 19,367 Resident fee and services — — — 2,668 — 2,668 Total revenues 9 — 161,606 21,903 — 183,518 Expenses: Depreciation and amortization 52 — 37,645 5,635 — 43,332 Interest — 37,129 4,642 5,187 — 46,958 Operating expenses — — — 1,930 — 1,930 General and administrative 17,922 2 5,561 330 — 23,815 Provision for doubtful accounts and write-offs 600 — 2,994 — — 3,594 Total expenses 18,574 37,131 50,842 13,082 — 119,629 Other income (expense): Loss on extinguishment of debt — (21,846 ) (472 ) (136 ) — (22,454 ) Other income — — 1,560 — — 1,560 Gain on sale of real estate — — 3,914 — — 3,914 Total other income (expense) — (21,846 ) 5,002 (136 ) — (16,980 ) Income in subsidiary 65,517 124,494 5,698 — (195,709 ) — Net income 46,952 65,517 121,464 8,685 (195,709 ) 46,909 Net loss attributable to noncontrolling interest — — — 43 — 43 Net income attributable to Sabra Health Care REIT, Inc. 46,952 65,517 121,464 8,728 (195,709 ) 46,952 Preferred stock dividends (10,242 ) — — — — (10,242 ) Net income attributable to common stockholders $ 36,710 $ 65,517 $ 121,464 $ 8,728 $ (195,709 ) $ 36,710 Net income attributable to common stockholders, per: Basic common share $ 0.79 Diluted common share $ 0.78 Weighted-average number of common shares outstanding, basic 46,351,544 Weighted-average number of common shares outstanding, diluted 46,889,531 CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2016 (in thousands) Parent Company Issuers Combined Combined Non-Guarantor Elimination Consolidated Net income $ 70,494 $ 78,783 $ 134,234 $ 6,628 $ (219,934 ) $ 70,205 Other comprehensive income (loss): Foreign currency translation — (2,080 ) 364 82 — (1,634 ) Unrealized loss on cash flow hedge — 7,169 — — — 7,169 Total other comprehensive loss — 5,089 364 82 — 5,535 Comprehensive income 70,494 83,872 134,598 6,710 (219,934 ) 75,740 Comprehensive loss attributable to noncontrolling interest — — — 71 — 71 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 70,494 $ 83,872 $ 134,598 $ 6,781 $ (219,934 ) $ 75,811 CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2015 (in thousands) Parent Company Issuers Combined Combined Non-Guarantor Elimination Consolidated Net income $ 79,444 $ 95,690 $ 145,366 $ 8,915 $ (250,032 ) $ 79,383 Other comprehensive income (loss): Foreign currency translation — 5,530 (5,495 ) (1,468 ) — (1,433 ) Unrealized loss on cash flow hedge — (4,358 ) — — — (4,358 ) Total other comprehensive income (loss) — 1,172 (5,495 ) (1,468 ) — (5,791 ) Comprehensive income 79,444 96,862 139,871 7,447 (250,032 ) 73,592 Comprehensive loss attributable to noncontrolling interest — — — 30 — 30 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 79,444 $ 96,862 $ 139,871 $ 7,477 $ (250,032 ) $ 73,622 CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2014 (in thousands) Parent Company Issuers Combined Guarantor Subsidiaries Combined Non-Guarantor Subsidiaries Elimination Consolidated Net income $ 46,952 $ 65,517 $ 121,464 $ 8,685 $ (195,709 ) $ 46,909 Other comprehensive income (loss): Unrealized loss on cash flow hedge — (1,542 ) — — — (1,542 ) Total other comprehensive loss — (1,542 ) — — — (1,542 ) Comprehensive income 46,952 63,975 121,464 8,685 (195,709 ) 45,367 Comprehensive loss attributable to noncontrolling interest — — — 43 — 43 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 46,952 $ 63,975 $ 121,464 $ 8,728 $ (195,709 ) $ 45,410 CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2016 (in thousands) Parent Company Issuers Combined Combined Non- Elimination Consolidated Net cash provided by operating activities $ 153,577 $ — $ 12,074 $ 11,088 $ — $ 176,739 Cash flows from investing activities: Acquisitions of real estate — — (133,797 ) (19,782 ) — (153,579 ) Origination and fundings of loans receivable — — (9,675 ) — — (9,675 ) Origination and fundings of preferred equity investments — — (7,348 ) — — (7,348 ) Additions to real estate (124 ) — (502 ) (377 ) — (1,003 ) Repayment of loan receivable — — 215,962 — — 215,962 Investment in Subsidiary (200 ) (200 ) — — 400 — Net proceeds from sale of real estate — — 97,407 599 — 98,006 Distribution from Subsidiary 6,404 6,404 — — (12,808 ) — Intercompany financing (23,484 ) 165,842 — — (142,358 ) — Net cash (used in) provided by investing activities (17,404 ) 172,046 162,047 (19,560 ) (154,766 ) 142,363 Cash flows from financing activities: Net repayment from revolving credit facility — (229,000 ) — — — (229,000 ) Proceeds from term loan — 45,000 24,360 — — 69,360 Principal payments on mortgage notes — — (10,766 ) (4,002 ) — (14,768 ) Payments of deferred financing costs — (5,326 ) (611 ) — — (5,937 ) Issuance of common stock (1,289 ) — — — — (1,289 ) Dividends paid on common and preferred stock (119,264 ) — — — — (119,264 ) Contribution from Parent — 200 — 200 (400 ) — Distribution to Parent — (6,404 ) — (6,404 ) 12,808 — Intercompany financing — 23,484 (184,957 ) 19,115 142,358 — Net cash (used in) provided by financing activities (120,553 ) (172,046 ) (171,974 ) 8,909 154,766 (300,898 ) Net increase in cash and cash equivalents 15,620 — 2,147 437 — 18,204 Effect of foreign currency translation on cash and cash equivalents — — 72 (47 ) — 25 Cash and cash equivalents, beginning of period 2,548 — 456 4,430 — 7,434 Cash and cash equivalents, end of period $ 18,168 $ — $ 2,675 $ 4,820 $ — $ 25,663 CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2015 (in thousands) Parent Company Issuers Combined Combined Non- Elimination Consolidated Net cash provided by operating activities $ 112,291 $ — $ 820 $ 7,990 $ — $ 121,101 Cash flows from investing activities: Acquisitions of real estate — — (450,082 ) (11,248 ) — (461,330 ) Origination and fundings of loans receivable — — (49,687 ) — — (49,687 ) Preferred equity investments — — (12,804 ) — — (12,804 ) Additions to real estate (34 ) — (1,286 ) (2,369 ) — (3,689 ) Investment in Subsidiary (414 ) (414 ) — — 828 — Distribution from Subsidiary 3,515 3,515 — — (7,030 ) — Intercompany financing (200,884 ) (387,652 ) — — 588,536 — Repayment of note receivable — — 5,803 — — 5,803 Release of contingent consideration held in escrow — — 5,240 — — 5,240 Net proceeds from sale of real estate — — 27,241 — — 27,241 Net cash (used in) provided by investing activities (197,817 ) (384,551 ) (475,575 ) (13,617 ) 582,334 (489,226 ) Cash flows from financing activities: Net proceeds from revolving credit facility — 187,000 — — — 187,000 Proceeds from term loan — — 73,242 — — 73,242 Proceeds from mortgage notes — — — 28,735 — 28,735 Principal payments on mortgage notes — — — (3,132 ) — (3,132 ) Payments of deferred financing costs — (232 ) (740 ) (480 ) — (1,452 ) Contributions by noncontrolling interest — — — 179 — 179 Issuance of common stock 139,403 — — — — 139,403 Dividends paid on common and preferred stock (109,897 ) — — — — (109,897 ) Contribution from Parent — 414 — 414 (828 ) — Distribution to Parent — (3,515 ) — (3,515 ) 7,030 — Intercompany financing — 200,884 402,745 (15,093 ) (588,536 ) — Net cash provided by (in used) financing activities 29,506 384,551 475,247 7,108 (582,334 ) 314,078 Net (decrease) increase in cash and cash equivalents (56,020 ) — 492 1,481 — (54,047 ) Effect of foreign currency translation on cash and cash equivalents (231 ) — (36 ) (45 ) — (312 ) Cash and cash equivalents, beginning of period 58,799 — — 2,994 — 61,793 Cash and cash equivalents, end of period $ 2,548 $ — $ 456 $ 4,430 $ — $ 7,434 CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2014 (in thousands) Parent Company Issuers Combined Combined Non- Elimination Consolidated Net cash provided by operating activities $ 53,292 $ — $ — $ 32,045 $ — $ 85,337 Cash flows from investing activities: Acquisitions of real estate — — (763,378 ) (8,101 ) — (771,479 ) Origination and fundings of loans receivable — — (66,397 ) — — (66,397 ) Preferred equity investments — — (15,486 ) — — (15,486 ) Additions to real estate (11 ) — (1,437 ) (23 ) — (1,471 ) Repayment of loans receivable — — 1,097 — — 1,097 Net proceeds from the sale of real estate — — 27,264 — — 27,264 Investment in Subsidiary (12,147 ) (12,147 ) — — 24,294 — Distribution from Subsidiary 1,246 1,246 — — (2,492 ) — Intercompany financing (415,790 ) (958,970 ) — — 1,374,760 — Net cash (used in) provided by investing activities (426,702 ) (969,871 ) (818,337 ) (8,124 ) 1,396,562 (826,472 ) Cash flows from financing activities: Proceeds from issuance of senior unsecured notes — 499,250 — — — 499,250 Principal payments on senior unsecured notes — (211,250 ) — — — (211,250 ) Net proceeds (repayment) from revolving credit facility — 268,000 (135,500 ) — — 132,500 Proceeds from mortgage notes — — — 57,703 — 57,703 Principal payments on mortgage notes — — — (89,110 ) — (89,110 ) Payments of deferred financing costs — (12,820 ) (5,133 ) (1,178 ) — (19,131 ) Issuance of common stock 510,147 — — — — 510,147 Dividends paid on common and preferred stock (81,489 ) — — — — (81,489 ) Contribution from Parent — 12,147 — 12,147 (24,294 ) — Distribution to Parent — (1,246 ) — (1,246 ) 2,492 — Intercompany financing — 415,790 958,970 — (1,374,760 ) — Net cash provided by (used in) financing activities 428,658 969,871 818,337 (21,684 ) (1,396,562 ) 798,620 Net increase in cash and cash equivalents 55,248 — — 2,237 — 57,485 Cash and cash equivalents, beginning of period 3,551 — — 757 — 4,308 Cash and cash equivalents, end of period $ 58,799 $ — $ — $ 2,994 $ — $ 61,793

PRO FORMA FINANCIAL INFORMATION

PRO FORMA FINANCIAL INFORMATION (UNAUDITED)	12 Months Ended
	Dec. 31, 2016
PRO FORMA FINANCIAL INFORMATION [Abstract]
PRO FORMA FINANCIAL INFORMATION (UNAUDITED)	PRO FORMA FINANCIAL INFORMATION (UNAUDITED) The following table summarizes, on an unaudited pro forma basis, the consolidated results of operations of the Company for the years ended December 31, 2016 and 2015 . During the year ended December 31, 2016 , the Company acquired one skilled nursing/transitional care facility and three senior housing facilities that were accounted for as business combinations. During the year ended December 31, 2015 , the Company acquired four skilled nursing/transitional care facilities and 20 senior housing facilities which were all accounted for as business combinations. The following unaudited pro forma information has been prepared to give effect to the acquisitions completed during the year ended December 31, 2016 and December 31, 2015 as if these acquisitions occurred on January 1, 2015 and 2014, respectively. This pro forma information does not purport to represent what the actual results of operations of the Company would have been had these acquisitions occurred on January 1, 2015 and 2014, nor does it purport to predict the results of operations for future periods (in thousands, except share and per share amounts): Year Ended December 31, 2016 2015 Revenues $ 266,727 $ 276,978 Depreciation and amortization 70,316 74,101 Net income attributable to common stockholders 65,530 99,004 Net income attributable to common stockholders, per: Basic common share 1.00 1.59 Diluted common share 1.00 1.59 Weighted average number of common shares outstanding, basic 65,284,251 62,235,014 Weighted average number of common shares outstanding, diluted 65,520,672 62,460,239 Expensed acquisition pursuit costs of $1.1 million related to the acquisitions completed during year the ended December 31, 2016 are not expected to have a continuing impact and, therefore, have been excluded from the pro forma results for the year ended December 31, 2016.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Environmental As an owner of real estate, the Company is subject to various environmental laws of federal, state and local governments. The Company is not aware of any environmental liability that could have a material adverse effect on its financial condition or results of operations. However, changes in applicable environmental laws and regulations, the uses and conditions of properties in the vicinity of the Company’s properties, the activities of its tenants and other environmental conditions of which the Company is unaware with respect to the properties could result in future environmental liabilities. As of December 31, 2016 , the Company does not expect that compliance with existing environmental laws will have a material adverse effect on the Company’s financial condition and results of operations. Income Taxes As a result of the Company’s separation from Sun effective November 15, 2010 (the “Separation Date”), the Company is the surviving taxpayer for income tax purposes. Accordingly, tax positions taken prior to the Separation Date remained the Company’s obligations after the Separation Date. Sun agreed to indemnify the Company against, among other things, federal, state and local taxes (including penalties and interest) related to periods prior to the Separation Date to the extent the deferred tax assets allocated to the Company are not sufficient and/or cannot be utilized to satisfy these taxes. Effective December 1, 2012, Sun was acquired by Genesis HealthCare LLC. As a result of its acquisition Sun, Genesis HealthCare LLC became successor to the obligations of Sun described above. Effective February 2, 2015, Genesis HealthCare LLC combined with Skilled Healthcare Group, Inc. and now operates under the name Genesis Healthcare, Inc. Legal Matters From time to time, the Company is party to legal proceedings that arise in the ordinary course of its business. Management is not aware of any legal proceedings where the likelihood of a loss contingency is reasonably possible and the amount or range of reasonably possible losses is material to the Company's results of operations, financial condition or cash flows.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS The Company evaluates subsequent events up until the date the consolidated financial statements are issued. Dividend Declaration On February 3, 2017 , the Company announced that its board of directors declared a quarterly cash dividend of $0.42 per share of common stock. The dividend will be paid on February 28, 2017 to stockholders of record as of the close of business on February 15, 2017 . Also on February 3, 2017 , the Company announced that its board of directors declared a quarterly cash dividend of $0.4453125 per share of Series A Preferred Stock. The dividend will be paid on February 28, 2017 to stockholders of record as of the close of business on February 15, 2017 .

SCHEDULE II VALUATION AND QUALI

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2016
Valuation and Qualifying Accounts [Abstract]
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS	SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS December 31, 2016 (dollars in thousands) Balance at Beginning of Year Charged to Earnings Uncollectible Accounts Written-off Foreign Currency Translation due to Charges Balance at End of Year Year ended December 31, 2016 Allowance for doubtful accounts $ 3,811 $ 235 $ (353 ) $ — $ 3,693 Straight-line rent receivable allowance 5,331 3,540 (5,191 ) (12 ) 3,668 Loan loss reserves 4,300 1,768 (3,318 ) — 2,750 $ 13,442 $ 5,543 $ (8,862 ) $ (12 ) $ 10,111 Year ended December 31, 2015 Allowance for doubtful accounts $ — $ 3,811 $ — $ — $ 3,811 Straight-line rent receivable allowance 600 4,731 — — 5,331 Loan loss reserves — 4,300 — — 4,300 $ 600 $ 12,842 $ — $ — $ 13,442 Year ended December 31, 2014 Straight-line rent receivable allowance — 600 — — 600

SCHEDULE III REAL ESTATE ASSETS

SCHEDULE III REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION	12 Months Ended
	Dec. 31, 2016
SEC Schedule III, Real Estate and Accumulated Depreciation Disclosure [Abstract]
SCHEDULE III REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION	SCHEDULE III REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION December 31, 2016 (dollars in thousands) Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (1) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Skilled Nursing/Transitional Care Facilities New Martinsville New Martinsville, WV 100% — $ 475 $ 10,543 $ 11,018 — $ 475 $ 10,355 $ 10,830 $ (4,059 ) 1982 11/15/10 39 Glenville Glenville, WV 100% — 484 2,839 3,323 — 484 2,729 3,213 (754 ) 1982/2006/2015 11/15/10 40 Renaissance Terrace Harriman, TN 100% — 76 4,459 4,535 — 76 3,943 4,019 (1,905 ) 1985/1989, 2008 11/15/10 38 Greenwood Warwick, RI 100% — 2,066 10,178 12,244 — 2,066 9,810 11,876 (4,194 ) 1964/2009 11/15/10 24 Forest Hills (SNF) Broken Arrow, OK 100% (4) 1,653 11,259 12,912 — 1,653 10,951 12,604 (4,017 ) 1994/2008, 2009/2010, 2015 11/15/10 40 Seminole Estates Seminole, OK 100% — 655 3,527 4,182 — 655 3,259 3,914 (888 ) 1987 11/15/10 32 Bryan Care Bryan, OH 100% — 1,278 6,477 7,755 — 1,278 6,081 7,359 (2,102 ) 1976 11/15/10 30 Sylvania Sylvania, OH 100% — 942 5,627 6,569 — 942 5,178 6,120 (2,323 ) 1967/1974, 1986, 1995, 2008, 2009 11/15/10 24 Point Place Toledo, OH 100% — 1,089 5,364 6,453 — 1,089 5,109 6,198 (1,462 ) 1995/2011 11/15/10 36 Perrysburg Perrysburg, OH 100% — 987 5,358 6,345 — 987 4,996 5,983 (1,710 ) 1984 11/15/10 32 Forest View Dayton, OH 100% — 819 4,214 5,033 — 819 3,945 4,764 (1,681 ) 1968 11/15/10 24 New Lebanon New Lebanon, OH 100% — 784 4,243 5,027 — 784 3,797 4,581 (1,418 ) 1979 11/15/10 28 New Lexington New Lexington, OH 100% — 63 3,487 3,550 — 63 3,138 3,201 (2,095 ) 1981 11/15/10 20 Twin Rivers Defiance, OH 100% — 280 3,004 3,284 — 280 2,758 3,038 (1,000 ) 1980 11/15/10 30 San Juan Farmington, NM 100% 9,709 799 4,163 4,962 3 799 3,866 4,665 (1,512 ) 1963/1993 11/15/10 24 McKinley Care Gallup, NM 100% 5,566 409 1,865 2,274 4 409 1,768 2,177 (687 ) 1968 11/15/10 24 Bedford Hills Bedford, NH 100% 6,316 1,911 12,245 14,156 — 1,911 11,391 13,302 (3,641 ) 1992/2010 11/15/10 36 Exeter on Hampton Exeter, NH 100% — 2,365 2,350 4,715 — 2,365 691 3,056 (373 ) 1976/2011 11/15/10 40 Pheasant Wood Petersborough, NH 100% — 625 3,986 4,611 — 625 3,479 4,104 (1,443 ) 1975/2016 11/15/10 28 Westwood Keene, NH 100% — 699 3,823 4,522 — 699 3,346 4,045 (1,623 ) 1965/2010 11/15/10 24 Colonial Hill Rochester, NH 100% — 412 3,960 4,372 — 412 3,644 4,056 (1,532 ) 1986/2010 11/15/10 44 Crestwood Care Milford, NH 100% — 557 3,441 3,998 — 557 3,007 3,564 (1,293 ) 1972 11/15/10 28 Applewood Winchester, NH 100% — 348 3,075 3,423 — 348 2,673 3,021 (963 ) 1987 11/15/10 32 The Elms Care Milford, NH 100% — 312 1,679 1,991 — 312 1,480 1,792 (801 ) 1890/2005 11/15/10 20 Woodland Hill Asheboro, NC 100% — 1,706 8,053 9,759 — 1,706 7,612 9,318 (2,378 ) 1987/2009 11/15/10 32 Missouri River Great Falls, MT 100% 11,064 2,023 16,967 18,990 — 2,023 16,516 18,539 (6,741 ) 1960/1990, 2010 11/15/10 30 Butte Care Butte, MT 100% — 1,092 12,654 13,746 — 1,092 12,469 13,561 (4,308 ) 1974/2012 11/15/10 35 Whitefish Care Whitefish, MT 100% — 651 6,339 6,990 — 651 6,206 6,857 (2,230 ) 1973/2012 11/15/10 35 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (1) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Deer Lodge Deer Lodge, MT 100% 4,218 190 3,032 3,222 2 190 2,963 3,153 (1,279 ) 1,973 11/15/10 30 Twin Oaks Danvers, MA 100% — 885 5,100 5,985 — 885 4,408 5,293 (1,810 ) 1969 11/15/10 24 Maplewood Amesbury, MA 100% — 771 4,550 5,321 — 771 3,710 4,481 (1,507 ) 1968/2010 11/15/10 24 Saugus Saugus, MA 100% — 285 1,643 1,928 — 285 1,039 1,324 (493 ) 1967 11/15/10 24 Kensington Manor Elizabethtown, KY 100% — 1,864 7,523 9,387 — 1,864 7,045 8,909 (2,337 ) 2001/2010 11/15/10 37 Regency Care Louisville, KY 100% — 1,169 5,989 7,158 1,587 1,169 7,048 8,217 (2,712 ) 1960/2014 11/15/10 25 Countryside Care Bardwell, KY 100% — 239 4,790 5,029 — 239 4,418 4,657 (1,307 ) 1993/2010 11/15/10 35 Bradford Square South Frankfort, KY 100% — 774 3,848 4,622 — 774 3,467 4,241 (1,447 ) 1960/1990 11/15/10 25 Hillside Villa Madisonville, KY 100% — 277 4,272 4,549 — 277 3,810 4,087 (1,625 ) 1962/1978, 1997 11/15/10 25 Klondike Care Louisville, KY 100% — 764 3,576 4,340 — 764 3,222 3,986 (1,220 ) 1974/1980, 1994, 1995, 2008 11/15/10 28 Colonial Manor Bowling Green, KY 100% — 792 3,050 3,842 — 792 2,753 3,545 (1,112 ) 1963 11/15/10 25 Barkley Center Paducah, KY 100% — 325 4,019 4,344 — 325 3,397 3,722 (995 ) 1999/2014 11/15/10 35 Hopkins Care Woodburn, KY 100% — 592 2,277 2,869 — 592 2,020 2,612 (831 ) 1960 11/15/10 25 Bridge Point Florence, KY 100% — — 2,278 2,278 — — 1,521 1,521 (908 ) 1969/2008, 2009, 2010 11/15/10 20 Magnolia Village Bowling Green, KY 100% — 14 629 643 — 14 286 300 (209 ) 1991 11/15/10 29 Decatur Township Indianapolis, IN 100% — 673 3,730 4,403 — 673 3,450 4,123 (1,199 ) 1985/2016 11/15/10 32 Gooding/Bennett Hills Gooding, ID 100% — — 1,731 1,731 — — 1,719 1,719 (923 ) 1968/2009 11/15/10 40 Fountain City Columbus, GA 100% — 253 2,797 3,050 — 253 1,904 2,157 (1,314 ) 1970/2012 11/15/10 40 Etowah Landing Rome, GA 100% — 43 842 885 — 43 674 717 (531 ) 1973/1977, 1987 11/15/10 40 Oakhurst Ocala, FL 100% — 1,474 8,212 9,686 — 1,474 7,514 8,988 (2,563 ) 1984/2010 11/15/10 32 Orchard Ridge New Port Richey, FL 100% — 536 5,685 6,221 — 536 5,268 5,804 (1,803 ) 1983/1995, 2012 11/15/10 32 Bay Tree Palm Harbor, FL 100% — 786 4,870 5,656 — 786 4,333 5,119 (1,663 ) 1981 11/15/10 32 West Bay Oldsmar, FL 100% — 775 4,660 5,435 — 775 4,110 4,885 (1,477 ) 1982/2010 11/15/10 32 Sunset Point Clearwater, FL 100% — 706 4,370 5,076 — 706 3,917 4,623 (1,501 ) 1983 11/15/10 32 Arden House Hamden, CT 100% 19,202 2,250 23,816 26,066 — 2,250 22,836 25,086 (8,042 ) 1973/2008, 2010 11/15/10 28 Pope John Paul Danbury, CT 100% — — 13,702 13,702 — — 12,660 12,660 (4,041 ) 1983/2009 11/15/10 32 St. Camillus Stamford, CT 100% — — 12,528 12,528 — — 11,413 11,413 (3,745 ) 1987/2008 11/15/10 32 Madison House Madison, CT 100% — 4,337 8,164 12,501 — 4,337 7,715 12,052 (2,320 ) 1994/2009, 2010 11/15/10 36 Willows (CT) Woodbridge, CT 100% — 1,838 9,961 11,799 — 1,838 9,130 10,968 (3,073 ) 1989/2011 11/15/10 32 The Reservoir West Hartford, CT 100% — 1,204 9,457 10,661 — 1,204 9,093 10,297 (2,784 ) 1995/2009, 2011 11/15/10 36 Glen Hill Danbury, CT 100% — 918 7,017 7,935 — 918 6,429 7,347 (2,882 ) 1963/2009 11/15/10 24 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (1) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Governor's House Simsbury, CT 100% — — 5,750 5,750 — — 5,209 5,209 (2,587 ) 1895/2008, 2010 11/15/10 20 Elms Haven Thornton, CO 100% 14,743 3,717 18,473 22,190 7 3,717 17,914 21,631 (5,903 ) 1987/1989, 1997, 2007, 2008/2016 11/15/10 40 Sable Aurora, CO 100% — 1,272 5,591 6,863 — 1,272 5,422 6,694 (1,987 ) 1973 11/15/10 35 Carmichael Carmichael, CA 100% — — 1,741 1,741 — — 1,263 1,263 (810 ) 1960/1976, 2010 11/15/10 40 Willows (CA) Willows, CA 100% — 137 1,426 1,563 — 137 1,194 1,331 (707 ) 1969/2010, 2015 11/15/10 40 Washington Care San Leandro, CA 100% 9,383 — 1,331 1,331 7 — 1,146 1,146 (580 ) 1969/2010 11/15/10 40 Lake Drive Henryetta, OK 100% — 160 549 709 — 160 87 247 (62 ) 1968 11/15/10 10 Mineral Springs North Conway, NH 100% 12,362 417 5,352 5,769 — 417 4,872 5,289 (1,665 ) 1988/2009 11/15/10 43 Wolfeboro Wolfeboro, NH 100% 10,413 454 4,531 4,985 — 454 4,153 4,607 (1,345 ) 1984/1986, 1987, 2009 11/15/10 41 Edmondson Care Brownsville, KY 100% — 446 5,087 5,533 — 446 4,563 5,009 (1,487 ) 1994/2009 11/15/10 35 Heartland Villa Lewisport, KY 100% — 532 4,025 4,557 — 532 3,660 4,192 (1,142 ) 1994/2009 11/15/10 35 Meridian Care Meridian, ID 100% — 840 8,342 9,182 — 840 8,032 8,872 (3,353 ) 1997/2009 11/15/10 39 St. Joseph's Trumbull, CT 100% — — 21,878 21,878 — — 20,801 20,801 (8,597 ) 1959 11/15/10 24 Broadmeadow Healthcare Middletown, DE 100% — 1,650 21,730 23,380 — 1,650 21,730 23,380 (3,385 ) 2005 08/01/11 40 Capitol Healthcare Dover, DE 100% — 4,940 15,500 20,440 — 4,940 15,500 20,440 (2,525 ) 1996/2016 08/01/11 40 Pike Creek Healthcare Wilmington, DE 100% — 2,460 25,240 27,700 — 2,460 25,240 27,700 (3,976 ) 2009 08/01/11 40 Renaissance Healthcare Millsboro, DE 100% — 1,640 22,620 24,260 — 1,640 22,620 24,260 (3,633 ) 2008 08/01/11 40 Clara Burke Plymouth Meeting, PA 100% — 2,527 12,453 14,980 90 2,527 12,543 15,070 (1,853 ) 1927/1990, 2007/2016 03/30/12 40 Warrington Warrington, PA 100% — 2,617 11,662 14,279 15 2,617 11,677 14,294 (1,588 ) 1958/2009/2016 03/30/12 40 Ridgecrest Duffield, VA 100% — 509 5,018 5,527 580 509 5,598 6,107 (913 ) 1981/2013 05/10/12 40 Camden Care Center Minneapolis, MN 100% — 1,235 5,777 7,012 — 1,235 5,777 7,012 (711 ) 1990 11/30/12 40 Arbrook Plaza Arlington, TX 100% — 3,783 14,219 18,002 — 3,783 14,219 18,002 (1,669 ) 2002/2012 11/30/12 40 Northgate Plaza Irving, TX 100% — 4,901 10,299 15,200 — 4,901 10,299 15,200 (1,245 ) 2003/2012, 2015 11/30/12 40 Gulf Pointe Plaza Rockport, TX 100% — 1,005 6,628 7,633 — 1,005 6,628 7,633 (842 ) 2002/2012 11/30/12 40 Gateway Senior Living Lincoln, NE 100% — 6,368 29,919 36,287 — 6,368 29,919 36,287 (2,456 ) 1962/1996/2013 02/14/14 40 Legacy Fremont, NE 100% — 615 16,176 16,791 — 615 16,176 16,791 (1,457 ) 2008 02/14/14 40 Pointe Fremont, NE 100% — 615 2,943 3,558 — 615 2,943 3,558 (315 ) 1970/1979/1983/1994 02/14/14 40 Regency South Sioux City, NE 100% — 246 6,206 6,452 — 246 6,206 6,452 (680 ) 1954/1968/1975/2000/2004 02/14/14 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (1) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Parkmoor Village Colorado Springs, CO 100% — 430 13,703 14,133 — 430 13,703 14,133 (1,281 ) 1985 03/05/14 40 Onion Creek Austin, TX 100% — 871 12,843 13,714 — 871 12,843 13,714 (920 ) 2011 10/21/14 40 Adams PARC Barlesville, OK 100% — 1,332 6,904 8,236 — 1,332 6,904 8,236 (470 ) 1989 10/29/14 40 PARCway Oklahoma City, OK 100% — 2,189 23,567 25,756 — 2,189 23,567 25,756 (1,428 ) 1963/1984 10/29/14 40 Brookhaven Extensive Care Norman, OK 100% — 869 5,236 6,105 — 869 5,236 6,105 (398 ) 2001/2013 10/29/14 40 St. Thomas More Medical Complex Hyattsville, MD 100% — 6,343 65,573 71,916 — 6,343 65,573 71,916 (2,962 ) 1950/1976, 2008 06/30/15 40 Bay Ridge Healthcare Center Annapolis, MD 100% — 1,548 40,773 42,321 — 1,548 40,773 42,321 (1,708 ) 1964/1993, 2012 06/30/15 40 NMS Healthcare of Silver Spring Wheaton, MD 100% — 676 56,897 57,573 — 676 56,897 57,573 (2,349 ) 1966/1991, 2012 06/30/15 40 NMS Healthcare of Hagerstown Hagerstown, MD 100% — 1,475 56,237 57,712 — 1,475 56,237 57,712 (1,701 ) 1953/1975, 2014 11/25/15 40 NMS Healthcare of Springbrook Silver Spring, MD 100% — 963 48,085 49,048 — 963 48,085 49,048 (562 ) 1965/2015 07/26/16 40 102,976 110,076 963,581 1,073,657 2,295 110,076 932,678 1,042,754 (190,038 ) Senior Housing Monroe House Moses Lake, WA 100% — — 182 182 — — 43 43 (33 ) 1997 11/15/10 15 Forest Hills (ALF) Broken Arrow, OK 100% (4) 1,803 3,927 5,730 — 1,803 3,775 5,578 (1,618 ) 2000 11/15/10 30 Langdon Place of Exeter Exeter, NH 100% 3,363 571 7,183 7,754 — 571 6,479 7,050 (2,230 ) 1987 11/15/10 43 Langdon Place of Nashua Nashua, NH 100% 5,330 — 5,654 5,654 — — 4,919 4,919 (1,429 ) 1989 11/15/10 40 Langdon Place of Keene Keene, NH 100% 4,737 304 3,992 4,296 — 304 3,591 3,895 (1,383 ) 1,995 11/15/10 46 Langdon Place of Dover Dover, NH 100% 4,177 801 10,036 10,837 — 801 9,191 9,992 (2,928 ) 1987/2009 11/15/10 42 Clipper Harbor Portsmouth, NH 100% — 846 7,632 8,478 — 846 6,964 7,810 (2,803 ) 1986/2009 11/15/10 43 Heritage Place Owensboro, KY 100% — 668 5,492 6,160 — 668 5,116 5,784 (1,369 ) 2001 11/15/10 38 Glen Crest Danbury, CT 100% — 1,356 6,666 8,022 — 1,356 6,544 7,900 (2,161 ) 1986 11/15/10 32 Village at Northrise Las Cruces, NM 100% — 1,432 6,003 7,435 — 1,432 5,236 6,668 (2,581 ) 1998/1999, 2010 11/15/10 29 Age-Well Senior Living Green Bay, WI 100% — 256 2,262 2,518 1,031 256 3,293 3,549 (966 ) 2004/2011 11/22/11 40 New Dawn Memory Care Aurora, CO 100% — 2,874 12,829 15,703 — 2,874 12,829 15,703 (1,477 ) 2009 09/20/12 40 Independence Village at Frankenmuth Frankenmuth, MI 100% — 5,027 20,929 25,956 — 5,027 20,929 25,956 (2,604 ) 1982/2008 09/21/12 40 Gulf Pointe Village Rockport, TX 100% — 789 607 1,396 — 789 607 1,396 (121 ) 1996 11/30/12 40 Aspen Ridge Retirement Village Gaylord, MI 100% — 2,024 5,467 7,491 — 2,024 5,467 7,491 (793 ) 2002 12/14/12 40 Green Acres of Cadillac Cadillac, MI 100% — 217 3,000 3,217 — 217 3,000 3,217 (368 ) 2001/2006 12/14/12 40 Green Acres of Greenville Greenville, MI 100% — 684 5,832 6,516 — 684 5,832 6,516 (712 ) 1999/2001, 2012, 2013 12/14/12 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (1) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Green Acres of Manistee Manistee, MI 100% — 952 2,578 3,530 — 952 2,578 3,530 (348 ) 2002 12/14/12 40 Green Acres of Mason Mason, MI 100% — 198 4,131 4,329 — 198 4,131 4,329 (528 ) 2009/2012 12/14/12 40 Nottingham Place Midland, MI 100% — 744 1,745 2,489 400 744 2,145 2,889 (241 ) 1995/2015 12/14/12 40 Royal View Mecosta, MI 100% — 307 2,477 2,784 — 307 2,477 2,784 (347 ) 2001 12/14/12 40 Tawas Village East Tawas, MI 100% — 258 3,713 3,971 45 258 3,758 4,016 (616 ) 2005 12/14/12 40 Turning Brook Alpena, MI 100% — 546 13,139 13,685 — 546 13,139 13,685 (1,443 ) 2006/2008, 2010 12/14/12 40 Stoney River Marshfield Marshfield, WI 100% — 574 8,733 9,307 — 574 8,733 9,307 (1,003 ) 2010 12/18/12 40 Greenfield of Woodstock Woodstock, VA 100% — 597 5,465 6,062 — 597 5,465 6,062 (557 ) 1996/2015 06/28/13 40 Nye Square Fremont, NE 100% — 504 17,670 18,174 — 504 17,670 18,174 (1,476 ) 1989/2002 02/14/14 40 The Meadows Norfolk, NE 100% — 217 9,906 10,123 — 217 9,906 10,123 (862 ) 1989/1991, 1994 02/14/14 40 Park Place Fort Wayne, IN 100% 13,685 2,300 21,115 23,415 2,747 2,300 23,862 26,162 (1,906 ) 2011/2016 04/30/14 40 Parkview In Allen Allen, TX 100% — 2,190 45,767 47,957 — 2,190 45,767 47,957 (2,912 ) 2004/2010 09/25/14 40 The Atrium At Gainesville Gainesville, FL 100% — 2,139 44,789 46,928 — 2,139 44,789 46,928 (2,999 ) 1986/2013, 2015 09/25/14 40 The Chateau Mckinney, TX 100% — 2,760 44,397 47,157 — 2,760 44,397 47,157 (2,863 ) 2006/2010 09/25/14 40 Gardens At Wakefield Plantation Raleigh, NC 100% — 2,344 37,506 39,850 — 2,344 37,506 39,850 (2,345 ) 2002/2014 09/25/14 40 Las Brisas San Luis Obispo, CA 100% — 4,992 30,909 35,901 — 4,992 30,909 35,901 (2,009 ) 1987/2006, 2015 09/25/14 40 Creekside Terrace Winston-Salem, NC 100% — 2,995 24,428 27,423 — 2,995 24,428 27,423 (1,619 ) 2001 09/25/14 40 Colonial Village Longview, TX 100% — 805 26,498 27,303 — 805 26,498 27,303 (1,731 ) 1985/2010 09/25/14 40 Garden Village Kansas City, MO 100% — 1,325 20,510 21,835 — 1,325 20,510 21,835 (1,412 ) 1983 09/25/14 40 Desert Rose Yuma, AZ 100% — 530 21,775 22,305 — 530 21,775 22,305 (1,438 ) 1996/2014 09/25/14 40 Windland South Nashville, TN 100% — 1,996 19,368 21,364 — 1,996 19,368 21,364 (1,366 ) 1986/2000 09/25/14 40 Cedar Woods Branford, CT 100% — 2,403 18,821 21,224 — 2,403 18,821 21,224 (1,242 ) 1987 09/25/14 40 Virginian Richmond, VA 100% — 1,080 19,545 20,625 — 1,080 19,545 20,625 (1,308 ) 1989/2007 09/25/14 40 Monarch Estates Auburn, AL 100% — 3,209 17,326 20,535 — 3,209 17,326 20,535 (1,191 ) 2001 09/25/14 40 Village At The Falls Menomonee Falls, WI 100% — 1,477 18,778 20,255 — 1,477 18,778 20,255 (1,288 ) 2005/2006, 2007/2011 09/25/14 40 Holiday At The Atrium Glenville, NY 100% — 978 18,257 19,235 — 978 18,257 19,235 (1,221 ) 2001/2014 09/25/14 40 Lake Ridge Village Eustis, FL 100% — 1,152 17,523 18,675 — 1,152 17,523 18,675 (1,197 ) 1984/1988, 2013 09/25/14 40 Heritage Village Mcallen, TX 100% — 4,092 13,823 17,915 — 4,092 13,823 17,915 (979 ) 1988 09/25/14 40 Madison Meadows Phoenix, AZ 100% — 2,567 12,029 14,596 — 2,567 12,029 14,596 (873 ) 1986 09/25/14 40 South Wind Heights Jonesboro, AR 100% — 1,782 11,244 13,026 — 1,782 11,244 13,026 (804 ) 1999 09/25/14 40 Harrison Regent Ogden, UT 100% — 794 10,873 11,667 — 794 10,873 11,667 (748 ) 1985/2016 09/25/14 40 Avalon MC - Boat Club Fort Worth, TX 100% — 359 8,126 8,485 — 359 8,126 8,485 (524 ) 1996/2015 09/29/14 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (1) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Avalon MC - 7200 Arlington, TX 100% — 123 4,914 5,037 — 123 4,914 5,037 (318 ) 1988/2014 09/29/14 40 Avalon MC - 7204 Arlington, TX 100% — 215 4,821 5,036 — 215 4,822 5,037 (314 ) 1988/2014 09/29/14 40 Avalon MC - 7140 Arlington, TX 100% — 143 6,653 6,796 — 143 6,653 6,796 (420 ) 2011 09/29/14 40 Delaney Creek Lodge Brandon, FL 100% — 1,283 8,424 9,707 35 1,283 8,459 9,742 (591 ) 1999/2016 10/01/14 40 Nature Coast Lodge Lecanto, FL 100% — 1,031 5,577 6,608 46 1,031 5,623 6,654 (448 ) 1997/2016 10/01/14 40 West Winds Zephyrhills, FL 100% — 1,688 9,098 10,786 55 1,688 9,153 10,841 (701 ) 2008/2016 10/01/14 40 Capital Place Olympia, WA 100% — 2,477 23,767 26,244 — 2,477 23,767 26,244 (1,554 ) 1986/2016 10/07/14 40 Tudor Heights Baltimore, MD 100% — 561 4,865 5,426 1,139 561 6,004 6,565 (453 ) 1920/1997, 2015 10/14/14 40 New Haven AL Schertz, TX 100% — 1,174 6,298 7,472 — 1,174 6,298 7,472 (340 ) 2012 04/10/15 40 Cherry Park Penticton, BC 100% 5,040 763 6,771 7,534 — 763 6,771 7,534 (321 ) 1990/1991, 2014 06/11/15 40 Orchard Valley Vernon, BC 100% 7,000 843 10,724 11,567 (573 ) 270 10,724 10,994 (480 ) 1990/2008 06/11/15 40 The Shores Kamloops, BC 100% 5,258 679 8,024 8,703 — 679 8,024 8,703 (382 ) 1992/2014 06/11/15 40 Kensington Court Windsor, ON 100% — 1,360 16,855 18,215 — 1,360 16,855 18,215 (771 ) 1998 06/11/15 40 Masonville Manor London, ON 100% — 960 19,056 20,016 — 960 19,056 20,016 (854 ) 1998/2015 06/11/15 40 Okanagan Chateau Kelowna, BC 100% — 2,321 8,308 10,629 — 2,321 8,308 10,629 (415 ) 1990 06/11/15 40 Court at Laurelwood Waterloo, ON 100% — 1,823 22,135 23,958 — 1,823 22,135 23,958 (987 ) 2005/2015 06/11/15 40 Fairwoods Lodge Sarnia, ON 100% — 1,187 20,346 21,533 — 1,187 20,346 21,533 (908 ) 2000 06/11/15 40 Birmingham Lodge Mount Forest, ON 100% — 143 2,402 2,545 — 143 2,402 2,545 (163 ) 1974/1976/1980 06/11/15 40 Life's Journey of Mattoon Mattoon, IL 100% — 812 6,796 7,608 — 812 6,796 7,608 (302 ) 2006/2008 09/01/15 40 Life's Journey of Pana Pana, IL 100% — 154 2,098 2,252 — 154 2,098 2,252 (105 ) 1998/2012 09/01/15 40 Life's Journey of Taylorville Taylorville, IL 100% — 267 5,201 5,468 — 267 5,201 5,468 (232 ) 2012/2014 09/01/15 40 Life's Journey Estates Mattoon, IL 100% — 134 659 793 — 134 659 793 (36 ) 1997 09/01/15 40 Life's Journey of Paris Paris, IL 100% — 132 3,090 3,222 — 132 3,090 3,222 (124 ) 1998/2013 09/01/15 40 Ashley Pointe Lake Stevens, WA 100% — 1,559 9,059 10,618 — 1,559 9,059 10,618 (348 ) 1998/2012 09/17/15 40 Farmington Square Eugene Eugene, OR 100% — 1,428 16,138 17,566 — 1,428 16,138 17,566 (549 ) 1996/1997, 2011 09/17/15 40 Farmington Square Tualatin Tualatin, OR 100% — 527 14,659 15,186 — 527 14,659 15,186 (502 ) 1995/1997 09/17/15 40 Farmington Square of Salem Salem, OR 100% — 1,074 19,421 20,495 — 1,074 19,421 20,495 (687 ) 1989/1995 09/17/15 40 Maison Senior Living Calgary, AB 100% — 3,908 20,996 24,904 — 3,908 20,996 24,904 (678 ) 2013 09/17/15 40 Colorado Springs Colorado Springs, CO 100% — 1,210 9,490 10,700 — 1,210 9,490 10,700 (312 ) 2013 11/16/15 40 Sun City West Sun City West, AZ 100% — 930 9,170 10,100 — 930 9,170 10,100 (135 ) 2012 07/01/16 40 Poet's Walk at Fredericksburg Fredericksburg, VA 100% — 1,379 21,209 22,588 — 1,379 21,209 22,588 (310 ) 2016 07/14/16 40 Poet's Walk at Chandler Oaks Round Rock, TX 100% — 679 13,642 14,321 — 679 13,642 14,321 (170 ) 2016 08/01/16 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (1) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired The Montecito Santa Fe Santa Fe, NM 100% — 2,536 19,441 21,977 — 2,536 19,441 21,977 (145 ) 2006 09/23/16 40 The Golden Crest Franklin, NH 100% — 292 6,889 7,181 — 292 6,889 7,181 (19 ) 1988 11/30/16 40 Poet's Walk at Henderson Henderson, NV 100% — 1,430 21,850 23,280 — 1,430 21,850 23,280 (52 ) 2016 12/01/16 40 Kruse Village Brenham, TX 100% — 476 11,912 12,388 — 476 11,912 12,388 (33 ) 1991 12/02/16 40 48,590 106,519 1,081,415 1,187,934 4,925 105,946 1,082,005 1,187,951 (82,131 ) Acute Care Hospital Texas Regional Medical Center Sunnyvale, TX 100% — 4,020 57,620 61,640 — 4,020 57,620 61,640 (10,387 ) 2009 05/03/11 40 — 4,020 57,620 61,640 — 4,020 57,620 61,640 (10,387 ) Multi-property Indebtedness 12,072 — — — — — — — — 163,638 220,615 2,102,616 2,323,231 7,220 220,042 2,072,303 2,292,345 (282,556 ) Corporate Assets — — 136 136 270 — 406 406 (256 ) $ 163,638 $ 220,615 $ 2,102,752 $ 2,323,367 $ 7,490 $ 220,042 $ 2,072,709 $ 2,292,751 $ (282,812 ) (1) Encumbrances do not include deferred financing costs of $2.9 million as of December 31, 2016 . (2) Building and building improvements include land improvements and furniture and equipment. (3) The aggregate cost of real estate for federal income tax purposes was $2.3 billion . (4) Property serves as collateral for a mortgage loan totaling $12.1 million as of December 31, 2016 . SABRA HEALTH CARE REIT, INC. SCHEDULE III REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION (dollars in thousands) Year Ended December 31, 2016 2015 2014 Real estate: Balance at the beginning of the period $ 2,277,457 $ 1,831,799 $ 1,066,496 Acquisitions 150,782 482,125 792,510 Real estate acquired through loan receivable foreclosure 10,100 — — Addition due to consolidation of variable interest entity — 10,700 — Improvements 1,003 3,689 1,471 Impairment (39,058 ) — — Sale of real estate (107,930 ) (29,395 ) (23,265 ) Foreign currency translation 4,623 (16,944 ) — Write-off of fully depreciated assets (4,226 ) (4,517 ) (5,413 ) Balance at the end of the year $ 2,292,751 $ 2,277,457 $ 1,831,799 Accumulated depreciation: Balance at the beginning of the period $ (237,841 ) $ (185,994 ) $ (151,078 ) Depreciation expense (64,463 ) (59,864 ) (42,021 ) Impairment 9,247 — — Sale of real estate 6,023 3,384 1,692 Foreign currency translation (4 ) 116 — Write-off of fully depreciated assets 4,226 4,517 5,413 Balance at the end of the year $ (282,812 ) $ (237,841 ) $ (185,994 )

SCHEDULE IV MORTGAGE LOANS ON R

SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE	12 Months Ended
	Dec. 31, 2016
Mortgage Loans on Real Estate [Abstract]
SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE	SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE December 31, 2016 (dollars in thousands) Description Contractual Interest Rate Maturity Date Periodic Payment Terms Prior Liens Principal Balance Book Value Principal Amount of Loans Subject to Delinquent Principal or Interest Mortgages: Weston 9.0 % 2016 (1) $ — $ 16,079 $ 16,079 $ 16,079 Ramsey 9.0 2018 (1) — 13,876 13,887 N/A Marshfield II 9.0 2018 (1) — 5,209 5,222 N/A Madeira 10.0 2017 (2) — 3,067 3,074 N/A — 38,231 38,262 Loan Loss Allowance — — (1,620 ) — 38,231 36,642 Construction Mortgages: McKinney 8.0 2021 (3) — 795 842 N/A $ — $ 39,026 $ 37,484 (1) Interest and principal for the first 12 months is deferred and due at the maturity date. Interest after the first 12 months is due monthly. (2) Interest and principal for the first 6 months is deferred and due at the maturity date. Interest after the first 6 months is due monthly. (3) Interest and principal for the first 36 months is deferred and due at the maturity date. Interest after the first 36 months is due monthly. Changes in mortgage loans are summarized as follows: Year Ended December 31, 2016 2015 2014 Balance at the beginning of the period $ 241,038 $ 209,275 $ 162,870 Additions during period: Draws — 8,713 51,217 New mortgage loans 3,767 20,411 4,500 Interest income added to principal 690 2,639 1,781 Deductions during period: Paydowns/Repayments (206,469 ) — (11,093 ) Balance at the end of the year $ 39,026 $ 241,038 $ 209,275

SUMMARY OF SIGNIFICANT ACCOUN30

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries as of December 31, 2016 and 2015 and for the years ended December 31, 2016 , 2015 and 2014 . All material intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Principles of Consolidation, Variable Interest Entity	GAAP requires the Company to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity's equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary. The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. As of December 31, 2016 , the Company determined it was the primary beneficiary of two variable interest entities–a senior housing facility and an exchange accommodation titleholder variable interest entity–and has consolidated the operations of these entities in the accompanying consolidated financial statements. As of December 31, 2016 , the Company determined that operations of the entities were not material to the Company’s results of operations, financial condition or cash flows. As it relates to investments in loans, in addition to the Company's assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine if the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower's expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2016 and 2015 , none of the Company's investments in loans are accounted for as real estate joint ventures. As it relates to investments in joint ventures, based on the type of rights held by the limited partner(s), GAAP may preclude consolidation by the sole general partner in certain circumstances in which the general partner would otherwise consolidate the joint venture. The Company assesses limited partners' rights and their impact on the presumption of control of the limited partnership by the sole general partner when an investor becomes the sole general partner, and the Company reassesses if: there is a change to the terms or in the exercisability of the rights of the limited partners; the sole general partner increases or decreases its ownership of limited partnership interests; or there is an increase or decrease in the number of outstanding limited partnership interests. The Company also applies this guidance to managing member interests in limited liability companies.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
Reclassifications	Reclassifications Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods. As a result, certain reclassifications were made to the consolidated balance sheets and consolidated statements of income. As of December 31, 2015, there was $17.3 million of deferred financing costs related to the Company's mortgage notes, term loans and senior unsecured notes that was previously reported within “prepaid expenses, deferred financing costs and other assets, net” that was reclassified in accordance with Accounting Standards Update ("ASU") 2015-03 to their respective debt liability financial statement line items on the Company’s consolidated balance sheets.
Real Estate Investments	Real Estate Acquisition Valuation All assets acquired and liabilities assumed in an acquisition of real estate are measured at their acquisition date fair values. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of tenant relationship and origination and absorption intangible assets are included in prepaid expenses, deferred financing costs and other assets in the accompanying consolidated balance sheets. Acquisition pursuit costs associated with business combinations are expensed as incurred and costs associated with asset acquisitions are capitalized. On October 1, 2016, the Company early adopted ASU 2017-01, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as businesses acquisitions. (See “Recently Issued Accounting Standards Update” below for further information). As a result of early adopting ASU 2017-01, real estate acquisitions completed subsequent to October 1, 2016 did not meet the definition of a business combination and were deemed asset acquisitions, and the Company capitalized $0.3 million of acquisition pursuit costs associated with these acquisitions. Real estate acquisitions completed prior to October 1, 2016 were deemed business combinations and the related acquisition pursuit costs were expensed as incurred. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the years ended December 31, 2016 , 2015 and 2014 , the Company acquired seven , 24 , and 42 real estate properties, respectively, and expensed $1.2 million , $7.0 million and $3.1 million of acquisition pursuit costs, respectively, which is included in general and administrative expense on the accompanying consolidated statements of income. Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the evaluation of the specific characteristics of each tenant's lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income. Depreciation and Amortization Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of lease intangibles are included in depreciation and amortization in the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, 3 to 40 years; buildings and building improvements, 3 to 40 years; and furniture and equipment, 1 to 20 years. Impairment of Real Estate Investments The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through its undiscounted future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential future cash flows. In these instances, the undiscounted future cash flows used to assess recoverability are probability-weighted based on the Company's best estimates as of the date of evaluation. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments.
Real Estate Investments, Inventory	Real Estate Acquisition Valuation All assets acquired and liabilities assumed in an acquisition of real estate are measured at their acquisition date fair values. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of tenant relationship and origination and absorption intangible assets are included in prepaid expenses, deferred financing costs and other assets in the accompanying consolidated balance sheets. Acquisition pursuit costs associated with business combinations are expensed as incurred and costs associated with asset acquisitions are capitalized. On October 1, 2016, the Company early adopted ASU 2017-01, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as businesses acquisitions. (See “Recently Issued Accounting Standards Update” below for further information). As a result of early adopting ASU 2017-01, real estate acquisitions completed subsequent to October 1, 2016 did not meet the definition of a business combination and were deemed asset acquisitions, and the Company capitalized $0.3 million of acquisition pursuit costs associated with these acquisitions. Real estate acquisitions completed prior to October 1, 2016 were deemed business combinations and the related acquisition pursuit costs were expensed as incurred. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the years ended December 31, 2016 , 2015 and 2014 , the Company acquired seven , 24 , and 42 real estate properties, respectively, and expensed $1.2 million , $7.0 million and $3.1 million of acquisition pursuit costs, respectively, which is included in general and administrative expense on the accompanying consolidated statements of income. Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the evaluation of the specific characteristics of each tenant's lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income. Depreciation and Amortization Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of lease intangibles are included in depreciation and amortization in the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, 3 to 40 years; buildings and building improvements, 3 to 40 years; and furniture and equipment, 1 to 20 years. Impairment of Real Estate Investments The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through its undiscounted future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential future cash flows. In these instances, the undiscounted future cash flows used to assess recoverability are probability-weighted based on the Company's best estimates as of the date of evaluation. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments.
Rental Revenue Recognition	Rental Revenue Recognition The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when collectability is reasonably assured. The Company makes estimates of the collectability of its tenant receivables related to base rents, straight-line rent and other revenues. When the Company analyzes accounts receivable and evaluates the adequacy of the allowance for doubtful accounts, it considers such things as historical bad debts, tenant creditworthiness, current economic trends, facility operating performance, lease structure, credit enhancements (including guarantees), current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. Specifically for straight-line rent receivables, the Company's assessment includes an estimation of a tenant's ability to fulfill its rental obligations over the remaining lease term. In addition, with respect to tenants in bankruptcy, management makes estimates of the expected recovery of pre-petition and post-petition claims in assessing the estimated collectability of the related receivable. When a tenant is in bankruptcy, the Company records a provision for doubtful accounts for management’s estimate of the tenant’s receivable balance that is uncollectible and generally will not recognize subsequent rental revenue until cash is received or until the tenant is no longer in bankruptcy and has the ability to make rental payments. The Company's collectability estimates for straight-line rent receivables include an assessment at the individual or master lease level as well as at an overall portfolio level.
Assets Held for Sale and Discontinued Operations	Assets Held for Sale and Discontinued Operations The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as “assets held for sale” for all periods presented in the accompanying consolidated financial statements. Mortgage notes payable and other liabilities related to real estate held for sale are classified as “liabilities related to assets held for sale” for all periods presented in the accompanying consolidated financial statements. Real estate classified as held for sale is no longer depreciated and is reported at the lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2016 and 2015, the Company did no t have any assets held for sale. Additionally, the Company records the operating results related to real estate that has been disposed of or classified as held for sale as discontinued operations for all periods presented if it represents a strategic shift that has or will have a major effect on the Company’s operations and financial results.
Loans Receivable and Interest Income	Loans Receivable and Interest Income Loans Receivable The Company’s loans receivable are recorded at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a loan receivable is the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan. On a quarterly basis the Company evaluates the collectability of its loan portfolio, including related interest income receivable, and establishes a reserve for loan losses. The Company's evaluation includes reviewing credit quality indicators such as payment status, changes affecting the underlying real estate collateral (for collateral dependent loans), changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The reserve for loan losses is a valuation allowance that reflects management’s estimate of loan losses inherent in the loan portfolio as of the balance sheet date. The reserve is adjusted through “Provision for doubtful accounts and loan losses” on the Company's consolidated statements of income and is decreased by charge-offs to specific loans when losses are confirmed. The reserve for loan losses includes an asset-specific component and a portfolio-based component. An asset-specific reserve relates to reserves for losses on loans considered impaired and interest income receivable that is deemed uncollectible. The Company considers a loan to be impaired when, based upon current information and events, management believes that it is probable that the Company will be unable to collect all amounts due under the contractual terms of the loan agreement resulting from the borrower’s failure to repay contractual amounts due, the granting of a concession by the Company or the expectation that the Company will receive assets with fair values less than the carrying value of the loan in satisfaction of the loan. If a loan is considered to be impaired, a reserve is established when the carrying value of that loan is greater than the present value of payments expected to be received, the observable market prices for similar instruments, the estimated fair value of the collateral (for loans that are dependent on the collateral for repayment) or other amounts expected to be received in satisfaction of the loan. A portfolio-based reserve covers the pool of loans that do not have asset-specific reserves. A provision for loan losses is recorded when available information as of each balance sheet date indicates that it is probable that a loss occurred in the pool of loans and the amount of the loss can be reasonably estimated, but the Company does not know which specific loans within the pool will ultimately result in losses. The required reserve balances for this pool of loans is derived based on estimated probabilities of default and estimated loss severities assuming a default occurs. Interest Income Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan or through the receipts of assets in satisfaction of contractual amounts due is probable, the Company will resume the accrual of interest. In instances where borrowers are in default under the terms of their loans, the Company may continue recognizing interest income provided that all amounts owed under the contractual terms of the loan, including accrued and unpaid interest, do not exceed the estimated fair value of the collateral, less costs to sell.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value. The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2016 . To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits the majority of all funds.
Restricted Cash	Restricted Cash Restricted cash primarily consists of amounts held by mortgage lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts to the tenants and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.
Stock-Based Compensation	Stock-Based Compensation Stock-based compensation expense for stock-based awards granted to Sabra’s employees and its non-employee directors are recognized in the statements of income based on their estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the employee providing additional services. Compensation expense for awards with performance-based vesting conditions is recognized based on the Company's estimate of the ultimate value of such award after considering the Company's expectations of future performance.
Deferred Financing Costs	Deferred Financing Costs Deferred financing costs representing fees paid to third parties to obtain financing are amortized over the terms of the respective financing agreements using the interest method. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close.
Income Taxes	Income Taxes The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT. As a result of certain acquisitions, the Company now records income tax expense or benefit with respect to certain of its entities that are taxed as taxable REIT subsidiaries under provisions similar to those applicable to regular corporations and not under the REIT provisions. The Company accounts for deferred income taxes using the asset and liability method and recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the Company's financial statements or tax returns. Under this method, the Company determines deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes a change in the Company's judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if the Company believes it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes a change in the Company's judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. The Company evaluates its tax positions using a two step approach: step one (recognition) occurs when a company concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination and step two (measurement) is only addressed if step one has been satisfied (i.e., the position is more likely than not to be sustained). Under step two, the tax benefit is measured as the largest amount of benefit (determined on a cumulative probability basis) that is more likely than not to be realized upon ultimate settlement. The Company will recognize tax penalties relating to unrecognized tax benefits as additional tax expense.
Foreign Currency	Foreign Currency Certain of the Company's subsidiaries’ functional currencies are the local currencies of their respective foreign jurisdictions. The Company translates the results of operations of its foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period presented, and it translates balance sheet accounts using exchange rates in effect at the end of the period presented. The Company records resulting currency translation adjustments in accumulated other comprehensive income, a component of stockholders’ equity, on its consolidated balance sheets, and it records foreign currency transaction gains and losses as a component of interest and other income on its consolidated statements of income.
Derivative Instruments	Derivative Instruments The Company uses certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception the Company must make an assessment that the transaction that the Company intends to hedge is probable of occurring and this assessment must be updated each reporting period. The Company recognizes all derivative instruments as assets or liabilities in the consolidated balance sheets at their fair value. For derivatives designated and qualified as a hedge, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive income (loss), whereas the change in fair value of the ineffective portion is recognized in earnings. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria for hedge accounting would be recognized in earnings. As of December 31, 2016 , all of the Company's derivative instruments met the criteria for hedge accounting. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific transactions as well as recognizing obligations or assets in the consolidated balance sheets. The Company also assesses and documents, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying transaction will not occur, the Company would discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the then-current fair value of the derivative.
Fair Value Measurements	Fair Value Measurements Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired real estate loans receivable and long-lived assets). Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories: • Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities; • Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable. When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items in Level 1 or Level 2. In instances where the market for a financial instrument is not active, regardless of the availability of a nonbinding quoted market price, observable inputs might not be relevant and could require the Company to make a significant adjustment to derive a fair value measurement. Additionally, in an inactive market, a market price quoted from an independent third party may rely more on models with inputs based on information available only to that independent third party. When the Company determines the market for a financial instrument owned by the Company to be illiquid or when market transactions for similar instruments do not appear orderly, the Company may use several valuation sources (including internal valuations, discounted cash flow analysis and quoted market prices) to establish a fair value. If more than one valuation source is used, the Company will assign weights to the various valuation sources. Additionally, when determining the fair value of liabilities in circumstances in which a quoted price in an active market for an identical liability is not available, the Company measures fair value using (i) a valuation technique that uses the quoted price of the identical liability when traded as an asset or quoted prices for similar liabilities or similar liabilities when traded as assets or (ii) another valuation technique that is consistent with the principles of fair value measurement, such as the income approach or the market approach. Changes in assumptions or estimation methodologies can have a material effect on these estimated fair values. In this regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, may not be realized in an immediate settlement of the instrument. The Company considers the following factors to be indicators of an inactive market: (i) there are few recent transactions, (ii) price quotations are not based on current information, (iii) price quotations vary substantially either over time or among market makers (for example, some brokered markets), (iv) indexes that previously were highly correlated with the fair values of the asset or liability are demonstrably uncorrelated with recent indications of fair value for that asset or liability, (v) there is a significant increase in implied liquidity risk premiums, yields, or performance indicators (such as delinquency rates or loss severities) for observed transactions or quoted prices when compared with the Company’s estimate of expected cash flows, considering all available market data about credit and other nonperformance risk for the asset or liability, (vi) there is a wide bid-ask spread or significant increase in the bid-ask spread, (vii) there is a significant decline or absence of a market for new issuances (that is, a primary market) for the asset or liability or similar assets or liabilities, and (viii) little information is released publicly (for example, a principal-to-principal market). The Company considers the following factors to be indicators of non-orderly transactions: (i) there was not adequate exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities under current market conditions, (ii) there was a usual and customary marketing period, but the seller marketed the asset or liability to a single market participant, (iii) the seller is in or near bankruptcy or receivership (that is, distressed), or the seller was required to sell to meet regulatory or legal requirements (that is, forced), and (iv) the transaction price is an outlier when compared with other recent transactions for the same or similar assets or liabilities. The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments. Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable, accrued liabilities, the Credit Facility are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows: Loans receivable: These instruments are presented in the accompanying consolidated balance sheets at their amortized cost and not at fair value. The fair value of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, the underlying collateral value and other credit enhancements. As such, the Company classifies these instruments as Level 3. Preferred equity investments: These instruments are presented in the accompanying consolidated balance sheets at their cost and not at fair value. The fair value of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investment, the underlying collateral value and other credit enhancements. As such, the Company classifies these instruments as Level 3. Derivative instruments: The Company’s derivative instruments are presented at fair value on the accompanying consolidated balance sheets. The Company estimates the fair value of derivative instruments, including its interest rate cap, interest rate swap and cross currency swaps, using the assistance of a third party using inputs that are observable in the market, which includes forward yield curves and other relevant information. Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivative financial instruments utilize level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by itself and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company has determined that its derivative financial instruments valuations in their entirety are classified in level 2 of the fair value hierarchy. Senior Notes: These instruments are presented in the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums (discounts) and not at fair value. The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades. As such, the Company classifies these instruments as Level 2. Mortgage indebtedness: These instruments are presented in the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums (discounts) and not at fair value. The fair values of the Company’s mortgage notes payable were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements. As such, the Company classifies these instruments as Level 3.
Per Share Data	Per Share Data Basic earnings per common share is computed by dividing net income applicable to common stockholders by the weighted average number of shares of common stock and common equivalents outstanding during the period. Diluted earnings per common share is calculated by including the effect of dilutive securities.
Industry Segments	ndustry Segments The Company has one reportable segment consisting of investments in healthcare-related real estate properties.
Recently Issued Accounting Standards Update	Recently Issued Accounting Standards Update In January 2016, the FASB issued ASU 2016-01, Financial Instruments–Overall (Subtopic 825-10) (“ASU 2016-01”). ASU 2016-01 updates guidance related to recognition and measurement of financial assets and financial liabilities. ASU 2016-01 requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under equity method of accounting or those that result in consolidation of the investee). The amendments in ASU 2016-01 also require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. In addition, the amendments in ASU 2016-01 eliminate the requirement to disclose the methods and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet for public business entities. ASU 2016-01 is effective for fiscal years and interim periods within those years beginning after December 15, 2017, with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements when adopted. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 supersedes guidance related to accounting for leases. ASU 2016-02 updates guidance around the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. The objective of ASU 2016-02 is to establish the principles that lessees and lessors shall apply to report useful information to users of financial statements about the amount, timing, and uncertainty of cash flows arising from a lease. ASU 2016-02 does not fundamentally change lessor accounting, however, some changes have been made to lessor accounting to conform and align that guidance with the lessee guidance and other areas within GAAP. ASU 2016-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2018, with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements when adopted. In March 2016, the FASB issued ASU 2016-07, Equity Method and Joint Ventures (Topic 323) (“ASU 2016-07”). ASU 2016-07 simplifies the accounting for equity method investments. ASU 2016-07 eliminates the requirement in Topic 323 that an entity retroactively adopt the equity method of accounting if an investment qualifies for use of the equity method as a result of an increase in the level of ownership or degree of influence. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor’s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. The Company adopted ASU 2016-07 on January 1, 2017. The Company does not expect the adoption of this ASU to have a significant impact on its consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”). ASU 2016-09 simplifies several aspects of the accounting for employee share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. In addition, the amendments in ASU 2016-09 eliminate the guidance in Topic 718 that was indefinitely deferred shortly after the issuance of FASB Statement No. 123 (revised 2004), Share-Based Payment. The Company adopted ASU 2016-09 on January 1, 2017. The Company does not expect the adoption of this ASU to have a significant impact on its consolidated financial statements. Between May 2014 and May 2016, the FASB issued three ASUs changing the requirements for recognizing and reporting revenue (together, herein referred to as the “Revenue ASUs”): (i) ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), (ii) ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”) and (iii) ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients (“ASU 2016-12”). ASU 2014-09 provides guidance for revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2016-08 is intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. ASU 2016-12 provides practical expedients and improvements on the previously narrow scope of ASU 2014-09. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date (“ASU 2015-14”). ASU 2015-14 defers the effective date of ASU 2014-09 by one year to fiscal years, and interim periods within, beginning after December 15, 2017. All subsequent ASUs related to ASU 2014-09, including ASU 2016-08 and ASU 2016-12, assumed the deferred effective date enforced by ASU 2015-14. Early adoption of the Revenue ASUs is permitted for annual periods, and interim periods within, beginning after December 15, 2016. A reporting entity may apply the amendments in the Revenue ASUs using either a modified retrospective approach, by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or full retrospective approach. The Company is evaluating the complete impact of the adoption of the Revenue ASUs on January 1, 2018 to its consolidated financial position and results of operations. As the primary source of revenue for the Company is generated through leasing arrangements, which are excluded from the Revenue ASUs, the Company expects that the impact of the Revenue ASUs to the Company will be limited to the recognition of non-lease revenue, such as certain resident fees in its Managed Properties structures (a portion of which are not generated through leasing arrangements) and therefore are not expected to have a material impact on its consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires that a financial asset (or a group of financial assets) measured at amortized cost basis be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The amendments in ASU 2016-13 are an improvement because they eliminate the probable initial recognition threshold in current GAAP and, instead, reflect an entity’s current estimate of all expected credit losses. Previously, when credit losses were measured under GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. ASU 2016-13 is effective for fiscal years and interim periods within those years beginning after December 15, 2019, with early adoption permitted as of the fiscal years beginning after December 15, 2018. An entity will apply the amendments in this update through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). The Company is currently evaluating the impact this guidance will have on its consolidated financial statements when adopted. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). ASU 2016-15 provides specific guidance on the following eight specific cash flow classification issues: debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (including bank-owned life insurance policies); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. ASU 2016-15 will reduce the current and potential future diversity in practice of cash flow classifications. ASU 2016-15 is effective for fiscal years and interim periods within those years beginning after December 15, 2017, with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements when adopted. In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”). ASU 2016-18 requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in ASU 2016-18 apply to all entities that have restricted cash or restricted cash equivalents and are required to present a statement of cash flows under Topic 230. ASU 2016-18 is effective for fiscal years and interim periods within those years beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of ASU 2016-18 to have a material impact to its consolidated statements of cash flows as the Company does not have material restricted cash activity. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the definition of a business (“ASU 2017-01”). ASU 2017-01 clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of businesses. When substantially all of the fair value of gross assets acquired is concentrated in a single asset (or a group of similar assets), the assets acquired would not represent a business. To be considered a business, an acquisition would have to include an input and a substantive process that together significantly contribute to the ability to create outputs. To be a business without outputs, there will now need to be an organized workforce. ASU 2017-01 is effective for fiscal years and interim periods within those years beginning after December 15, 2017, with early adoption permitted. The Company adopted ASU 2017-01 on October 1, 2016 on a prospective basis. The Company expects that the majority of its future acquisitions of real estate will be accounted for as asset acquisitions under the new guidance. This adoption will impact how the Company accounts for acquisition pursuit costs and contingent consideration which may result in lower expensed acquisition pursuit costs and eliminate fair value adjustments related to future contingent consideration arrangements.

RECENT REAL ESTATE ACQUISITIO31

RECENT REAL ESTATE ACQUISITIONS (Tables)	12 Months Ended
	Dec. 31, 2016
Business Combinations [Abstract]
Schedule of Purchase Price Allocation	The consideration was allocated as follows (in thousands): Year Ended December 31, 2016 2015 Land $ 7,755 $ 32,336 Building and Improvements 143,027 449,789 Tenant Origination and Absorption Costs 2,202 7,556 Tenant Relationship 642 2,106 Total Consideration $ 153,626 $ 491,787

REAL ESTATE PROPERTIES HELD F32

REAL ESTATE PROPERTIES HELD FOR INVESTMENT (Tables)	12 Months Ended
	Dec. 31, 2016
Real Estate Investments, Net [Abstract]
Schedule of Real Estate Properties Held for Investment	The Company’s real estate properties held for investment consisted of the following (dollars in thousands): As of December 31, 2016 Property Type Number of Properties Number of Beds/Units Total Real Estate at Cost Accumulated Depreciation Total Real Estate Investments, Net Skilled Nursing/Transitional Care 97 10,819 $ 1,042,754 $ (190,038 ) $ 852,716 Senior Housing 85 7,989 1,187,951 (82,131 ) 1,105,820 Acute Care Hospital 1 70 61,640 (10,387 ) 51,253 183 18,878 2,292,345 (282,556 ) 2,009,789 Corporate Level 406 (256 ) 150 $ 2,292,751 $ (282,812 ) $ 2,009,939 As of December 31, 2015 Property Type Number of Properties Number of Beds/Units Total Real Estate at Cost Accumulated Depreciation Total Real Estate Investments, Net Skilled Nursing/Transitional Care 100 11,012 $ 1,029,291 $ (167,968 ) $ 861,323 Senior Housing 78 7,213 1,072,060 (52,494 ) 1,019,566 Acute Care Hospitals 2 124 175,807 (17,127 ) 158,680 180 18,349 2,277,158 (237,589 ) 2,039,569 Corporate Level 299 (252 ) 47 $ 2,277,457 $ (237,841 ) $ 2,039,616 December 31, 2016 December 31, 2015 Building and improvements $ 1,983,769 $ 1,954,129 Furniture and equipment 85,196 97,840 Land improvements 3,744 3,594 Land 220,042 221,894 2,292,751 2,277,457 Accumulated depreciation (282,812 ) (237,841 ) $ 2,009,939 $ 2,039,616
Schedule of Future Minimum Rental Payments from Non-cancelable Operating Leases	As of December 31, 2016 , the future minimum rental payments from the Company’s properties under non-cancelable operating leases was as follows (in thousands): 2017 $ 214,701 2018 220,677 2019 227,049 2020 233,275 2021 203,442 Thereafter 1,145,204 $ 2,244,348

TENANT ORIGINATION AND ABSORP33

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP ASSETS (Tables)	12 Months Ended
	Dec. 31, 2016
TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP [Abstract]
Schedule of Tenant Origination and Absorption Costs and Tenant Relationship Assets	As of December 31, 2016 and 2015 , the Company’s tenant origination and absorption costs and tenant relationship assets were as follows (in thousands): Tenant Origination and Absorption Costs Tenant Relationship December 31, 2016 2015 2016 2015 Cost $ 23,987 $ 24,492 $ 7,430 $ 7,269 Accumulated amortization (4,432 ) (4,215 ) (735 ) (679 ) Net amount $ 19,555 $ 20,277 $ 6,695 $ 6,590
Schedule of Decrease in Net Income as a Result of Amortization	Decreases in net income as a result of amortization of the Company’s tenant origination and absorption costs and tenant relationship assets for the years ended December 31, 2016 , 2015 and 2014 are as follows (in thousands): Tenant Origination and Absorption Costs Tenant Relationship For the Year Ended December 31, 2016 2015 2014 2016 2015 2014 Amortization $ (2,705 ) $ (2,729 ) $ (1,109 ) $ (477 ) $ (466 ) $ (192 )
Schedule of Unamortized Balance for Outstanding Intangible Assets and Liabilities	The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2016 will be amortized for the years ending December 31 as follows (dollars in thousands): Tenant Origination and Absorption Costs Tenant Relationship 2017 $ 1,868 $ 326 2018 1,868 326 2019 1,868 326 2020 1,868 326 2021 1,868 326 Thereafter 10,215 5,065 $ 19,555 $ 6,695 Weighted-Average Remaining Amortization Period 13.4 years 23.1 years

LOANS RECEIVABLE AND OTHER IN34

LOANS RECEIVABLE AND OTHER INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2016
REAL ESTATE LOANS RECEIVABLE [Abstract]
Schedule of Loans Receivable and Other Investments	As of December 31, 2016 and 2015 , the Company’s loans receivable and other investments consisted of the following (dollars in thousands): December 31, 2016 Investment Quantity as of December 31, 2016 Facility Type Principal Balance as of December 31, 2016 (1) Book Value as of December 31, 2016 Book Value as of December 31, 2015 Weighted Average Contractual Interest Rate / Rate of Return Weighted Average Annualized Effective Interest Rate / Rate of Return Maturity Date as of December 31, 2016 Loans Receivable: Mortgage 4 Skilled Nursing / Senior Housing $ 38,231 $ 38,262 $ 166,277 9.1 % 8.9 % 11/07/16 - 04/30/18 Construction 1 Senior Housing 795 842 75,201 8.0 % 7.7 % 03/31/21 Mezzanine 1 Senior Housing 9,640 9,656 15,613 11.0 % 10.8 % 08/31/17 Pre-development 3 Senior Housing 4,005 4,023 3,768 9.0 % 7.7 % 01/28/17 - 09/09/17 Debtor-in-possession 1 Acute Care Hospital 813 813 13,625 5.0 % 5.0 % N/A 10 53,484 53,596 274,484 9.3 % 9.1 % Loan loss reserve — (2,750 ) (4,300 ) 53,484 50,846 270,184 Other Investments: Preferred Equity 12 Skilled Nursing/Senior Housing 44,882 45,190 29,993 12.9 % 12.9 % N/A Total 22 $ 98,366 $ 96,036 $ 300,177 10.9 % 10.8 %

DEBT (Tables)

DEBT (Tables)	12 Months Ended
	Dec. 31, 2016
Debt Instrument [Line Items]
Schedule of Maturities of Debt	The following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2016 (in thousands): Mortgage Indebtedness Revolving Credit Facility (1) Terms Loans Senior Notes Total 2017 $ 4,128 $ — $ — $ — $ 4,128 2018 4,265 — — — 4,265 2019 4,408 — — — 4,408 2020 4,555 26,000 — — 30,555 2021 19,402 — 338,000 500,000 857,402 Thereafter 126,880 — — 200,000 326,880 Total Principal Balance 163,638 26,000 338,000 700,000 1,227,638 Discount — — — (515 ) (515 ) Deferred Financing Costs (2,886 ) — (2,327 ) (11,239 ) (16,452 ) Total Debt, net 160,752 26,000 335,673 688,246 1,210,671 (1) Revolving Credit Facility is subject to two six -month extension options
Mortgages [Member]
Debt Instrument [Line Items]
Schedule of Long Term Debt	The Company’s mortgage notes payable consist of the following (dollars in thousands): Interest Rate Type Book Value as of (1) Book Value as of (1) Weighted Average Effective Interest Rate at (2) Maturity Date Fixed Rate $ 163,638 $ 177,850 3.87 % December 2021 - (1) Principal balance does not include deferred financing costs of $2.9 million and $3.0 million as of December 31, 2016 and 2015 , respectively. (2) Weighted average effective interest rate includes private mortgage insurance.
Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Schedule of Long Term Debt	The Company’s senior unsecured notes consist of the following (dollars in thousands): Principal Balance as of Title Maturity Date December 31, 2016 (1) December 31, 2015 (1) 5.5% senior unsecured notes due 2021 (“2021 Notes”) February 1, 2021 $ 500,000 $ 500,000 5.375% senior unsecured notes due 2023 (“2023 Notes”) June 1, 2023 200,000 200,000 $ 700,000 $ 700,000 (1) Principal balance does not include discount of $0.5 million and $0.6 million as of December 31, 2016 and 2015 , respectively

DERIVATIVE AND HEDGING INSTRU36

DERIVATIVE AND HEDGING INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The following presents the notional amount of derivatives instruments as of the dates indicated (in thousands): December 31, 2016 December 31, 2015 Derivatives designated as cash flow hedges: Denominated in U.S. Dollars $ 245,000 $ 200,000 Denominated in Canadian Dollars $ 125,000 $ 90,000 Derivatives designated as net investment hedges: Denominated in Canadian Dollars $ 56,300 $ 56,300 Financial instrument designated as net investment hedge: Denominated in Canadian Dollars $ 125,000 $ 90,000
Summary of Derivative and Financial Instruments Designated as Hedging Instruments	The following is a summary of the derivative and financial instruments designated as hedging instruments held by the Company at December 31, 2016 and 2015 (in thousands): Fair Value Maturity Dates December 31, Type Designation Count 2016 2015 Balance Sheet Location Assets: Interest rate cap Cash Flow — $ — $ 1,695 2019 Prepaid expenses, deferred financing costs and other assets, net Interest rate swap Cash Flow 3 8,083 — 2021 Prepaid expenses, deferred financing costs and other assets, net Cross currency interest rate swaps Net Investment 2 3,157 5,392 2025 Prepaid expenses, deferred financing costs and other assets, net $ 11,240 $ 7,087 Liabilities: Interest rate swap Cash Flow 1 $ 716 $ 1,468 2020 - 2021 Accounts payable and accrued liabilities CAD Term Loan Net Investment 1 93,000 64,890 2020 Term loans, net $ 93,716 $ 66,358
Schedule of Hedging Instruments on the Condensed Consolidated Statements of Income and Condensed Consolidated Statements of Equity	The following presents the effect of the Company’s hedging instruments on the consolidated statements of income and the consolidated statements of equity for years ended December 31, 2016 , 2015 and 2014 : Gain (Loss) Recognized in Other Comprehensive Income (Effective Portion) Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income (Effective Portion) Income Statement Location For the year ended December 31, 2016 2015 2014 2016 2015 2014 Cash Flow Hedges: Interest Rate Products $ 5,879 $ (4,764 ) $ (1,542 ) $ (1,360 ) $ (319 ) $ — Interest Expense Net Investment Hedges: Foreign Currency Products (2,085 ) 5,476 — — — — N/A CAD Term Loan (3,750 ) (8,352 ) — — — — N/A $ 44 $ (7,640 ) $ (1,542 ) $ (1,360 ) $ (319 ) $ —
Schedule of the Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives, Assets	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2016 and 2015 : As of December 31, 2016 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 11,240 $ — $ 11,240 $ (716 ) $ — $ 10,524 Offsetting Liabilities: Derivatives $ 716 $ — $ 716 $ (716 ) $ — $ — As of December 31, 2015 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 7,087 $ — $ 7,087 $ (1,468 ) $ — $ 5,619 Offsetting Liabilities: Derivatives $ 1,468 $ — $ 1,468 $ (1,468 ) $ — $ —
Schedule of the Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives, Liabilities	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2016 and 2015 : As of December 31, 2016 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 11,240 $ — $ 11,240 $ (716 ) $ — $ 10,524 Offsetting Liabilities: Derivatives $ 716 $ — $ 716 $ (716 ) $ — $ — As of December 31, 2015 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 7,087 $ — $ 7,087 $ (1,468 ) $ — $ 5,619 Offsetting Liabilities: Derivatives $ 1,468 $ — $ 1,468 $ (1,468 ) $ — $ —

FAIR VALUE DISCLOSURES (Tables)

FAIR VALUE DISCLOSURES (Tables)	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Summary of Face Values, Carrying Amounts and Fair Values of Financial Instruments	The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2016 and 2015 whose carrying amounts do not approximate their fair value (in thousands): December 31, 2016 December 31, 2015 Carrying Amount (1) Face Value (2) Fair Value Carrying (1) Face Value (2) Fair Value Financial assets: Loans receivable $ 53,596 $ 53,484 $ 51,914 $ 270,184 $ 273,811 $ 274,628 Preferred equity investments 45,190 44,882 48,332 29,993 29,643 30,838 Financial liabilities: Senior Notes 688,246 700,000 709,500 685,704 700,000 718,500 Mortgage indebtedness 160,752 163,638 150,091 174,846 177,850 165,296 (1) Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts). (2) Face value represents amounts contractually due under the terms of the respective agreements.
Schedule of Inputs used for Carrying Amounts which do not Approximate Fair Value with Valuation Methods	The Company determined the fair value of financial instruments as of December 31, 2016 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands): Fair Value Measurements Using Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Total (Level 1) (Level 2) (Level 3) Financial assets: Loans receivable $ 51,914 $ — $ — $ 51,914 Preferred equity investments 48,332 — — 48,332 Financial liabilities: Senior Notes 709,500 — 709,500 — Mortgage indebtedness 150,091 — — 150,091
Schedule of Amounts Measured at Fair Value	During the year ended December 31, 2016 , the Company recorded the following amounts measured at fair value (in thousands): Fair Value Measurements Using Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Total (Level 1) (Level 2) (Level 3) Recurring Basis: Financial assets: Interest rate swap $ 8,083 $ — $ 8,083 $ — Cross currency swap 3,157 — 3,157 — Financial liabilities: Contingent consideration liability 818 — — 818 Interest rate swap 716 — 716 —
Schedule of Reconciliation for Contingent Consideration Liability/Asset Recorded at Fair Value using Level 3 Inputs	The following reconciliation provides the details of activity for contingent consideration liability recorded at fair value using Level 3 inputs (in thousands): Balance as of December 31, 2014 $ 3,900 Decrease in contingent liability (1,200 ) Balance as of December 31, 2015 $ 2,700 Decrease in contingent liability (1,876 ) Foreign currency translation (6 ) Balance as of December 31, 2016 $ 818
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	The following reconciliation provides the details of activity for contingent consideration asset recorded at fair value using Level 3 inputs (in thousands): Balance as of December 31, 2014 $ — Increase in contingent asset 350 Balance as of December 31, 2015 $ 350 Decrease in contingent asset (350 ) Balance as of December 31, 2016 —

EQUITY (Tables)

EQUITY (Tables)	12 Months Ended
	Dec. 31, 2016
Equity [Abstract]
Schedule of Other Common Stock Issuances	The following is a summary of the Company’s other common stock issuances during the years ended December 31, 2016 and 2015 : Year Ended December 31, 2016 2015 Vesting of common stock units 103,279 235,334
Summary of Accumulated Other Comprehensive Loss	The following is a summary of the Company’s accumulated other comprehensive loss (in thousands): Year Ended December 31, 2016 2015 Foreign currency translation $ (3,067 ) $ (1,433 ) Unrealized gains (losses) on cash flow hedges 1,269 (5,900 ) Total accumulated other comprehensive loss $ (1,798 ) $ (7,333 )

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2016
STOCK-BASED COMPENSATION [Abstract]
Summary of Additional Information Concerning Restricted Stock Units	The following table summarizes additional information concerning restricted stock units at December 31, 2016 : Restricted Stock Units Weighted Average Grant Date Fair Value Per Unit Unvested as of December 31, 2015 732,756 $ 21.37 Granted 393,532 22.05 Vested (214,671 ) 22.01 Dividends reinvested 73,888 22.07 Cancelled/Forfeited (81,538 ) 21.13 Unvested as of December 31, 2016 903,967 $ 21.58
Summary of Assumptions used in Total Stockholder Return-Based Stock Units Valuation	2016 2015 2014 Risk Free Interest Rate 0.78% - 1.60% 0.87% - 1.31% 1.07% - 1.09% Expected Stock Price Volatility 27.40% - 28.42% 23.55% - 27.02% 24.14% - 24.22% Expected Service Period 2.3 - 3.0 years 2.5 - 3.0 years 3.0 years Expected Dividend Yield (assuming full reinvestment) — % — % — %

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Schedule of Reconciliation of Beginning and Ending Unrecognized Tax Benefits	The following is a reconciliation of the Company’s beginning and ending unrecognized tax benefits (in thousands): Balance at December 31, 2014 $ 24,212 Additions (reductions) based on prior years’ tax positions — Additions (reductions) based on 2015 tax positions — Balance at December 31, 2015 $ 24,212 Additions (reductions) based on prior years’ tax positions (24,212 ) Additions (reductions) based on 2016 tax positions — Balance at December 31, 2016 $ —

EARNINGS PER COMMON SHARE (Tabl

EARNINGS PER COMMON SHARE (Tables)	12 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Earnings Per Share	The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts): Year Ended December 31, 2016 2015 2014 Numerator Net income attributable to common stockholders $ 60,034 $ 69,171 $ 36,710 Denominator Basic weighted average common shares and common equivalents 65,284,251 62,235,014 46,351,544 Dilutive stock options and restricted stock units 236,421 225,225 537,987 Diluted weighted average common shares 65,520,672 62,460,239 46,889,531 Net income attributable to common stockholders, per: Basic common share $ 0.92 $ 1.11 $ 0.79 Diluted common share $ 0.92 $ 1.11 $ 0.78

SUMMARIZED CONSOLIDATING INFO42

SUMMARIZED CONSOLIDATING INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2016
SUMMARIZED CONDENSED CONSOLIDATING INFORMATION [Abstract]
Schedule of Consolidating Balance Sheet	CONSOLIDATING BALANCE SHEET December 31, 2016 (in thousands, except share and per share amounts) Parent Company Issuers Combined Guarantor Subsidiaries Combined Non- Guarantor Subsidiaries Elimination Consolidated Assets Real estate investments, net of accumulated depreciation $ 150 $ — $ 1,828,629 $ 181,160 $ — $ 2,009,939 Loans receivable and other investments, net (410 ) — 96,446 — — 96,036 Cash and cash equivalents 18,168 — 2,675 4,820 — 25,663 Restricted cash — — 57 8,945 — 9,002 Prepaid expenses, deferred financing costs and other assets, net 2,859 18,023 95,740 10,566 (1,909 ) 125,279 Intercompany 368,281 686,376 — — (1,054,657 ) — Investment in subsidiaries 640,238 908,253 12,364 — (1,560,855 ) — Total assets $ 1,029,286 $ 1,612,652 $ 2,035,911 $ 205,491 $ (2,617,421 ) $ 2,265,919 Liabilities Mortgage notes, net $ — $ — $ — $ 160,752 $ — $ 160,752 Revolving credit facility — 26,000 — — — 26,000 Term loans, net — 243,626 92,047 — — 335,673 Senior unsecured notes, net — 688,246 — — — 688,246 Accounts payable and accrued liabilities 13,712 14,542 11,333 1,961 (1,909 ) 39,639 Intercompany — — 1,048,309 6,348 (1,054,657 ) — Total liabilities 13,712 972,414 1,151,689 169,061 (1,056,566 ) 1,250,310 Total Sabra Health Care REIT, Inc. stockholders’ equity: 1,015,574 640,238 884,222 36,395 (1,560,855 ) 1,015,574 Noncontrolling interests — — — 35 — 35 Total equity 1,015,574 640,238 884,222 36,430 (1,560,855 ) 1,015,609 Total liabilities and equity $ 1,029,286 $ 1,612,652 $ 2,035,911 $ 205,491 $ (2,617,421 ) $ 2,265,919 CONSOLIDATING BALANCE SHEET December 31, 2015 (in thousands, except share and per share amounts) Parent Company Issuers Combined Guarantor Subsidiaries Combined Non- Guarantor Subsidiaries Elimination Consolidated Assets Real estate investments, net of accumulated depreciation $ 48 $ — $ 1,874,394 $ 165,174 $ — $ 2,039,616 Loans receivable and other investments, net — — 302,282 — (2,105 ) 300,177 Cash and cash equivalents 2,548 — 456 4,430 — 7,434 Restricted cash — — 1,788 8,025 — 9,813 Prepaid expenses, deferred financing costs and other assets, net 2,047 13,384 91,225 7,996 (2,855 ) 111,797 Intercompany 489,763 918,209 — — (1,407,972 ) — Investment in subsidiaries 568,841 792,065 8,855 — (1,369,761 ) — Total assets $ 1,063,247 $ 1,723,658 $ 2,279,000 $ 185,625 $ (2,782,693 ) $ 2,468,837 Liabilities Mortgage notes $ — $ — $ 10,766 $ 164,080 $ — $ 174,846 Revolving credit facility — 255,000 — — — 255,000 Term loans, net — 200,000 64,229 — — 264,229 Senior unsecured notes, net — 685,704 — — — 685,704 Accounts payable and accrued liabilities 9,477 14,113 11,392 2,056 (1,856 ) 35,182 Intercompany — — 1,399,041 8,931 (1,407,972 ) — Total liabilities 9,477 1,154,817 1,485,428 175,067 (1,409,828 ) 1,414,961 Total Sabra Health Care REIT, Inc. stockholders' equity 1,053,770 568,841 793,572 10,452 (1,372,865 ) 1,053,770 Noncontrolling interests — — — 106 — 106 Total equity 1,053,770 568,841 793,572 10,558 (1,372,865 ) 1,053,876 Total liabilities and equity $ 1,063,247 $ 1,723,658 $ 2,279,000 $ 185,625 $ (2,782,693 ) $ 2,468,837
Schedule of Consolidating Statement of Income	CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2016 (in thousands, except share and per share amounts) Parent Company Issuers Combined Guarantor Subsidiaries Combined Non- Guarantor Subsidiaries Elimination Consolidated Revenues: Rental income $ — $ — $ 206,406 $ 21,197 $ (2,328 ) $ 225,275 Interest and other income 3 — 27,712 1 (253 ) 27,463 Resident fees and services — — — 7,788 — 7,788 Total revenues 3 — 234,118 28,986 (2,581 ) 260,526 Expenses: Depreciation and amortization 816 — 60,910 6,746 — 68,472 Interest — 54,589 3,497 6,787 — 64,873 Operating expenses — — — 8,066 (2,363 ) 5,703 General and administrative 16,218 57 3,284 359 — 19,918 Provision for doubtful accounts and loan losses (1,376 ) — 6,498 421 — 5,543 Impairment of real estate — — 29,811 — — 29,811 Total expenses 15,658 54,646 104,000 22,379 (2,363 ) 194,320 Other income (expense): Loss on extinguishment of debt — (468 ) (88 ) — — (556 ) Other income (expense) 7,366 (196 ) 3,507 — — 10,677 Net (loss) gain on sales of real estate — — (6,143 ) 21 — (6,122 ) Total other income (expense) 7,366 (664 ) (2,724 ) 21 — 3,999 Income in subsidiary 78,783 134,093 6,840 — (219,716 ) — Net income 70,494 78,783 134,234 6,628 (219,934 ) 70,205 Net loss attributable to noncontrolling interest — — — 71 — 71 Net income attributable to Sabra Health Care REIT, Inc. 70,494 78,783 134,234 6,699 (219,934 ) 70,276 Preferred stock dividends (10,242 ) — — — — (10,242 ) Net income attributable to common stockholders $ 60,252 $ 78,783 $ 134,234 $ 6,699 $ (219,934 ) $ 60,034 Net income attributable to common stockholders, per: Basic common share $ 0.92 Diluted common share $ 0.92 Weighted-average number of common shares outstanding, basic 65,284,251 Weighted-average number of common shares outstanding, diluted 65,520,672 CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2015 (in thousands, except share and per share amounts) Parent Company Issuers Combined Combined Non- Elimination Consolidated Revenues: Rental income $ — $ — $ 190,582 $ 20,470 $ (1,201 ) $ 209,851 Interest and other income 2 334 25,472 1 (304 ) 25,505 Resident fees and services — — — 3,508 — 3,508 Total revenues 2 334 216,054 23,979 (1,505 ) 238,864 Expenses: Depreciation and amortization 47 — 57,141 5,891 — 63,079 Interest — 52,208 1,536 5,735 (261 ) 59,218 Operating expenses — — — 3,789 (1,213 ) 2,576 General and administrative 14,910 30 8,566 359 — 23,865 Provision for doubtful accounts and loan losses 1,291 — 11,551 — — 12,842 Total expenses 16,248 52,238 78,794 15,774 (1,474 ) 161,580 Other income (expense): Other income (expense) — 1,651 (101 ) 710 — 2,260 Net loss on sales of real estate — — (161 ) — — (161 ) Total other income (expense) — 1,651 (262 ) 710 — 2,099 Income in subsidiary 95,690 145,943 8,368 — (250,001 ) — Net income 79,444 95,690 145,366 8,915 (250,032 ) 79,383 Net loss attributable to noncontrolling interest — — — 30 — 30 Net income attributable to Sabra Health Care REIT, Inc. 79,444 95,690 145,366 8,945 (250,032 ) 79,413 Preferred stock dividends (10,242 ) — — — — (10,242 ) Net income attributable to common stockholders $ 69,202 $ 95,690 $ 145,366 $ 8,945 $ (250,032 ) $ 69,171 Net income attributable to common stockholders, per: Basic common share $ 1.11 Diluted common share $ 1.11 Weighted-average number of common shares outstanding, basic 62,235,014 Weighted-average number of common shares outstanding, diluted 62,460,239 CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2014 (in thousands, except share and per share amounts) Parent Company Issuers Combined Combined Non- Elimination Consolidated Revenues: Rental income $ — $ — $ 142,249 $ 19,234 $ — $ 161,483 Interest and other income 9 — 19,357 1 — 19,367 Resident fee and services — — — 2,668 — 2,668 Total revenues 9 — 161,606 21,903 — 183,518 Expenses: Depreciation and amortization 52 — 37,645 5,635 — 43,332 Interest — 37,129 4,642 5,187 — 46,958 Operating expenses — — — 1,930 — 1,930 General and administrative 17,922 2 5,561 330 — 23,815 Provision for doubtful accounts and write-offs 600 — 2,994 — — 3,594 Total expenses 18,574 37,131 50,842 13,082 — 119,629 Other income (expense): Loss on extinguishment of debt — (21,846 ) (472 ) (136 ) — (22,454 ) Other income — — 1,560 — — 1,560 Gain on sale of real estate — — 3,914 — — 3,914 Total other income (expense) — (21,846 ) 5,002 (136 ) — (16,980 ) Income in subsidiary 65,517 124,494 5,698 — (195,709 ) — Net income 46,952 65,517 121,464 8,685 (195,709 ) 46,909 Net loss attributable to noncontrolling interest — — — 43 — 43 Net income attributable to Sabra Health Care REIT, Inc. 46,952 65,517 121,464 8,728 (195,709 ) 46,952 Preferred stock dividends (10,242 ) — — — — (10,242 ) Net income attributable to common stockholders $ 36,710 $ 65,517 $ 121,464 $ 8,728 $ (195,709 ) $ 36,710 Net income attributable to common stockholders, per: Basic common share $ 0.79 Diluted common share $ 0.78 Weighted-average number of common shares outstanding, basic 46,351,544 Weighted-average number of common shares outstanding, diluted 46,889,531
Schedule of Condensed Consolidating Statement of Comprehensive Income	CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2016 (in thousands) Parent Company Issuers Combined Combined Non-Guarantor Elimination Consolidated Net income $ 70,494 $ 78,783 $ 134,234 $ 6,628 $ (219,934 ) $ 70,205 Other comprehensive income (loss): Foreign currency translation — (2,080 ) 364 82 — (1,634 ) Unrealized loss on cash flow hedge — 7,169 — — — 7,169 Total other comprehensive loss — 5,089 364 82 — 5,535 Comprehensive income 70,494 83,872 134,598 6,710 (219,934 ) 75,740 Comprehensive loss attributable to noncontrolling interest — — — 71 — 71 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 70,494 $ 83,872 $ 134,598 $ 6,781 $ (219,934 ) $ 75,811 CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2015 (in thousands) Parent Company Issuers Combined Combined Non-Guarantor Elimination Consolidated Net income $ 79,444 $ 95,690 $ 145,366 $ 8,915 $ (250,032 ) $ 79,383 Other comprehensive income (loss): Foreign currency translation — 5,530 (5,495 ) (1,468 ) — (1,433 ) Unrealized loss on cash flow hedge — (4,358 ) — — — (4,358 ) Total other comprehensive income (loss) — 1,172 (5,495 ) (1,468 ) — (5,791 ) Comprehensive income 79,444 96,862 139,871 7,447 (250,032 ) 73,592 Comprehensive loss attributable to noncontrolling interest — — — 30 — 30 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 79,444 $ 96,862 $ 139,871 $ 7,477 $ (250,032 ) $ 73,622 CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2014 (in thousands) Parent Company Issuers Combined Guarantor Subsidiaries Combined Non-Guarantor Subsidiaries Elimination Consolidated Net income $ 46,952 $ 65,517 $ 121,464 $ 8,685 $ (195,709 ) $ 46,909 Other comprehensive income (loss): Unrealized loss on cash flow hedge — (1,542 ) — — — (1,542 ) Total other comprehensive loss — (1,542 ) — — — (1,542 ) Comprehensive income 46,952 63,975 121,464 8,685 (195,709 ) 45,367 Comprehensive loss attributable to noncontrolling interest — — — 43 — 43 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 46,952 $ 63,975 $ 121,464 $ 8,728 $ (195,709 ) $ 45,410
Schedule of Consolidating Statement of Cash Flows	CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2016 (in thousands) Parent Company Issuers Combined Combined Non- Elimination Consolidated Net cash provided by operating activities $ 153,577 $ — $ 12,074 $ 11,088 $ — $ 176,739 Cash flows from investing activities: Acquisitions of real estate — — (133,797 ) (19,782 ) — (153,579 ) Origination and fundings of loans receivable — — (9,675 ) — — (9,675 ) Origination and fundings of preferred equity investments — — (7,348 ) — — (7,348 ) Additions to real estate (124 ) — (502 ) (377 ) — (1,003 ) Repayment of loan receivable — — 215,962 — — 215,962 Investment in Subsidiary (200 ) (200 ) — — 400 — Net proceeds from sale of real estate — — 97,407 599 — 98,006 Distribution from Subsidiary 6,404 6,404 — — (12,808 ) — Intercompany financing (23,484 ) 165,842 — — (142,358 ) — Net cash (used in) provided by investing activities (17,404 ) 172,046 162,047 (19,560 ) (154,766 ) 142,363 Cash flows from financing activities: Net repayment from revolving credit facility — (229,000 ) — — — (229,000 ) Proceeds from term loan — 45,000 24,360 — — 69,360 Principal payments on mortgage notes — — (10,766 ) (4,002 ) — (14,768 ) Payments of deferred financing costs — (5,326 ) (611 ) — — (5,937 ) Issuance of common stock (1,289 ) — — — — (1,289 ) Dividends paid on common and preferred stock (119,264 ) — — — — (119,264 ) Contribution from Parent — 200 — 200 (400 ) — Distribution to Parent — (6,404 ) — (6,404 ) 12,808 — Intercompany financing — 23,484 (184,957 ) 19,115 142,358 — Net cash (used in) provided by financing activities (120,553 ) (172,046 ) (171,974 ) 8,909 154,766 (300,898 ) Net increase in cash and cash equivalents 15,620 — 2,147 437 — 18,204 Effect of foreign currency translation on cash and cash equivalents — — 72 (47 ) — 25 Cash and cash equivalents, beginning of period 2,548 — 456 4,430 — 7,434 Cash and cash equivalents, end of period $ 18,168 $ — $ 2,675 $ 4,820 $ — $ 25,663 CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2015 (in thousands) Parent Company Issuers Combined Combined Non- Elimination Consolidated Net cash provided by operating activities $ 112,291 $ — $ 820 $ 7,990 $ — $ 121,101 Cash flows from investing activities: Acquisitions of real estate — — (450,082 ) (11,248 ) — (461,330 ) Origination and fundings of loans receivable — — (49,687 ) — — (49,687 ) Preferred equity investments — — (12,804 ) — — (12,804 ) Additions to real estate (34 ) — (1,286 ) (2,369 ) — (3,689 ) Investment in Subsidiary (414 ) (414 ) — — 828 — Distribution from Subsidiary 3,515 3,515 — — (7,030 ) — Intercompany financing (200,884 ) (387,652 ) — — 588,536 — Repayment of note receivable — — 5,803 — — 5,803 Release of contingent consideration held in escrow — — 5,240 — — 5,240 Net proceeds from sale of real estate — — 27,241 — — 27,241 Net cash (used in) provided by investing activities (197,817 ) (384,551 ) (475,575 ) (13,617 ) 582,334 (489,226 ) Cash flows from financing activities: Net proceeds from revolving credit facility — 187,000 — — — 187,000 Proceeds from term loan — — 73,242 — — 73,242 Proceeds from mortgage notes — — — 28,735 — 28,735 Principal payments on mortgage notes — — — (3,132 ) — (3,132 ) Payments of deferred financing costs — (232 ) (740 ) (480 ) — (1,452 ) Contributions by noncontrolling interest — — — 179 — 179 Issuance of common stock 139,403 — — — — 139,403 Dividends paid on common and preferred stock (109,897 ) — — — — (109,897 ) Contribution from Parent — 414 — 414 (828 ) — Distribution to Parent — (3,515 ) — (3,515 ) 7,030 — Intercompany financing — 200,884 402,745 (15,093 ) (588,536 ) — Net cash provided by (in used) financing activities 29,506 384,551 475,247 7,108 (582,334 ) 314,078 Net (decrease) increase in cash and cash equivalents (56,020 ) — 492 1,481 — (54,047 ) Effect of foreign currency translation on cash and cash equivalents (231 ) — (36 ) (45 ) — (312 ) Cash and cash equivalents, beginning of period 58,799 — — 2,994 — 61,793 Cash and cash equivalents, end of period $ 2,548 $ — $ 456 $ 4,430 $ — $ 7,434 CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2014 (in thousands) Parent Company Issuers Combined Combined Non- Elimination Consolidated Net cash provided by operating activities $ 53,292 $ — $ — $ 32,045 $ — $ 85,337 Cash flows from investing activities: Acquisitions of real estate — — (763,378 ) (8,101 ) — (771,479 ) Origination and fundings of loans receivable — — (66,397 ) — — (66,397 ) Preferred equity investments — — (15,486 ) — — (15,486 ) Additions to real estate (11 ) — (1,437 ) (23 ) — (1,471 ) Repayment of loans receivable — — 1,097 — — 1,097 Net proceeds from the sale of real estate — — 27,264 — — 27,264 Investment in Subsidiary (12,147 ) (12,147 ) — — 24,294 — Distribution from Subsidiary 1,246 1,246 — — (2,492 ) — Intercompany financing (415,790 ) (958,970 ) — — 1,374,760 — Net cash (used in) provided by investing activities (426,702 ) (969,871 ) (818,337 ) (8,124 ) 1,396,562 (826,472 ) Cash flows from financing activities: Proceeds from issuance of senior unsecured notes — 499,250 — — — 499,250 Principal payments on senior unsecured notes — (211,250 ) — — — (211,250 ) Net proceeds (repayment) from revolving credit facility — 268,000 (135,500 ) — — 132,500 Proceeds from mortgage notes — — — 57,703 — 57,703 Principal payments on mortgage notes — — — (89,110 ) — (89,110 ) Payments of deferred financing costs — (12,820 ) (5,133 ) (1,178 ) — (19,131 ) Issuance of common stock 510,147 — — — — 510,147 Dividends paid on common and preferred stock (81,489 ) — — — — (81,489 ) Contribution from Parent — 12,147 — 12,147 (24,294 ) — Distribution to Parent — (1,246 ) — (1,246 ) 2,492 — Intercompany financing — 415,790 958,970 — (1,374,760 ) — Net cash provided by (used in) financing activities 428,658 969,871 818,337 (21,684 ) (1,396,562 ) 798,620 Net increase in cash and cash equivalents 55,248 — — 2,237 — 57,485 Cash and cash equivalents, beginning of period 3,551 — — 757 — 4,308 Cash and cash equivalents, end of period $ 58,799 $ — $ — $ 2,994 $ — $ 61,793

PRO FORMA FINANCIAL INFORMATI43

PRO FORMA FINANCIAL INFORMATION (UNAUDITED) (Tables)	12 Months Ended
	Dec. 31, 2016
PRO FORMA FINANCIAL INFORMATION [Abstract]
Schedule of Pro Forma Information	This pro forma information does not purport to represent what the actual results of operations of the Company would have been had these acquisitions occurred on January 1, 2015 and 2014, nor does it purport to predict the results of operations for future periods (in thousands, except share and per share amounts): Year Ended December 31, 2016 2015 Revenues $ 266,727 $ 276,978 Depreciation and amortization 70,316 74,101 Net income attributable to common stockholders 65,530 99,004 Net income attributable to common stockholders, per: Basic common share 1.00 1.59 Diluted common share 1.00 1.59 Weighted average number of common shares outstanding, basic 65,284,251 62,235,014 Weighted average number of common shares outstanding, diluted 65,520,672 62,460,239

SUMMARY OF SIGNIFICANT ACCOUN44

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	12 Months Ended
	Dec. 31, 2016USD ($)Propertyvariable_interest_entitySegmentInvestment	Dec. 31, 2015USD ($)PropertyInvestment	Dec. 31, 2014USD ($)Property	Oct. 01, 2016USD ($)
Property, Plant and Equipment [Line Items]
Acquisition costs	$ 1,100,000
Number of variable interest entities | variable_interest_entity	2
Number of investments in loans accounted for as real estate joint ventures | Investment	0	0
Number of real estate properties acquired | Property	7	24	42
Acquisition pursuit costs	$ 1,200,000	$ 7,000,000	$ 3,100,000
Impairment losses on real estate investments	29,811,000	0	$ 0
Assets held for sale	0	0
Restricted cash	9,002,000	9,813,000
Deferred financing costs, net of amortization	$ 16,452,000
Number of reportable segments | Segment	1
Cash Obligations [Member]
Property, Plant and Equipment [Line Items]
Restricted cash	$ 6,800,000	5,000,000
Land Improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	3 years
Land Improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	40 years
Buildings and Building Improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	3 years
Buildings and Building Improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	40 years
Furniture and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	1 year
Furniture and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	20 years
Forest Park - Frisco [Member]
Property, Plant and Equipment [Line Items]
Impairment losses on real estate investments	$ 29,800,000
Accounting Standards Update 2015-03 [Member] | Prepaid Expenses, Deferred Financing Costs and Other Assets, Net [Member]
Property, Plant and Equipment [Line Items]
Deferred financing costs, net of amortization		(17,300,000)
Accounting Standards Update 2015-03 [Member] | Long-term Debt [Member]
Property, Plant and Equipment [Line Items]
Deferred financing costs, net of amortization		$ 17,300,000
New Accounting Pronouncement, Early Adoption, Effect [Member] | Accounting Standards Update 2017-01 [Member]
Property, Plant and Equipment [Line Items]
Acquisition costs				$ 300,000

RECENT REAL ESTATE ACQUISITIO45

RECENT REAL ESTATE ACQUISITIONS - Schedule of Purchase Price Allocation (Details) - Series of Individually Immaterial Business Acquisitions [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Business Acquisition [Line Items]
Land	$ 7,755	$ 32,336
Building and Improvements	143,027	449,789
Total Consideration	153,626	491,787
Tenant Origination and Absorption Costs [Member]
Business Acquisition [Line Items]
Tenant	2,202	7,556
Tenant Relationship [Member]
Business Acquisition [Line Items]
Tenant	$ 642	$ 2,106

RECENT REAL ESTATE ACQUISITIO46

RECENT REAL ESTATE ACQUISITIONS - Narrative (Details) CAD in Millions	Nov. 25, 2015USD ($)Facilitiyloan	Jun. 30, 2015USD ($)FacilitiyRenewal_Option	Jun. 11, 2015USD ($)FacilitiyRenewal_Optionunit	Jun. 11, 2015CADFacilitiyloanRenewal_Optionunit	Nov. 25, 2015USD ($)skilled_nursing_bedloan	Dec. 31, 2016USD ($)CustomerPropertyFacilitiy	Dec. 31, 2015USD ($)PropertyFacilitiy	Dec. 31, 2014USD ($)Property
Business Acquisition [Line Items]
Number of real estate properties acquired | Property						7	24	42
Total revenues						$ 260,526,000	$ 238,864,000	$ 183,518,000
Net income attributable to common stockholders						60,034,000	69,171,000	36,710,000
Acquisition pursuit costs						1,200,000	7,000,000	$ 3,100,000
Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Total revenues						4,600,000	17,600,000
Net income attributable to common stockholders						2,200,000	5,300,000
Acquisition pursuit costs						$ 1,100,000	$ 6,700,000
Series of Individually Immaterial Business Acquisitions [Member] | Tenant Origination and Absorption Costs [Member]
Business Acquisition [Line Items]
Finite-lived intangible assets, weighted average amortization period as of date of acquisition						15 years
Series of Individually Immaterial Business Acquisitions [Member] | Tenant Relationship [Member]
Business Acquisition [Line Items]
Finite-lived intangible assets, weighted average amortization period as of date of acquisition						25 years
Series of Individually Immaterial Business Acquisitions [Member] | Senior Housing Facilities [Member]
Business Acquisition [Line Items]
Number of real estate properties acquired						3	20
Number of acquired properties | Facilitiy						6
Series of Individually Immaterial Business Acquisitions [Member] | Skilled Nursing/Transitional Care Facilities [Member]
Business Acquisition [Line Items]
Number of real estate properties acquired | Facilitiy						1	4
Canadian Portfolio [Member] | Mortgages [Member]
Business Acquisition [Line Items]
Expected annual lease revenue | CAD				CAD 11.9
Number of mortgage loans | loan				3
Outstanding principal amounts | CAD				CAD 24.2
Canadian Portfolio [Member] | Senior Lifestyle Corporation [Member]
Business Acquisition [Line Items]
Master lease initial term			10 years	10 years
Number of lease renewal options | Renewal_Option			2	2
Lease renewal term			5 years	5 years
Annual rent increase in year two			4.00%	4.00%
Annual rent increase in year three			4.00%	4.00%
Rent increase during remainder of lease term			3.00%	3.00%
Canadian Portfolio [Member] | Senior Housing Facilities [Member] | British Columbia and Ontario, Canada [Member]
Business Acquisition [Line Items]
Number of acquired properties | Facilitiy			9	9
Number of acquired units | unit			865	865
Purchase price			$ 138,800,000	CAD 170.5
NMS Portfolio [Member]
Business Acquisition [Line Items]
Master lease initial term		15 years
Number of lease renewal options | Renewal_Option		2
Lease renewal term		10 years
Annual rent escalator		2.50%
NMS Portfolio [Member] | Maximum [Member]
Business Acquisition [Line Items]
Annual rent escalator		2.75%
NMS Portfolio [Member] | Skilled Nursing/Transitional Care Facilities [Member] | Maryland [Member]
Business Acquisition [Line Items]
Number of acquired properties | Facilitiy	1	3
Purchase price	$ 58,900,000	$ 175,500,000
Number of acquired beds | skilled_nursing_bed					678
NMS Portfolio [Member] | Skilled Nursing/Transitional Care Facilities [Member] | Maryland [Member] | HUD Loan [Member]
Business Acquisition [Line Items]
Number of mortgage loans | loan	1				1
Debt assumed in transaction	$ 10,800,000				$ 10,800,000
Interest rate	5.60%				5.60%
NMS Portfolio [Member] | NMS Portfolio Facilities [Member] | Maryland [Member]
Business Acquisition [Line Items]
Number of acquired properties | Facilitiy		3

REAL ESTATE PROPERTIES HELD F47

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Schedule of Real Estate Properties Held for Investment (Details) $ in Thousands	Dec. 31, 2016USD ($)BedFacilitiy	Dec. 31, 2015USD ($)BedFacilitiy
Real Estate Properties [Line Items]
Building and improvements	$ 1,983,769	$ 1,954,129
Furniture and equipment	85,196	97,840
Land improvements	3,744	3,594
Land	220,042	221,894
Total Real Estate at Cost	2,292,751	2,277,457
Accumulated Depreciation	(282,812)	(237,841)
Total Real Estate Investments, Net	$ 2,009,939	$ 2,039,616
Operating Segments [Member]
Real Estate Properties [Line Items]
Number of Properties | Facilitiy	183	180
Number of Beds/Units | Bed	18,878	18,349
Total Real Estate at Cost	$ 2,292,345	$ 2,277,158
Accumulated Depreciation	(282,556)	(237,589)
Total Real Estate Investments, Net	$ 2,009,789	$ 2,039,569
Skilled Nursing/Transitional Care Facilities [Member]
Real Estate Properties [Line Items]
Number of Properties | Facilitiy	97	100
Number of Beds/Units | Bed	10,819	11,012
Total Real Estate at Cost	$ 1,042,754	$ 1,029,291
Accumulated Depreciation	(190,038)	(167,968)
Total Real Estate Investments, Net	$ 852,716	$ 861,323
Senior Housing [Member]
Real Estate Properties [Line Items]
Number of Properties | Facilitiy	85	78
Number of Beds/Units | Bed	7,989	7,213
Total Real Estate at Cost	$ 1,187,951	$ 1,072,060
Accumulated Depreciation	(82,131)	(52,494)
Total Real Estate Investments, Net	$ 1,105,820	$ 1,019,566
Acute Care Hospitals [Member]
Real Estate Properties [Line Items]
Number of Properties | Facilitiy	1	2
Number of Beds/Units | Bed	70	124
Total Real Estate at Cost	$ 61,640	$ 175,807
Accumulated Depreciation	(10,387)	(17,127)
Total Real Estate Investments, Net	51,253	158,680
Corporate Level [Member]
Real Estate Properties [Line Items]
Total Real Estate at Cost	406	299
Accumulated Depreciation	(256)	(252)
Total Real Estate Investments, Net	$ 150	$ 47

REAL ESTATE PROPERTIES HELD F48

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Narrative (Details)	12 Months Ended
	Dec. 31, 2016USD ($)CustomerPropertyacquisition	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Real Estate Properties [Line Items]
Change in fair value of contingent consideration	$ 1,526,000	$ 1,550,000	$ 1,560,000
Security deposit liability	2,700,000	1,300,000
Reserve for unpaid cash rents	3,200,000	3,500,000
Reserve associated with straight-line rental income	$ 3,700,000	$ 5,300,000
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Real Estate Properties [Line Items]
Number of major customers | Customer	3
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Genesis [Member]
Real Estate Properties [Line Items]
Concentration risk percent	32.30%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Holiday [Member]
Real Estate Properties [Line Items]
Concentration risk percent	16.20%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | NMS [Member]
Real Estate Properties [Line Items]
Concentration risk percent	12.40%
Minimum [Member]
Real Estate Properties [Line Items]
Operating lease expiration period	4 years
Maximum [Member]
Real Estate Properties [Line Items]
Operating lease expiration period	16 years
Weighted Average [Member]
Real Estate Properties [Line Items]
Operating lease expiration period	9 years
Accounts Payable and Accrued Liabilities [Member]
Real Estate Properties [Line Items]
Contingent consideration liability	$ 800,000
Genesis [Member]
Real Estate Properties [Line Items]
Number of properties marketed | Property	35
Number of properties remaining | Property	43
Acquisitions With Contingent Consideration Arrangements [Member]
Real Estate Properties [Line Items]
Number of real estate acquisitions | acquisition	4
Estimated earn-out value	$ 3,200,000
Contingent consideration asset	$ 0

REAL ESTATE PROPERTIES HELD F49

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Schedule of Future Minimum Rental Payments from Non-cancelable Operating Leases (Details) $ in Thousands	Dec. 31, 2016USD ($)
Real Estate Investments, Net [Abstract]
2,017	$ 214,701
2,018	220,677
2,019	227,049
2,020	233,275
2,021	203,442
Thereafter	1,145,204
Total	$ 2,244,348

DISPOSITIONS - Narrative (Detai

DISPOSITIONS - Narrative (Details)	12 Months Ended
	Dec. 31, 2016USD ($)Facilitiy	Dec. 31, 2015USD ($)Facilitiy	Dec. 31, 2014USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impairment losses on real estate investments	$ 29,811,000	$ 0	$ 0
2016 Dispositions [Member] | Discontinued Operations, Disposed of by Sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal, aggregate consideration	98,000,000
Selling expenses	2,700,000
Impairment losses on real estate investments	29,800,000
Carrying value of assets and liabilities	104,100,000
Loss on disposal	6,100,000
Net income (loss)	$ 700,000	$ (2,300,000)	13,300,000
Skilled Nursing/Transitional Care Facilities [Member] | 2016 Dispositions [Member] | Discontinued Operations, Disposed of by Sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties sold | Facilitiy	4
Skilled Nursing/Transitional Care Facilities [Member] | 2015 Dispositions [Member] | Discontinued Operations, Disposed of by Sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties sold | Facilitiy		5
Disposal, aggregate consideration		$ 27,200,000
Selling expenses		500,000
Carrying value of assets and liabilities		27,400,000
Loss on disposal		200,000
Net income (loss)		$ 1,800,000	$ 2,300,000
Acute Care Hospitals [Member] | 2016 Dispositions [Member] | Discontinued Operations, Disposed of by Sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties sold | Facilitiy	1
Land [Member] | 2016 Dispositions [Member] | Discontinued Operations, Disposed of by Sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties sold | Facilitiy	1

TENANT ORIGINATION AND ABSORP51

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP ASSETS - Schedule of Tenant Origination and Absorption Costs and Tenant Relationship Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Tenant Origination and Absorption Costs [Member]
Intangible Assets, Net
Cost	$ 23,987	$ 24,492
Accumulated amortization	(4,432)	(4,215)
Net amount	19,555	20,277
Tenant Relationship [Member]
Intangible Assets, Net
Cost	7,430	7,269
Accumulated amortization	(735)	(679)
Net amount	$ 6,695	$ 6,590

TENANT ORIGINATION AND ABSORP52

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP ASSETS - Schedule of Decrease in Net Income as a Result of Amortization (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Tenant Origination and Absorption Costs [Member]
Finite-Lived Intangible Assets
Amortization	$ (2,705)	$ (2,729)	$ (1,109)
Tenant Relationship [Member]
Finite-Lived Intangible Assets
Amortization	$ (477)	$ (466)	$ (192)

TENANT ORIGINATION AND ABSORP53

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP ASSETS - Schedule of Unamortized Balance for Outstanding Intangible Assets and Liabilities (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)
Tenant Origination and Absorption Costs [Member]
Finite-Lived Intangible Assets
2,017	$ 1,868
2,018	1,868
2,019	1,868
2,020	1,868
2,021	1,868
Thereafter	10,215
Total	$ 19,555
Tenant Origination and Absorption Costs [Member] | Weighted Average [Member]
Finite-Lived Intangible Assets
Weighted-Average Remaining Amortization Period	13 years 5 months
Tenant Relationship [Member]
Finite-Lived Intangible Assets
2,017	$ 326
2,018	326
2,019	326
2,020	326
2,021	326
Thereafter	5,065
Total	$ 6,695
Tenant Relationship [Member] | Weighted Average [Member]
Finite-Lived Intangible Assets
Weighted-Average Remaining Amortization Period	23 years 1 month

LOANS RECEIVABLE AND OTHER IN54

LOANS RECEIVABLE AND OTHER INVESTMENTS - Schedule of Loans Receivable and Other Investments (Details) $ in Thousands	Dec. 31, 2016USD ($)Investment	Dec. 31, 2015USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans Receivable, Quantity | Investment	10
Loans Receivable, Principal Balance	$ 53,484
Loans Receivable, Book Value	$ 53,596	$ 274,484
Loans Receivable, Weighted Average Contractual Interest Rate / Rate of Return	9.30%
Loans Receivable, Weighted Average Annualized Effective Interest Rate / Rate of Return	9.10%
Loan loss reserve	$ (2,750)	(4,300)
Loans Receivable, Net Amount	$ 50,846	270,184
Preferred Equity, Quantity | Investment	12
Preferred Equity, Principal Balance	$ 44,882	29,643
Preferred Equity, Book Value	$ 45,190	29,993
Preferred Equity, Weighted Average Contractual Interest Rate / Rate of Return	12.90%
Preferred Equity, Weighted Average Annualized Effective Interest Rate / Rate of Return	12.90%
Total Quantity | Investment	22
Total Principal Balance	$ 98,366
Total Book Value	$ 96,036	300,177
Total Weighted Average Contractual Interest Rate / Rate of Return	10.90%
Total Weighted Average Annualized Effective Interest Rate / Rate of Return	10.80%
Mortgage Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans Receivable, Quantity | Investment	4
Loans Receivable, Principal Balance	$ 38,231
Loans Receivable, Book Value	$ 38,262	166,277
Loans Receivable, Weighted Average Contractual Interest Rate / Rate of Return	9.10%
Loans Receivable, Weighted Average Annualized Effective Interest Rate / Rate of Return	8.90%
Construction Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans Receivable, Quantity | Investment	1
Loans Receivable, Principal Balance	$ 795
Loans Receivable, Book Value	$ 842	75,201
Loans Receivable, Weighted Average Contractual Interest Rate / Rate of Return	8.00%
Loans Receivable, Weighted Average Annualized Effective Interest Rate / Rate of Return	7.70%
Mezzanine Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans Receivable, Quantity | Investment	1
Loans Receivable, Principal Balance	$ 9,640
Loans Receivable, Book Value	$ 9,656	15,613
Loans Receivable, Weighted Average Contractual Interest Rate / Rate of Return	11.00%
Loans Receivable, Weighted Average Annualized Effective Interest Rate / Rate of Return	10.80%
Pre-development Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans Receivable, Quantity | Investment	3
Loans Receivable, Principal Balance	$ 4,005
Loans Receivable, Book Value	$ 4,023	3,768
Loans Receivable, Weighted Average Contractual Interest Rate / Rate of Return	9.00%
Loans Receivable, Weighted Average Annualized Effective Interest Rate / Rate of Return	7.70%
Debtor-in-possession Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans Receivable, Quantity | Investment	1
Loans Receivable, Principal Balance	$ 813
Loans Receivable, Book Value	$ 813	$ 13,625
Loans Receivable, Weighted Average Contractual Interest Rate / Rate of Return	5.00%
Loans Receivable, Weighted Average Annualized Effective Interest Rate / Rate of Return	5.00%

LOANS RECEIVABLE AND OTHER IN55

LOANS RECEIVABLE AND OTHER INVESTMENTS - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)Investmentloan	Dec. 31, 2015USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding principal balance	$ 53,596	$ 274,484
Number of loans | Investment	10
Loan loss reserve	$ 2,750	4,300
Forest Park - Dallas and Fort Worth [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Proceeds received	196,100
Outstanding principal balance	170,800
Accrued and unpaid interest and fees	25,300
Nonperforming Financial Instruments [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding principal balance	$ 17,400	30,000
Number of loans | loan	3
Provision for loan losses	$ 3,100
Number of loans on which provision for losses were recorded | loan	4
Number of loans partially repaid prior to year end with on which provision for losses were recorded | loan	1
Number of loans on nonaccrual status | loan	4
Value of loans on nonaccrual status	$ 31,200
Portfolio-Based Loan Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for loan losses		2,600
Decrease in provision	1,300
Loan loss reserve	2,300
Specific Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision for loan losses		$ 1,800
Loan loss reserve	$ 400

DEBT - Schedule of Long Term De

DEBT - Schedule of Long Term Debt - Mortgage Notes (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Deferred financing costs, net of amortization	$ 16,452
Mortgages [Member]
Debt Instrument [Line Items]
Deferred financing costs, net of amortization	2,886	$ 3,000
Mortgages [Member] | Fixed Rate Mortgages [Member]
Debt Instrument [Line Items]
Book value	$ 163,638	$ 177,850
Weighted average effective interest rate	3.87%

DEBT - Narrative (Details)

DEBT - Narrative (Details)

Aug. 10, 2016USD ($)instrument

Jan. 14, 2016USD ($)extension_optioninvestment_grading_company

Jun. 10, 2015USD ($)

Oct. 10, 2014USD ($)

Sep. 10, 2014USD ($)

Jan. 23, 2014USD ($)

May 23, 2013USD ($)

Dec. 31, 2016USD ($)

Dec. 31, 2015USD ($)

Dec. 31, 2014USD ($)

Jan. 14, 2016CADextension_optioninvestment_grading_company

Jun. 10, 2015CAD

Debt Instrument [Line Items]

Debt, aggregate principal amount

$ 1,210,671,000

Interest expense

64,873,000

$ 59,218,000

$ 46,958,000

Long-term debt

1,227,638,000

Number of investment grading companies | investment_grading_company

2

2

Deferred financing costs amortization

5,040,000

5,143,000

$ 4,045,000

Interest payable

$ 13,800,000

$ 13,300,000

5.5% Senior Unsecured Notes due 2021 [Member]

Debt Instrument [Line Items]

Debt amount

$ 350,000,000

Interest rate

5.50%

5.50%

Gross proceeds from debt

$ 350,000,000

Net proceeds from debt

$ 340,800,000

Additional Senior Unsecured Notes due 2021 [Member]

Debt Instrument [Line Items]

Debt amount

$ 150,000,000

Net proceeds from debt

$ 145,600,000

Debt, issued price, percent

99.50%

Debt, yield-to-maturity

5.593%

5.375% Senior Unsecured Notes Due 2023 [Member]

Debt Instrument [Line Items]

Debt amount

$ 200,000,000

Interest rate

5.375%

Gross proceeds from debt

$ 200,000,000

Net proceeds from debt

$ 194,600,000

5.375% Senior Unsecured Notes Due 2023 [Member] | Prior to June 2018 [Member]

Debt Instrument [Line Items]

Debt, redemption premium

100.00%

5.375% Senior Unsecured Notes Due 2023 [Member] | Prior to June 2016 [Member]

Debt Instrument [Line Items]

Debt, redeem up to, percent

35.00%

Debt, redemption premium using proceeds of specific kinds of equity offerings

105.375%

Prior Revolving Credit Facility [Member] | Revolving Credit Facility [Member]

Debt Instrument [Line Items]

Borrowing capacity (up to)

$ 650,000,000

Accordion feature, additional capacity

$ 100,000,000

Term loan

$ 200,000,000

Interest rate cap contract term

5 years

5 years

Available borrowing capacity

$ 474,000,000

Interest rate

2.77%

Prior Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Minimum [Member]

Debt Instrument [Line Items]

Annum percent unused borrowing fee

0.25%

Prior Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Maximum [Member]

Debt Instrument [Line Items]

Annum percent unused borrowing fee

0.35%

Prior Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | LIBOR [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

2.00%

2.00%

1.00%

Prior Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | LIBOR [Member] | Minimum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

2.00%

Prior Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | LIBOR [Member] | Maximum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

2.60%

Prior Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Federal Funds Rate [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

0.50%

Prior Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Minimum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

1.00%

Prior Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Maximum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

1.60%

Prior Canadian Term Loan [Member]

Debt Instrument [Line Items]

Interest rate swap, fixed

1.59%

1.59%

Prior Canadian Term Loan [Member] | Sabra Canadian Holdings, LLC [Member]

Debt Instrument [Line Items]

Debt amount

$ 73,200,000

CAD 90,000,000

Prior Canadian Term Loan [Member] | CDOR [Member] | Minimum [Member] | Sabra Canadian Holdings, LLC [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

2.00%

Prior Canadian Term Loan [Member] | CDOR [Member] | Maximum [Member] | Sabra Canadian Holdings, LLC [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

2.60%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member]

Debt Instrument [Line Items]

Borrowing capacity (up to)

$ 500,000,000

Borrowing capacity in certain foreign currencies (up to)

$ 125,000,000

Number of optional extensions | extension_option

2

2

Optional extension period

6 months

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Minimum [Member]

Debt Instrument [Line Items]

Annum percent unused borrowing fee

0.25%

Facility fee, contingent event

0.125%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Maximum [Member]

Debt Instrument [Line Items]

Annum percent unused borrowing fee

0.30%

Facility fee, contingent event

0.30%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | LIBOR [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

1.00%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | LIBOR [Member] | Minimum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

1.80%

Basis spread on variable rate, contingent event

0.90%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | LIBOR [Member] | Maximum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

2.40%

Basis spread on variable rate, contingent event

1.70%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Federal Funds Rate [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

0.50%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Minimum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

0.80%

Basis spread on variable rate, contingent event

0.00%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Maximum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

1.40%

Basis spread on variable rate, contingent event

0.70%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | LIBOR or CDOR [Member] | Minimum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate, contingent event

1.00%

Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | LIBOR or CDOR [Member] | Maximum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate, contingent event

1.95%

U.S. Dollar Term Loan [Member]

Debt Instrument [Line Items]

Debt amount

$ 245,000,000

$ 245,000,000

Interest rate swap, fixed

0.90%

Derivative instruments | instrument

2

U.S. Dollar Term Loan [Member] | LIBOR [Member] | Minimum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

1.75%

U.S. Dollar Term Loan [Member] | LIBOR [Member] | Maximum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

2.35%

U.S. Dollar Term Loan [Member] | Base Rate [Member] | Minimum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

0.75%

U.S. Dollar Term Loan [Member] | Base Rate [Member] | Maximum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

1.35%

U.S. Dollar Term Loan [Member] | CDOR [Member] | Minimum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

1.75%

U.S. Dollar Term Loan [Member] | CDOR [Member] | Maximum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

2.35%

U.S. Dollar Term Loan [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Minimum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate, contingent event

0.00%

U.S. Dollar Term Loan [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Maximum [Member]

Debt Instrument [Line Items]

Basis spread on variable rate, contingent event

0.95%

Canadian Term Loan [Member]

Debt Instrument [Line Items]

Debt amount

$ 35,000,000

CAD 125,000,000

Interest rate swap, fixed

0.93%

Derivative instruments | instrument

1

Credit Facility [Member] | Revolving Credit Facility [Member]

Debt Instrument [Line Items]

Accordion feature, additional capacity

$ 1,250,000,000

Line of Credit [Member]

Debt Instrument [Line Items]

Debt, aggregate principal amount

$ 26,000,000

Long-term debt

26,000,000

Mortgages [Member]

Debt Instrument [Line Items]

Debt, aggregate principal amount

160,752,000

Long-term debt

$ 163,638,000

DEBT - Schedule of Long Term 58

DEBT - Schedule of Long Term Debt - Senior Unsecured Notes (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Principal Balance	$ 700,000	$ 700,000
Discount	515
Deferred financing costs, net of amortization	16,452
5.5% Senior Unsecured Notes due 2021 [Member]
Debt Instrument [Line Items]
Principal Balance	500,000	500,000
5.375% Senior Unsecured Notes Due 2023 [Member]
Debt Instrument [Line Items]
Principal Balance	200,000	200,000
Senior Notes [Member]
Debt Instrument [Line Items]
Discount	515	600
Deferred financing costs, net of amortization	$ 11,239	$ 13,700

DEBT - Schedule of Maturities o

DEBT - Schedule of Maturities of Debt (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
2,017	$ 4,128
2,018	4,265
2,019	4,408
2,020	30,555
2,021	857,402
Thereafter	326,880
Total Principal Balance	1,227,638
Discount	(515)
Deferred Financing Costs	(16,452)
Total Debt, net	1,210,671
Mortgage Indebtedness [Member]
Debt Instrument [Line Items]
2,017	4,128
2,018	4,265
2,019	4,408
2,020	4,555
2,021	19,402
Thereafter	126,880
Total Principal Balance	163,638
Discount	0
Deferred Financing Costs	(2,886)	$ (3,000)
Total Debt, net	160,752
Senior Notes [Member]
Debt Instrument [Line Items]
2,017	0
2,018	0
2,019	0
2,020	0
2,021	500,000
Thereafter	200,000
Total Principal Balance	700,000
Discount	(515)	(600)
Deferred Financing Costs	(11,239)	$ (13,700)
Total Debt, net	688,246
Prior Revolving Credit Facility [Member]
Debt Instrument [Line Items]
2,017	0
2,018	0
2,019	0
2,020	26,000
2,021	0
Thereafter	0
Total Principal Balance	26,000
Discount	0
Deferred Financing Costs	0
Total Debt, net	26,000
Prior Term Loans [Member]
Debt Instrument [Line Items]
2,017	0
2,018	0
2,019	0
2,020	0
2,021	338,000
Thereafter	0
Total Principal Balance	338,000
Discount	0
Deferred Financing Costs	(2,327)
Total Debt, net	$ 335,673
Optional extension period	1 year

DERIVATIVE AND HEDGING INSTRU60

DERIVATIVE AND HEDGING INSTRUMENTS - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivative [Line Items]
Hedge ineffectiveness recorded in earnings	$ 800,000	$ 0	$ 0
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Interest Rate Cap [Member]
Derivative [Line Items]
Losses included in accumulated other comprehensive loss which are expected to be reclassified into earnings in the next 12 months	3,300,000
Proceeds from hedging	$ 300,000

DERIVATIVE AND HEDGING INSTRU61

DERIVATIVE AND HEDGING INSTRUMENTS - Summary of Notional Amounts of Derivative Instruments (Details) - Designated as Hedging Instrument [Member] - Cross Currency Interest Rate Swaps [Member] CAD in Thousands, $ in Thousands	Dec. 31, 2016USD ($)	Dec. 31, 2016CAD	Dec. 31, 2015USD ($)	Dec. 31, 2015CAD
Cash Flow Hedging [Member]
Derivative [Line Items]
Notional amount	$ 245,000	CAD 125,000	$ 200,000	CAD 90,000
Net Investment Hedging [Member]
Derivative [Line Items]
Notional amount		56,300		56,300
Notional amount		CAD 125,000		CAD 90,000

DERIVATIVE AND HEDGING INSTRU62

DERIVATIVE AND HEDGING INSTRUMENTS - Summary of Derivative and Financial Instruments Designated as Hedging Instruments (Details) $ in Thousands	Dec. 31, 2016USD ($)instrument	Dec. 31, 2015USD ($)
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	$ 11,240	$ 7,087
Derivative liability, fair value	716	1,468
Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	11,240	7,087
Derivative liability, fair value	$ 93,716	66,358
Designated as Hedging Instrument [Member] | Interest Rate Cap [Member] | Cash Flow [Member] | Prepaid Expenses, Deferred Financing Costs and Other Assets, Net [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, count | instrument	0
Derivative asset, fair value	$ 0	1,695
Designated as Hedging Instrument [Member] | Interest Rate Swap [Member] | Cash Flow [Member] | Prepaid Expenses, Deferred Financing Costs and Other Assets, Net [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, count | instrument	3
Derivative asset, fair value	$ 8,083	0
Designated as Hedging Instrument [Member] | Interest Rate Swap [Member] | Cash Flow [Member] | Accounts Payable and Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, count | instrument	1
Derivative liability, fair value	$ 716	1,468
Designated as Hedging Instrument [Member] | Cross Currency Interest Rate Swaps [Member] | Net Investment [Member] | Prepaid Expenses, Deferred Financing Costs and Other Assets, Net [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, count | instrument	2
Derivative asset, fair value	$ 3,157	5,392
Designated as Hedging Instrument [Member] | Prior Canadian Term Loan [Member] | Net Investment [Member] | Term Loans [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, count | instrument	1
Derivative liability, fair value	$ 93,000	$ 64,890

DERIVATIVE AND HEDGING INSTRU63

DERIVATIVE AND HEDGING INSTRUMENTS - Schedule of Hedging Instruments on the Consolidated Statements of Income and Consolidated Statements of Equity (Details) - Designated as Hedging Instrument [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Other Comprehensive Income (Effective Portion)	$ 44	$ (7,640)	$ (1,542)
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income (Effective Portion)	(1,360)	(319)	0
Interest Rate Products [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Other Comprehensive Income (Effective Portion)	5,879	(4,764)	(1,542)
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income (Effective Portion)	(1,360)	(319)	0
Foreign Currency Products [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Other Comprehensive Income (Effective Portion)	(2,085)	5,476	0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income (Effective Portion)	0	0	0
Prior Canadian Term Loan [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Other Comprehensive Income (Effective Portion)	(3,750)	(8,352)	0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income (Effective Portion)	$ 0	$ 0	$ 0

DERIVATIVE AND HEDGING INSTRU64

DERIVATIVE AND HEDGING INSTRUMENTS - Schedule of the Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Offsetting Assets:
Gross Amounts of Recognized Assets / Liabilities	$ 11,240	$ 7,087
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts of Assets / Liabilities presented in the Balance Sheet	11,240	7,087
Financial Instruments	(716)	(1,468)
Cash Collateral Received	0	0
Net Amount	10,524	5,619
Offsetting Liabilities:
Gross Amounts of Recognized Assets / Liabilities	716	1,468
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts of Assets / Liabilities presented in the Balance Sheet	716	1,468
Financial Instruments	(716)	(1,468)
Cash Collateral Received	0	0
Net Amount	$ 0	$ 0

FAIR VALUE DISCLOSURES - Summar

FAIR VALUE DISCLOSURES - Summary of Face Values, Carrying Amounts and Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable, face value	$ 53,484	$ 273,811
Preferred equity investments, face value	44,882	29,643
Senior Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities, face value	700,000	700,000
Mortgage indebtedness [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities, face value	163,638	177,850
Carrying Amount [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	53,596	270,184
Preferred equity investments	45,190	29,993
Carrying Amount [Member] | Senior Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	688,246	685,704
Carrying Amount [Member] | Mortgage indebtedness [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	160,752	174,846
Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	51,914	274,628
Preferred equity investments	48,332	30,838
Fair Value [Member] | Senior Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	709,500	718,500
Fair Value [Member] | Mortgage indebtedness [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	$ 150,091	$ 165,296

FAIR VALUE DISCLOSURES - Schedu

FAIR VALUE DISCLOSURES - Schedule of Inputs used for Carrying Amounts which do not Approximate Fair Value with Valuation Methods (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Total [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	$ 51,914	$ 274,628
Preferred equity investments	48,332	30,838
Total [Member] | Senior Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	709,500	718,500
Total [Member] | Mortgage indebtedness [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	150,091	$ 165,296
Recurring [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	0
Preferred equity investments	0
Recurring [Member] | Level 1 [Member] | Senior Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring [Member] | Level 1 [Member] | Mortgage indebtedness [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	0
Preferred equity investments	0
Recurring [Member] | Level 2 [Member] | Senior Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	709,500
Recurring [Member] | Level 2 [Member] | Mortgage indebtedness [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	51,914
Preferred equity investments	48,332
Recurring [Member] | Level 3 [Member] | Senior Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring [Member] | Level 3 [Member] | Mortgage indebtedness [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	150,091
Recurring [Member] | Total [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	51,914
Preferred equity investments	48,332
Recurring [Member] | Total [Member] | Senior Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	709,500
Recurring [Member] | Total [Member] | Mortgage indebtedness [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	$ 150,091

FAIR VALUE DISCLOSURES - Sche67

FAIR VALUE DISCLOSURES - Schedule of Amounts Measured at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	$ 11,240	$ 7,087
Financial liability	716	1,468
Recurring [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	0
Recurring [Member] | Level 1 [Member] | Cross Currency Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Recurring [Member] | Level 1 [Member] | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Financial liability	0
Recurring [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	0
Recurring [Member] | Level 2 [Member] | Cross Currency Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	3,157
Recurring [Member] | Level 2 [Member] | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	8,083
Financial liability	716
Recurring [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	818	$ 2,700	$ 3,900
Recurring [Member] | Level 3 [Member] | Cross Currency Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Recurring [Member] | Level 3 [Member] | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Financial liability	0
Recurring [Member] | Total [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	818
Recurring [Member] | Total [Member] | Cross Currency Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	3,157
Recurring [Member] | Total [Member] | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	8,083
Financial liability	$ 716

FAIR VALUE DISCLOSURES - Narrat

FAIR VALUE DISCLOSURES - Narrative (Details)	12 Months Ended
	Dec. 31, 2016USD ($)acquisition	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Recurring [Member] | Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contingent consideration liability	$ 818,000	$ 2,700,000	$ 3,900,000
Contingent consideration asset	$ 0	$ 350,000	$ 0
Acquisitions With Contingent Consideration Arrangements [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of real estate acquisitions | acquisition	4
Contingent consideration asset	$ 0

FAIR VALUE DISCLOSURES - Sche69

FAIR VALUE DISCLOSURES - Schedule of Reconciliation for Contingent Consideration Liability/Asset Recorded at Fair Value using Level 3 Inputs (Details) - Recurring [Member] - Level 3 [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Business Combination, Contingent Consideration, Liability [Abstract]
Beginning balance	$ 2,700	$ 3,900
Decrease in contingent liability	(1,876)	(1,200)
Foreign currency translation	(6)
Ending balance	818	2,700
Business Combination, Contingent Consideration, Asset [Abstract]
Beginning balance	350	0
Increase in contingent asset	(350)	350
Ending balance	$ 0	$ 350

EQUITY - Narrative (Details)

EQUITY - Narrative (Details) - USD ($)	Jun. 30, 2015	Mar. 21, 2013	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Equity [Abstract]
Preferred stock, shares issued (in shares)		5,800,000	5,750,000	5,750,000
Preferred stock, dividend rate, percentage		7.125%
Redemption price per share (in dollars per share)		$ 25
Preferred stock, net proceeds from offering		$ 138,300,000
Preferred stock, dividends in arrears			$ 0
Convertible preferred stock, conversion price (in dollars per share)		$ 25
Convertible preferred stock, shares issued upon conversion (in shares)		1.7864
Common stock issuance (in shares)	5,900,000
Common stock, net proceeds from offering	$ 147,900,000		(1,289,000)	$ 139,403,000	$ 510,147,000
Price per share (in dollars per share)	$ 25.06
Tax withholding obligations			$ 1,500,000	$ 5,000,000

EQUITY - Schedule of Other Comm

EQUITY - Schedule of Other Common Stock Issuances (Details) - shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Equity [Abstract]
Vesting of common stock units	103,279	235,334

EQUITY - Summary of Accumulated

EQUITY - Summary of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	$ 1,015,574	$ 1,053,770
Total accumulated other comprehensive loss [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(1,798)	(7,333)
Foreign currency translation [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(3,067)	(1,433)
Unrealized losses on cash flow hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	$ 1,269	$ (5,900)

STOCK-BASED COMPENSATION - Narr

STOCK-BASED COMPENSATION - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of stock options exercised			$ 700
Total fair value of stock options vested			200
Stock options outstanding (in shares)	0	0
Total fair value of units vested	$ 4,700	$ 8,500	9,600
Stock-based compensation expense	7,496	6,123	9,851
Total unrecognized stock-based compensation expense	$ 10,400
Weighted average period to recognized stock-based compensation expense	2 years 7 months
Discretionary matching contribution percent	3.00%
Matching contributions	$ 73	$ 35	$ 51
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average remaining vesting period	2 years 2 months
Weighted average fair value per share (in dollars per share)	$ 22.05	$ 21.11	$ 25.88
FFO Units [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%
FFO Units [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	250.00%
TSR Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Historical volatility rate period	3 years
TSR Units [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%
TSR Units [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	200.00%
Performance Incentive Plan of 2009 [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock convertible upon each performance-based restricted stock unit vesting (in shares)	1
Performance Incentive Plan of 2009 [Member] | Restricted Stock Units [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Performance Incentive Plan of 2009 [Member] | Restricted Stock Units [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	5 years

STOCK-BASED COMPENSATION - Summ

STOCK-BASED COMPENSATION - Summary of Additional Information Concerning Restricted Stock Units (Details) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Restricted Stock Units Activity
Vested (in shares)	(103,279)	(235,334)
Restricted Stock Units [Member]
Restricted Stock Units Activity
Unvested beginning balance (in shares)	732,756
Granted (in shares)	393,532
Vested (in shares)	(214,671)
Dividends reinvested (in shares)	73,888
Cancelled (in shares)	(81,538)
Unvested ending balance (in shares)	903,967	732,756
Weighted Average Grant Date Fair Value Per Unit
Unvested beginning balance (in dollars per share)	$ 21.37
Granted (in dollars per share)	22.05	$ 21.11	$ 25.88
Vested (in dollars per share)	22.01
Dividends reinvested (in dollars per share)	22.07
Cancelled (in dollars per share)	21.13
Unvested ending balance (in dollars per share)	$ 21.58	$ 21.37

STOCK-BASED COMPENSATION - Su75

STOCK-BASED COMPENSATION - Summary of Assumptions used in Total Stockholder Return-Based Stock Units Valuation (Details) - TSR Units [Member]	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Assumptions used in fair value valuation
Expected Service Period			3 years
Expected Dividend Yield (assuming full reinvestment)	0.00%	0.00%	0.00%
Minimum [Member]
Assumptions used in fair value valuation
Risk Free Interest Rate	0.78%	0.87%	1.07%
Expected Stock Price Volatility	27.40%	23.55%	24.14%
Expected Service Period	2 years 3 months 18 days	2 years 6 months
Maximum [Member]
Assumptions used in fair value valuation
Risk Free Interest Rate	1.60%	1.31%	1.09%
Expected Stock Price Volatility	28.42%	27.02%	24.22%
Expected Service Period	3 years	3 years

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($)	Jan. 01, 2011	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Business Acquisition [Line Items]
Income tax expense (benefit)			$ 0	$ 0
Built-in-gains tax associated to properties	$ 145,800,000
Corporate tax rate	40.00%
Acquisitions in Canada [Member] | Foreign Tax Authority [Member] | Canada Revenue Agency [Member]
Business Acquisition [Line Items]
Income tax expense (benefit)		$ (700,000)
Valuation allowance		$ 700,000

INCOME TAXES - Schedule of Reco

INCOME TAXES - Schedule of Reconciliation of Beginning and Ending Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Reconciliation of Unrecognized Tax Benefits
Unrecognized tax benefits, beginning balance	$ 24,212	$ 24,212
Additions (reductions) based on prior years’ tax positions	(24,212)	0
Additions (reductions) based on current year tax positions	0	0
Unrecognized tax benefits, ending balance	$ 0	$ 24,212

EARNINGS PER COMMON SHARE - Sch

EARNINGS PER COMMON SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Numerator
Net income attributable to common stockholders	$ 60,034	$ 69,171	$ 36,710
Denominator
Basic weighted average common shares (in shares)	65,284,251	62,235,014	46,351,544
Dilutive stock options and restricted stock units (in shares)	236,421	225,225	537,987
Dilutive weighted average common shares (in shares)	65,520,672	62,460,239	46,889,531
Net income attributable to common stockholders, per:
Basic common share (in dollars per share)	$ 0.92	$ 1.11	$ 0.79
Diluted common share (in dollars per share)	$ 0.92	$ 1.11	$ 0.78

EARNINGS PER COMMON SHARE - Nar

EARNINGS PER COMMON SHARE - Narrative (Details) - shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share
Stock options outstanding (in shares)	0	0
Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share
Anti-dilutive shares excluded from the computation of earnings per share	128,000	76,000	54,000
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share
Anti-dilutive shares excluded from the computation of earnings per share			0

SUMMARIZED CONSOLIDATING INFO80

SUMMARIZED CONSOLIDATING INFORMATION - Schedule of Consolidating Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Assets
Real estate investments, net of accumulated depreciation	$ 2,009,939	$ 2,039,616
Loans receivable and other investments, net	96,036	300,177
Cash and cash equivalents	25,663	7,434	$ 61,793	$ 4,308
Restricted cash	9,002	9,813
Prepaid expenses, deferred financing costs and other assets, net	125,279	111,797
Intercompany	0	0
Investment in subsidiaries	0	0
Total assets	2,265,919	2,468,837
Liabilities
Mortgage notes, net	160,752	174,846
Revolving credit facility	26,000	255,000
Term loans, net	335,673	264,229
Senior unsecured notes, net	688,246	685,704
Accounts payable and accrued liabilities	39,639	35,182
Intercompany	0	0
Total liabilities	1,250,310	1,414,961
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity:	1,015,574	1,053,770
Noncontrolling interests	35	106
Total equity	1,015,609	1,053,876	941,823	460,164
Total liabilities and equity	2,265,919	2,468,837
Elimination [Member]
Assets
Real estate investments, net of accumulated depreciation	0	0
Loans receivable and other investments, net	0	(2,105)
Cash and cash equivalents	0	0	0	0
Restricted cash	0	0
Prepaid expenses, deferred financing costs and other assets, net	(1,909)	(2,855)
Intercompany	(1,054,657)	(1,407,972)
Investment in subsidiaries	(1,560,855)	(1,369,761)
Total assets	(2,617,421)	(2,782,693)
Liabilities
Mortgage notes, net	0	0
Revolving credit facility	0	0
Term loans, net	0	0
Senior unsecured notes, net	0	0
Accounts payable and accrued liabilities	(1,909)	(1,856)
Intercompany	(1,054,657)	(1,407,972)
Total liabilities	(1,056,566)	(1,409,828)
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity:	(1,560,855)	(1,372,865)
Noncontrolling interests	0	0
Total equity	(1,560,855)	(1,372,865)
Total liabilities and equity	(2,617,421)	(2,782,693)
Parent Company [Member]
Assets
Real estate investments, net of accumulated depreciation	150	48
Loans receivable and other investments, net	(410)	0
Cash and cash equivalents	18,168	2,548	58,799	3,551
Restricted cash	0	0
Prepaid expenses, deferred financing costs and other assets, net	2,859	2,047
Intercompany	368,281	489,763
Investment in subsidiaries	640,238	568,841
Total assets	1,029,286	1,063,247
Liabilities
Mortgage notes, net	0	0
Revolving credit facility	0	0
Term loans, net	0	0
Senior unsecured notes, net	0	0
Accounts payable and accrued liabilities	13,712	9,477
Intercompany	0	0
Total liabilities	13,712	9,477
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity:	1,015,574	1,053,770
Noncontrolling interests	0	0
Total equity	1,015,574	1,053,770
Total liabilities and equity	1,029,286	1,063,247
Issuers [Member]
Assets
Real estate investments, net of accumulated depreciation	0	0
Loans receivable and other investments, net	0	0
Cash and cash equivalents	0	0	0	0
Restricted cash	0	0
Prepaid expenses, deferred financing costs and other assets, net	18,023	13,384
Intercompany	686,376	918,209
Investment in subsidiaries	908,253	792,065
Total assets	1,612,652	1,723,658
Liabilities
Mortgage notes, net	0	0
Revolving credit facility	26,000	255,000
Term loans, net	243,626	200,000
Senior unsecured notes, net	688,246	685,704
Accounts payable and accrued liabilities	14,542	14,113
Intercompany	0	0
Total liabilities	972,414	1,154,817
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity:	640,238	568,841
Noncontrolling interests	0	0
Total equity	640,238	568,841
Total liabilities and equity	1,612,652	1,723,658
Combined Guarantor Subsidiaries [Member]
Assets
Real estate investments, net of accumulated depreciation	1,828,629	1,874,394
Loans receivable and other investments, net	96,446	302,282
Cash and cash equivalents	2,675	456	0	0
Restricted cash	57	1,788
Prepaid expenses, deferred financing costs and other assets, net	95,740	91,225
Intercompany	0	0
Investment in subsidiaries	12,364	8,855
Total assets	2,035,911	2,279,000
Liabilities
Mortgage notes, net	0	10,766
Revolving credit facility	0	0
Term loans, net	92,047	64,229
Senior unsecured notes, net	0	0
Accounts payable and accrued liabilities	11,333	11,392
Intercompany	1,048,309	1,399,041
Total liabilities	1,151,689	1,485,428
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity:	884,222	793,572
Noncontrolling interests	0	0
Total equity	884,222	793,572
Total liabilities and equity	2,035,911	2,279,000
Combined Non-Guarantor Subsidiaries [Member]
Assets
Real estate investments, net of accumulated depreciation	181,160	165,174
Loans receivable and other investments, net	0	0
Cash and cash equivalents	4,820	4,430	$ 2,994	$ 757
Restricted cash	8,945	8,025
Prepaid expenses, deferred financing costs and other assets, net	10,566	7,996
Intercompany	0	0
Investment in subsidiaries	0	0
Total assets	205,491	185,625
Liabilities
Mortgage notes, net	160,752	164,080
Revolving credit facility	0	0
Term loans, net	0	0
Senior unsecured notes, net	0	0
Accounts payable and accrued liabilities	1,961	2,056
Intercompany	6,348	8,931
Total liabilities	169,061	175,067
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity:	36,395	10,452
Noncontrolling interests	35	106
Total equity	36,430	10,558
Total liabilities and equity	$ 205,491	$ 185,625

SUMMARIZED CONSOLIDATING INFO81

SUMMARIZED CONSOLIDATING INFORMATION - Schedule of Consolidating Statement of Income (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues:
Rental income	$ 225,275,000	$ 209,851,000	$ 161,483,000
Interest and other income	27,463,000	25,505,000	19,367,000
Resident fees and services	7,788,000	3,508,000	2,668,000
Total revenues	260,526,000	238,864,000	183,518,000
Expenses:
Depreciation and amortization	68,472,000	63,079,000	43,332,000
Interest	64,873,000	59,218,000	46,958,000
Operating expenses	5,703,000	2,576,000	1,930,000
General and administrative	19,918,000	23,865,000	23,815,000
Provision for doubtful accounts and loan losses	5,543,000	12,842,000	3,594,000
Impairment of real estate	29,811,000	0	0
Total expenses	194,320,000	161,580,000	119,629,000
Other income (expense):
Loss on extinguishment of debt	(556,000)	0	(22,454,000)
Other income	10,677,000	2,260,000	1,560,000
Net (loss) gain on sales of real estate	(6,122,000)	(161,000)	3,914,000
Total other income (expense)	3,999,000	2,099,000	(16,980,000)
Income in subsidiary	0	0	0
Net income	70,205,000	79,383,000	46,909,000
Net loss attributable to noncontrolling interest	71,000	30,000	43,000
Net income attributable to Sabra Health Care REIT, Inc.	70,276,000	79,413,000	46,952,000
Preferred stock dividends	(10,242,000)	(10,242,000)	(10,242,000)
Net income attributable to common stockholders	$ 60,034,000	$ 69,171,000	$ 36,710,000
Net income attributable to common stockholders, per:
Basic common share (in dollars per share)	$ 0.92	$ 1.11	$ 0.79
Diluted common share (in dollars per share)	$ 0.92	$ 1.11	$ 0.78
Weighted-average number of common shares outstanding, basic (in shares)	65,284,251	62,235,014	46,351,544
Weighted-average number of common shares outstanding, diluted (in shares)	65,520,672	62,460,239	46,889,531
Elimination [Member]
Revenues:
Rental income	$ (2,328,000)	$ (1,201,000)	$ 0
Interest and other income	(253,000)	(304,000)	0
Resident fees and services	0	0	0
Total revenues	(2,581,000)	(1,505,000)	0
Expenses:
Depreciation and amortization	0	0	0
Interest	0	(261,000)	0
Operating expenses	(2,363,000)	(1,213,000)	0
General and administrative	0	0	0
Provision for doubtful accounts and loan losses	0	0	0
Impairment of real estate	0
Total expenses	(2,363,000)	(1,474,000)	0
Other income (expense):
Loss on extinguishment of debt	0		0
Other income	0	0	0
Net (loss) gain on sales of real estate	0	0	0
Total other income (expense)	0	0	0
Income in subsidiary	(219,716,000)	(250,001,000)	(195,709,000)
Net income	(219,934,000)	(250,032,000)	(195,709,000)
Net loss attributable to noncontrolling interest	0	0	0
Net income attributable to Sabra Health Care REIT, Inc.	(219,934,000)	(250,032,000)	(195,709,000)
Preferred stock dividends	0	0	0
Net income attributable to common stockholders	(219,934,000)	(250,032,000)	(195,709,000)
Parent Company [Member]
Revenues:
Rental income	0	0	0
Interest and other income	3,000	2,000	9,000
Resident fees and services	0	0	0
Total revenues	3,000	2,000	9,000
Expenses:
Depreciation and amortization	816,000	47,000	52,000
Interest	0	0	0
Operating expenses	0	0	0
General and administrative	16,218,000	14,910,000	17,922,000
Provision for doubtful accounts and loan losses	(1,376,000)	1,291,000	600,000
Impairment of real estate	0
Total expenses	15,658,000	16,248,000	18,574,000
Other income (expense):
Loss on extinguishment of debt	0		0
Other income	7,366,000	0	0
Net (loss) gain on sales of real estate	0	0	0
Total other income (expense)	7,366,000	0	0
Income in subsidiary	78,783,000	95,690,000	65,517,000
Net income	70,494,000	79,444,000	46,952,000
Net loss attributable to noncontrolling interest	0	0	0
Net income attributable to Sabra Health Care REIT, Inc.	70,494,000	79,444,000	46,952,000
Preferred stock dividends	(10,242,000)	(10,242,000)	(10,242,000)
Net income attributable to common stockholders	60,252,000	69,202,000	36,710,000
Issuers [Member]
Revenues:
Rental income	0	0	0
Interest and other income	0	334,000	0
Resident fees and services	0	0	0
Total revenues	0	334,000	0
Expenses:
Depreciation and amortization	0	0	0
Interest	54,589,000	52,208,000	37,129,000
Operating expenses	0	0	0
General and administrative	57,000	30,000	2,000
Provision for doubtful accounts and loan losses	0	0	0
Impairment of real estate	0
Total expenses	54,646,000	52,238,000	37,131,000
Other income (expense):
Loss on extinguishment of debt	(468,000)		(21,846,000)
Other income	(196,000)	1,651,000	0
Net (loss) gain on sales of real estate	0	0	0
Total other income (expense)	(664,000)	1,651,000	(21,846,000)
Income in subsidiary	134,093,000	145,943,000	124,494,000
Net income	78,783,000	95,690,000	65,517,000
Net loss attributable to noncontrolling interest	0	0	0
Net income attributable to Sabra Health Care REIT, Inc.	78,783,000	95,690,000	65,517,000
Preferred stock dividends	0	0	0
Net income attributable to common stockholders	78,783,000	95,690,000	65,517,000
Combined Guarantor Subsidiaries [Member]
Revenues:
Rental income	206,406,000	190,582,000	142,249,000
Interest and other income	27,712,000	25,472,000	19,357,000
Resident fees and services	0	0	0
Total revenues	234,118,000	216,054,000	161,606,000
Expenses:
Depreciation and amortization	60,910,000	57,141,000	37,645,000
Interest	3,497,000	1,536,000	4,642,000
Operating expenses	0	0	0
General and administrative	3,284,000	8,566,000	5,561,000
Provision for doubtful accounts and loan losses	6,498,000	11,551,000	2,994,000
Impairment of real estate	29,811,000
Total expenses	104,000,000	78,794,000	50,842,000
Other income (expense):
Loss on extinguishment of debt	(88,000)		(472,000)
Other income	3,507,000	(101,000)	1,560,000
Net (loss) gain on sales of real estate	(6,143,000)	(161,000)	3,914,000
Total other income (expense)	(2,724,000)	(262,000)	5,002,000
Income in subsidiary	6,840,000	8,368,000	5,698,000
Net income	134,234,000	145,366,000	121,464,000
Net loss attributable to noncontrolling interest	0	0	0
Net income attributable to Sabra Health Care REIT, Inc.	134,234,000	145,366,000	121,464,000
Preferred stock dividends	0	0	0
Net income attributable to common stockholders	134,234,000	145,366,000	121,464,000
Combined Non-Guarantor Subsidiaries [Member]
Revenues:
Rental income	21,197,000	20,470,000	19,234,000
Interest and other income	1,000	1,000	1,000
Resident fees and services	7,788,000	3,508,000	2,668,000
Total revenues	28,986,000	23,979,000	21,903,000
Expenses:
Depreciation and amortization	6,746,000	5,891,000	5,635,000
Interest	6,787,000	5,735,000	5,187,000
Operating expenses	8,066,000	3,789,000	1,930,000
General and administrative	359,000	359,000	330,000
Provision for doubtful accounts and loan losses	421,000	0	0
Impairment of real estate	0
Total expenses	22,379,000	15,774,000	13,082,000
Other income (expense):
Loss on extinguishment of debt	0		(136,000)
Other income	0	710,000	0
Net (loss) gain on sales of real estate	21,000	0	0
Total other income (expense)	21,000	710,000	(136,000)
Income in subsidiary	0	0	0
Net income	6,628,000	8,915,000	8,685,000
Net loss attributable to noncontrolling interest	71,000	30,000	43,000
Net income attributable to Sabra Health Care REIT, Inc.	6,699,000	8,945,000	8,728,000
Preferred stock dividends	0	0	0
Net income attributable to common stockholders	$ 6,699,000	$ 8,945,000	$ 8,728,000

SUMMARIZED CONSOLIDATING INFO82

SUMMARIZED CONSOLIDATING INFORMATION - Schedule of Condensed Consolidating Statement of Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]
Net income	$ 70,205	$ 79,383	$ 46,909
Other comprehensive income (loss):
Foreign currency translation	(1,634)	(1,433)	0
Unrealized gain (loss) on cash flow hedge	7,169	(4,358)	(1,542)
Total other comprehensive income (loss)	5,535	(5,791)	(1,542)
Comprehensive income	75,740	73,592	45,367
Comprehensive loss attributable to noncontrolling interest	71	30	43
Comprehensive income attributable to Sabra Health Care REIT, Inc.	75,811	73,622	45,410
Elimination [Member]
Condensed Financial Statements, Captions [Line Items]
Net income	(219,934)	(250,032)	(195,709)
Other comprehensive income (loss):
Foreign currency translation	0	0
Unrealized gain (loss) on cash flow hedge	0	0	0
Total other comprehensive income (loss)	0	0	0
Comprehensive income	(219,934)	(250,032)	(195,709)
Comprehensive loss attributable to noncontrolling interest	0	0	0
Comprehensive income attributable to Sabra Health Care REIT, Inc.	(219,934)	(250,032)	(195,709)
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Net income	70,494	79,444	46,952
Other comprehensive income (loss):
Foreign currency translation	0	0
Unrealized gain (loss) on cash flow hedge	0	0	0
Total other comprehensive income (loss)	0	0	0
Comprehensive income	70,494	79,444	46,952
Comprehensive loss attributable to noncontrolling interest	0	0	0
Comprehensive income attributable to Sabra Health Care REIT, Inc.	70,494	79,444	46,952
Issuers [Member]
Condensed Financial Statements, Captions [Line Items]
Net income	78,783	95,690	65,517
Other comprehensive income (loss):
Foreign currency translation	(2,080)	5,530
Unrealized gain (loss) on cash flow hedge	7,169	(4,358)	(1,542)
Total other comprehensive income (loss)	5,089	1,172	(1,542)
Comprehensive income	83,872	96,862	63,975
Comprehensive loss attributable to noncontrolling interest	0	0	0
Comprehensive income attributable to Sabra Health Care REIT, Inc.	83,872	96,862	63,975
Combined Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net income	134,234	145,366	121,464
Other comprehensive income (loss):
Foreign currency translation	364	(5,495)
Unrealized gain (loss) on cash flow hedge	0	0	0
Total other comprehensive income (loss)	364	(5,495)	0
Comprehensive income	134,598	139,871	121,464
Comprehensive loss attributable to noncontrolling interest	0	0	0
Comprehensive income attributable to Sabra Health Care REIT, Inc.	134,598	139,871	121,464
Combined Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net income	6,628	8,915	8,685
Other comprehensive income (loss):
Foreign currency translation	82	(1,468)
Unrealized gain (loss) on cash flow hedge	0	0	0
Total other comprehensive income (loss)	82	(1,468)	0
Comprehensive income	6,710	7,447	8,685
Comprehensive loss attributable to noncontrolling interest	71	30	43
Comprehensive income attributable to Sabra Health Care REIT, Inc.	$ 6,781	$ 7,477	$ 8,728

SUMMARIZED CONSOLIDATING INFO83

SUMMARIZED CONSOLIDATING INFORMATION - Schedule of Consolidating Statement of Cash Flows (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Mar. 21, 2013	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities			$ 176,739	$ 121,101	$ 85,337
Cash flows from investing activities:
Acquisitions of real estate			(153,579)	(461,330)	(771,479)
Origination and fundings of loans receivable			(9,675)	(49,687)	(66,397)
Origination and fundings of preferred equity investments			(7,348)	(12,804)	(15,486)
Additions to real estate			(1,003)	(3,689)	(1,471)
Repayment of loans receivable			215,962	5,803	1,097
Investment in Subsidiary			0	0	0
Net proceeds from sale of real estate			98,006	27,241	27,264
Distribution from Subsidiary			0	0	0
Intercompany financing			0	0	0
Release of contingent consideration held in escrow			0	5,240	0
Net cash (used in) provided by investing activities			142,363	(489,226)	(826,472)
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes			0	0	499,250
Principal payments on senior unsecured notes			0	0	(211,250)
Net proceeds (repayment) from revolving credit facility			(229,000)	187,000	132,500
Proceeds from term loan			69,360	73,242	0
Proceeds from mortgage notes			0	28,735	57,703
Principal payments on mortgage notes			(14,768)	(3,132)	(89,110)
Payments of deferred financing costs			(5,937)	(1,452)	(19,131)
Contributions by noncontrolling interests			0	179	0
Issuance of preferred stock		$ 138,300
Issuance of common stock, net	$ 147,900		(1,289)	139,403	510,147
Dividends paid on common and preferred stock			(119,264)	(109,897)	(81,489)
Contribution from Parent			0	0	0
Distribution to Parent			0	0	0
Intercompany financing			0	0	0
Net cash provided by (in used) financing activities			(300,898)	314,078	798,620
Net increase (decrease) in cash and cash equivalents			18,204	(54,047)	57,485
Effect of foreign currency translation on cash and cash equivalents			25	(312)	0
Cash and cash equivalents, beginning of period			7,434	61,793	4,308
Cash and cash equivalents, end of period			25,663	7,434	61,793
Elimination [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities			0	0	0
Cash flows from investing activities:
Acquisitions of real estate			0	0	0
Origination and fundings of loans receivable			0	0	0
Origination and fundings of preferred equity investments			0	0	0
Additions to real estate			0	0	0
Repayment of loans receivable			0	0	0
Investment in Subsidiary			400	828	24,294
Net proceeds from sale of real estate			0	0	0
Distribution from Subsidiary			(12,808)	(7,030)	(2,492)
Intercompany financing			(142,358)	588,536	1,374,760
Release of contingent consideration held in escrow				0
Net cash (used in) provided by investing activities			(154,766)	582,334	1,396,562
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes					0
Principal payments on senior unsecured notes					0
Net proceeds (repayment) from revolving credit facility			0	0	0
Proceeds from term loan			0	0
Proceeds from mortgage notes				0	0
Principal payments on mortgage notes			0	0	0
Payments of deferred financing costs			0	0	0
Contributions by noncontrolling interests				0
Issuance of common stock, net			0	0	0
Dividends paid on common and preferred stock			0	0	0
Contribution from Parent			(400)	(828)	(24,294)
Distribution to Parent			12,808	7,030	2,492
Intercompany financing			142,358	(588,536)	(1,374,760)
Net cash provided by (in used) financing activities			154,766	(582,334)	(1,396,562)
Net increase (decrease) in cash and cash equivalents			0	0	0
Effect of foreign currency translation on cash and cash equivalents			0	0
Cash and cash equivalents, beginning of period			0	0	0
Cash and cash equivalents, end of period			0	0	0
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities			153,577	112,291	53,292
Cash flows from investing activities:
Acquisitions of real estate			0	0	0
Origination and fundings of loans receivable			0	0	0
Origination and fundings of preferred equity investments			0	0	0
Additions to real estate			(124)	(34)	(11)
Repayment of loans receivable			0	0	0
Investment in Subsidiary			(200)	(414)	(12,147)
Net proceeds from sale of real estate			0	0	0
Distribution from Subsidiary			6,404	3,515	1,246
Intercompany financing			(23,484)	(200,884)	(415,790)
Release of contingent consideration held in escrow				0
Net cash (used in) provided by investing activities			(17,404)	(197,817)	(426,702)
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes					0
Principal payments on senior unsecured notes					0
Net proceeds (repayment) from revolving credit facility			0	0	0
Proceeds from term loan			0	0
Proceeds from mortgage notes				0	0
Principal payments on mortgage notes			0	0	0
Payments of deferred financing costs			0	0	0
Contributions by noncontrolling interests				0
Issuance of common stock, net			(1,289)	139,403	510,147
Dividends paid on common and preferred stock			(119,264)	(109,897)	(81,489)
Contribution from Parent			0	0	0
Distribution to Parent			0	0	0
Intercompany financing			0	0	0
Net cash provided by (in used) financing activities			(120,553)	29,506	428,658
Net increase (decrease) in cash and cash equivalents			15,620	(56,020)	55,248
Effect of foreign currency translation on cash and cash equivalents			0	(231)
Cash and cash equivalents, beginning of period			2,548	58,799	3,551
Cash and cash equivalents, end of period			18,168	2,548	58,799
Issuers [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities			0	0	0
Cash flows from investing activities:
Acquisitions of real estate			0	0	0
Origination and fundings of loans receivable			0	0	0
Origination and fundings of preferred equity investments			0	0	0
Additions to real estate			0	0	0
Repayment of loans receivable			0	0	0
Investment in Subsidiary			(200)	(414)	(12,147)
Net proceeds from sale of real estate			0	0	0
Distribution from Subsidiary			6,404	3,515	1,246
Intercompany financing			165,842	(387,652)	(958,970)
Release of contingent consideration held in escrow				0
Net cash (used in) provided by investing activities			172,046	(384,551)	(969,871)
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes					499,250
Principal payments on senior unsecured notes					(211,250)
Net proceeds (repayment) from revolving credit facility			(229,000)	187,000	268,000
Proceeds from term loan			45,000	0
Proceeds from mortgage notes				0	0
Principal payments on mortgage notes			0	0	0
Payments of deferred financing costs			(5,326)	(232)	(12,820)
Contributions by noncontrolling interests				0
Issuance of common stock, net			0	0	0
Dividends paid on common and preferred stock			0	0	0
Contribution from Parent			200	414	12,147
Distribution to Parent			(6,404)	(3,515)	(1,246)
Intercompany financing			23,484	200,884	415,790
Net cash provided by (in used) financing activities			(172,046)	384,551	969,871
Net increase (decrease) in cash and cash equivalents			0	0	0
Effect of foreign currency translation on cash and cash equivalents			0	0
Cash and cash equivalents, beginning of period			0	0	0
Cash and cash equivalents, end of period			0	0	0
Combined Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities			12,074	820	0
Cash flows from investing activities:
Acquisitions of real estate			(133,797)	(450,082)	(763,378)
Origination and fundings of loans receivable			(9,675)	(49,687)	(66,397)
Origination and fundings of preferred equity investments			(7,348)	(12,804)	(15,486)
Additions to real estate			(502)	(1,286)	(1,437)
Repayment of loans receivable			215,962	5,803	1,097
Investment in Subsidiary			0	0	0
Net proceeds from sale of real estate			97,407	27,241	27,264
Distribution from Subsidiary			0	0	0
Intercompany financing			0	0	0
Release of contingent consideration held in escrow				5,240
Net cash (used in) provided by investing activities			162,047	(475,575)	(818,337)
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes					0
Principal payments on senior unsecured notes					0
Net proceeds (repayment) from revolving credit facility			0	0	(135,500)
Proceeds from term loan			24,360	73,242
Proceeds from mortgage notes				0	0
Principal payments on mortgage notes			(10,766)	0	0
Payments of deferred financing costs			(611)	(740)	(5,133)
Contributions by noncontrolling interests				0
Issuance of common stock, net			0	0	0
Dividends paid on common and preferred stock			0	0	0
Contribution from Parent			0	0	0
Distribution to Parent			0	0	0
Intercompany financing			(184,957)	402,745	958,970
Net cash provided by (in used) financing activities			(171,974)	475,247	818,337
Net increase (decrease) in cash and cash equivalents			2,147	492	0
Effect of foreign currency translation on cash and cash equivalents			72	(36)
Cash and cash equivalents, beginning of period			456	0	0
Cash and cash equivalents, end of period			2,675	456	0
Combined Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities			11,088	7,990	32,045
Cash flows from investing activities:
Acquisitions of real estate			(19,782)	(11,248)	(8,101)
Origination and fundings of loans receivable			0	0	0
Origination and fundings of preferred equity investments			0	0	0
Additions to real estate			(377)	(2,369)	(23)
Repayment of loans receivable			0	0	0
Investment in Subsidiary			0	0	0
Net proceeds from sale of real estate			599	0	0
Distribution from Subsidiary			0	0	0
Intercompany financing			0	0	0
Release of contingent consideration held in escrow				0
Net cash (used in) provided by investing activities			(19,560)	(13,617)	(8,124)
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes					0
Principal payments on senior unsecured notes					0
Net proceeds (repayment) from revolving credit facility			0	0	0
Proceeds from term loan			0	0
Proceeds from mortgage notes				28,735	57,703
Principal payments on mortgage notes			(4,002)	(3,132)	(89,110)
Payments of deferred financing costs			0	(480)	(1,178)
Contributions by noncontrolling interests				179
Issuance of common stock, net			0	0	0
Dividends paid on common and preferred stock			0	0	0
Contribution from Parent			200	414	12,147
Distribution to Parent			(6,404)	(3,515)	(1,246)
Intercompany financing			19,115	(15,093)	0
Net cash provided by (in used) financing activities			8,909	7,108	(21,684)
Net increase (decrease) in cash and cash equivalents			437	1,481	2,237
Effect of foreign currency translation on cash and cash equivalents			(47)	(45)
Cash and cash equivalents, beginning of period			4,430	2,994	757
Cash and cash equivalents, end of period			$ 4,820	$ 4,430	$ 2,994

PRO FORMA FINANCIAL INFORMATI84

PRO FORMA FINANCIAL INFORMATION (UNAUDITED) - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)CustomerPropertyFacilitiy	Dec. 31, 2015PropertyFacilitiy	Dec. 31, 2014Property
Business Acquisition [Line Items]
Number of real estate properties acquired | Property	7	24	42
Acquisition pursuit costs | $	$ 1.1
Skilled Nursing/Transitional Care Facilities [Member] | Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Number of real estate properties acquired | Facilitiy	1	4
Senior Housing [Member] | Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Number of real estate properties acquired	3	20

PRO FORMA FINANCIAL INFORMATI85

PRO FORMA FINANCIAL INFORMATION (UNAUDITED) - Schedule of Pro Forma Information (Details) - Series of Individually Immaterial Business Acquisitions [Member] - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Business Acquisition, Pro Forma Information [Abstract]
Revenues	$ 266,727	$ 276,978
Depreciation and amortization	70,316	74,101
Net income attributable to common stockholders	$ 65,530	$ 99,004
Net income attributable to common stockholders, per:
Basic common share (in dollars per share)	$ 1	$ 1.59
Diluted common share (in dollars per share)	$ 1	$ 1.59
Weighted-average number of common shares outstanding, basic (in shares)	65,284,251	62,235,014
Weighted-average number of common shares outstanding, diluted (in shares)	65,520,672	62,460,239

SUBSEQUENT EVENTS - Narrative (

SUBSEQUENT EVENTS - Narrative (Details) - $ / shares	Feb. 03, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Subsequent Event
Common stock dividends, declared (in dollars per share)		$ 1.67	$ 1.60	$ 1.51
Subsequent Event [Member] | Dividend Declared [Member]
Subsequent Event
Common stock dividends, declared (in dollars per share)	$ 0.42
Subsequent Event [Member] | Dividend Declared [Member] | Series A Preferred Stock [Member]
Subsequent Event
Preferred stock dividends, declared (in dollars per share)	$ 0.4453125

SCHEDULE II VALUATION AND QUA87

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	$ 13,442	$ 600
Charged to Earnings	5,543	12,842
Uncollectible Accounts Written-off	(8,862)	0
Foreign Currency Translation due to Charges	(12)	0
Balance at End of Year	10,111	13,442	$ 600
Allowance for doubtful accounts [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	3,811	0
Charged to Earnings	235	3,811
Uncollectible Accounts Written-off	(353)	0
Foreign Currency Translation due to Charges	0	0
Balance at End of Year	3,693	3,811	0
Straight-line rent receivable allowance [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	5,331	600	0
Charged to Earnings	3,540	4,731	600
Uncollectible Accounts Written-off	(5,191)	0	0
Foreign Currency Translation due to Charges	(12)	0	0
Balance at End of Year	3,668	5,331	600
Loan loss reserves [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	4,300	0
Charged to Earnings	1,768	4,300
Uncollectible Accounts Written-off	(3,318)	0
Foreign Currency Translation due to Charges	0	0
Balance at End of Year	$ 2,750	$ 4,300	$ 0

SCHEDULE III REAL ESTATE ASSE88

SCHEDULE III REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - Rollforward of Real Estate and Accumulated Depreciation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Real estate:
Balance at the beginning of the period	$ 2,277,457	$ 1,831,799	$ 1,066,496
Acquisitions	150,782	482,125	792,510
Real estate acquired through loan receivable foreclosure	10,100	0	0
Addition due to consolidation of variable interest entity	0	10,700	0
Improvements	1,003	3,689	1,471
Impairment	(39,058)	0	0
Sale of real estate	(107,930)	(29,395)	(23,265)
Foreign currency translation	4,623	(16,944)	0
Write-off of fully depreciated assets	(4,226)	(4,517)	(5,413)
Balance at the end of the year	2,292,751	2,277,457	1,831,799
Accumulated depreciation:
Balance at the beginning of the period	(237,841)	(185,994)	(151,078)
Depreciation expense	(64,463)	(59,864)	(42,021)
Impairment	9,247	0	0
Sale of real estate	6,023	3,384	1,692
Foreign currency translation	(4)	116	0
Write-off of fully depreciated assets	4,226	4,517	5,413
Balance at the end of the year	$ (282,812)	$ (237,841)	$ (185,994)

SCHEDULE III REAL ESTATE ASSE89

SCHEDULE III REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - Summary of Real Estate Properties (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Real Estate and Accumulated Depreciation
Encumbrances	$ 163,638
Initial Cost to Company
Land	220,615
Buildings and Improvements	2,102,752
Total	2,323,367
Cost Capitalized Subsequent to Acquisition	7,490
Gross Amount at which Carried at Close of Period
Land	220,042
Building and Improvements	2,072,709
Total	2,292,751	$ 2,277,457	$ 1,831,799	$ 1,066,496
Accumulated Depreciation and Amortization	(282,812)	(237,841)	$ (185,994)	$ (151,078)
Deferred Financing Costs	(16,452)
Aggregate cost of real estate for federal income tax purposes	2,300,000
Mortgages [Member]
Gross Amount at which Carried at Close of Period
Deferred Financing Costs	(2,886)	$ (3,000)
Operating Segments [Member]
Real Estate and Accumulated Depreciation
Encumbrances	163,638
Initial Cost to Company
Land	220,615
Buildings and Improvements	2,102,616
Total	2,323,231
Cost Capitalized Subsequent to Acquisition	7,220
Gross Amount at which Carried at Close of Period
Land	220,042
Building and Improvements	2,072,303
Total	2,292,345
Accumulated Depreciation and Amortization	(282,556)
Corporate Level [Member]
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	0
Buildings and Improvements	136
Total	136
Cost Capitalized Subsequent to Acquisition	270
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	406
Total	406
Accumulated Depreciation and Amortization	(256)
New Martinsville [Member]
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	475
Buildings and Improvements	10,543
Total	11,018
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	475
Building and Improvements	10,355
Total	10,830
Accumulated Depreciation and Amortization	$ (4,059)
Life on Which Depreciation in Latest Income Statement is Computed	39 years
Glenville [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	484
Buildings and Improvements	2,839
Total	3,323
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	484
Building and Improvements	2,729
Total	3,213
Accumulated Depreciation and Amortization	$ (754)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Renaissance Terrace [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	76
Buildings and Improvements	4,459
Total	4,535
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	76
Building and Improvements	3,943
Total	4,019
Accumulated Depreciation and Amortization	$ (1,905)
Life on Which Depreciation in Latest Income Statement is Computed	38 years
Greenwood [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,066
Buildings and Improvements	10,178
Total	12,244
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,066
Building and Improvements	9,810
Total	11,876
Accumulated Depreciation and Amortization	$ (4,194)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Forest Hills, SNF [Member]
Initial Cost to Company
Land	$ 1,653
Buildings and Improvements	11,259
Total	12,912
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,653
Building and Improvements	10,951
Total	12,604
Accumulated Depreciation and Amortization	$ (4,017)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Seminole Estates [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	655
Buildings and Improvements	3,527
Total	4,182
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	655
Building and Improvements	3,259
Total	3,914
Accumulated Depreciation and Amortization	$ (888)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Bryan Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,278
Buildings and Improvements	6,477
Total	7,755
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,278
Building and Improvements	6,081
Total	7,359
Accumulated Depreciation and Amortization	$ (2,102)
Life on Which Depreciation in Latest Income Statement is Computed	30 years
Sylvania [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	942
Buildings and Improvements	5,627
Total	6,569
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	942
Building and Improvements	5,178
Total	6,120
Accumulated Depreciation and Amortization	$ (2,323)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Point Place [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,089
Buildings and Improvements	5,364
Total	6,453
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,089
Building and Improvements	5,109
Total	6,198
Accumulated Depreciation and Amortization	$ (1,462)
Life on Which Depreciation in Latest Income Statement is Computed	36 years
Perrysburg [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	987
Buildings and Improvements	5,358
Total	6,345
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	987
Building and Improvements	4,996
Total	5,983
Accumulated Depreciation and Amortization	$ (1,710)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Forest View [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	819
Buildings and Improvements	4,214
Total	5,033
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	819
Building and Improvements	3,945
Total	4,764
Accumulated Depreciation and Amortization	$ (1,681)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
New Lebanon [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	784
Buildings and Improvements	4,243
Total	5,027
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	784
Building and Improvements	3,797
Total	4,581
Accumulated Depreciation and Amortization	$ (1,418)
Life on Which Depreciation in Latest Income Statement is Computed	28 years
New Lexington [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	63
Buildings and Improvements	3,487
Total	3,550
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	63
Building and Improvements	3,138
Total	3,201
Accumulated Depreciation and Amortization	$ (2,095)
Life on Which Depreciation in Latest Income Statement is Computed	20 years
Twin Rivers [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	280
Buildings and Improvements	3,004
Total	3,284
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	280
Building and Improvements	2,758
Total	3,038
Accumulated Depreciation and Amortization	$ (1,000)
Life on Which Depreciation in Latest Income Statement is Computed	30 years
San Juan [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 9,709
Initial Cost to Company
Land	799
Buildings and Improvements	4,163
Total	4,962
Cost Capitalized Subsequent to Acquisition	3
Gross Amount at which Carried at Close of Period
Land	799
Building and Improvements	3,866
Total	4,665
Accumulated Depreciation and Amortization	$ (1,512)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Mckinley Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 5,566
Initial Cost to Company
Land	409
Buildings and Improvements	1,865
Total	2,274
Cost Capitalized Subsequent to Acquisition	4
Gross Amount at which Carried at Close of Period
Land	409
Building and Improvements	1,768
Total	2,177
Accumulated Depreciation and Amortization	$ (687)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Bedford Hills [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 6,316
Initial Cost to Company
Land	1,911
Buildings and Improvements	12,245
Total	14,156
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,911
Building and Improvements	11,391
Total	13,302
Accumulated Depreciation and Amortization	$ (3,641)
Life on Which Depreciation in Latest Income Statement is Computed	36 years
Exeter on Hampton [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,365
Buildings and Improvements	2,350
Total	4,715
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,365
Building and Improvements	691
Total	3,056
Accumulated Depreciation and Amortization	$ (373)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Pheasant Wood [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	625
Buildings and Improvements	3,986
Total	4,611
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	625
Building and Improvements	3,479
Total	4,104
Accumulated Depreciation and Amortization	$ (1,443)
Life on Which Depreciation in Latest Income Statement is Computed	28 years
Westwood [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	699
Buildings and Improvements	3,823
Total	4,522
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	699
Building and Improvements	3,346
Total	4,045
Accumulated Depreciation and Amortization	$ (1,623)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Colonial Hill [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	412
Buildings and Improvements	3,960
Total	4,372
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	412
Building and Improvements	3,644
Total	4,056
Accumulated Depreciation and Amortization	$ (1,532)
Life on Which Depreciation in Latest Income Statement is Computed	44 years
Crestwood Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	557
Buildings and Improvements	3,441
Total	3,998
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	557
Building and Improvements	3,007
Total	3,564
Accumulated Depreciation and Amortization	$ (1,293)
Life on Which Depreciation in Latest Income Statement is Computed	28 years
Applewood [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	348
Buildings and Improvements	3,075
Total	3,423
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	348
Building and Improvements	2,673
Total	3,021
Accumulated Depreciation and Amortization	$ (963)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Elms Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	312
Buildings and Improvements	1,679
Total	1,991
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	312
Building and Improvements	1,480
Total	1,792
Accumulated Depreciation and Amortization	$ (801)
Life on Which Depreciation in Latest Income Statement is Computed	20 years
Woodland Hill [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,706
Buildings and Improvements	8,053
Total	9,759
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,706
Building and Improvements	7,612
Total	9,318
Accumulated Depreciation and Amortization	$ (2,378)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Missouri River [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 11,064
Initial Cost to Company
Land	2,023
Buildings and Improvements	16,967
Total	18,990
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,023
Building and Improvements	16,516
Total	18,539
Accumulated Depreciation and Amortization	$ (6,741)
Life on Which Depreciation in Latest Income Statement is Computed	30 years
Butte Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,092
Buildings and Improvements	12,654
Total	13,746
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,092
Building and Improvements	12,469
Total	13,561
Accumulated Depreciation and Amortization	$ (4,308)
Life on Which Depreciation in Latest Income Statement is Computed	35 years
Whitefish Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	651
Buildings and Improvements	6,339
Total	6,990
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	651
Building and Improvements	6,206
Total	6,857
Accumulated Depreciation and Amortization	$ (2,230)
Life on Which Depreciation in Latest Income Statement is Computed	35 years
Deer Lodge [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,218
Initial Cost to Company
Land	190
Buildings and Improvements	3,032
Total	3,222
Cost Capitalized Subsequent to Acquisition	2
Gross Amount at which Carried at Close of Period
Land	190
Building and Improvements	2,963
Total	3,153
Accumulated Depreciation and Amortization	$ (1,279)
Life on Which Depreciation in Latest Income Statement is Computed	30 years
Twin Oaks [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	885
Buildings and Improvements	5,100
Total	5,985
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	885
Building and Improvements	4,408
Total	5,293
Accumulated Depreciation and Amortization	$ (1,810)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Maplewood [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	771
Buildings and Improvements	4,550
Total	5,321
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	771
Building and Improvements	3,710
Total	4,481
Accumulated Depreciation and Amortization	$ (1,507)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Saugus [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	285
Buildings and Improvements	1,643
Total	1,928
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	285
Building and Improvements	1,039
Total	1,324
Accumulated Depreciation and Amortization	$ (493)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Kensington Manor [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,864
Buildings and Improvements	7,523
Total	9,387
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,864
Building and Improvements	7,045
Total	8,909
Accumulated Depreciation and Amortization	$ (2,337)
Life on Which Depreciation in Latest Income Statement is Computed	37 years
Regency Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,169
Buildings and Improvements	5,989
Total	7,158
Cost Capitalized Subsequent to Acquisition	1,587
Gross Amount at which Carried at Close of Period
Land	1,169
Building and Improvements	7,048
Total	8,217
Accumulated Depreciation and Amortization	$ (2,712)
Life on Which Depreciation in Latest Income Statement is Computed	25 years
Countryside Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	239
Buildings and Improvements	4,790
Total	5,029
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	239
Building and Improvements	4,418
Total	4,657
Accumulated Depreciation and Amortization	$ (1,307)
Life on Which Depreciation in Latest Income Statement is Computed	35 years
Bradford Square [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	774
Buildings and Improvements	3,848
Total	4,622
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	774
Building and Improvements	3,467
Total	4,241
Accumulated Depreciation and Amortization	$ (1,447)
Life on Which Depreciation in Latest Income Statement is Computed	25 years
Hillside Villa [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	277
Buildings and Improvements	4,272
Total	4,549
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	277
Building and Improvements	3,810
Total	4,087
Accumulated Depreciation and Amortization	$ (1,625)
Life on Which Depreciation in Latest Income Statement is Computed	25 years
Klondike Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	764
Buildings and Improvements	3,576
Total	4,340
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	764
Building and Improvements	3,222
Total	3,986
Accumulated Depreciation and Amortization	$ (1,220)
Life on Which Depreciation in Latest Income Statement is Computed	28 years
Colonial Manor [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	792
Buildings and Improvements	3,050
Total	3,842
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	792
Building and Improvements	2,753
Total	3,545
Accumulated Depreciation and Amortization	$ (1,112)
Life on Which Depreciation in Latest Income Statement is Computed	25 years
Barkley Center [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	325
Buildings and Improvements	4,019
Total	4,344
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	325
Building and Improvements	3,397
Total	3,722
Accumulated Depreciation and Amortization	$ (995)
Life on Which Depreciation in Latest Income Statement is Computed	35 years
Hopkins Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	592
Buildings and Improvements	2,277
Total	2,869
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	592
Building and Improvements	2,020
Total	2,612
Accumulated Depreciation and Amortization	$ (831)
Life on Which Depreciation in Latest Income Statement is Computed	25 years
Bridge Point [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	2,278
Total	2,278
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	1,521
Total	1,521
Accumulated Depreciation and Amortization	$ (908)
Life on Which Depreciation in Latest Income Statement is Computed	20 years
Magnolia Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	14
Buildings and Improvements	629
Total	643
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	14
Building and Improvements	286
Total	300
Accumulated Depreciation and Amortization	$ (209)
Life on Which Depreciation in Latest Income Statement is Computed	29 years
Decatur Township [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	673
Buildings and Improvements	3,730
Total	4,403
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	673
Building and Improvements	3,450
Total	4,123
Accumulated Depreciation and Amortization	$ (1,199)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Gooding/Bennett Hills [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	1,731
Total	1,731
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	1,719
Total	1,719
Accumulated Depreciation and Amortization	$ (923)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Fountain City [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	253
Buildings and Improvements	2,797
Total	3,050
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	253
Building and Improvements	1,904
Total	2,157
Accumulated Depreciation and Amortization	$ (1,314)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Etowah Landing [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	43
Buildings and Improvements	842
Total	885
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	43
Building and Improvements	674
Total	717
Accumulated Depreciation and Amortization	$ (531)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Oakhurst [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,474
Buildings and Improvements	8,212
Total	9,686
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,474
Building and Improvements	7,514
Total	8,988
Accumulated Depreciation and Amortization	$ (2,563)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Orchard Ridge [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	536
Buildings and Improvements	5,685
Total	6,221
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	536
Building and Improvements	5,268
Total	5,804
Accumulated Depreciation and Amortization	$ (1,803)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Bay Tree [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	786
Buildings and Improvements	4,870
Total	5,656
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	786
Building and Improvements	4,333
Total	5,119
Accumulated Depreciation and Amortization	$ (1,663)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
West Bay [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	775
Buildings and Improvements	4,660
Total	5,435
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	775
Building and Improvements	4,110
Total	4,885
Accumulated Depreciation and Amortization	$ (1,477)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Sunset Point [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	706
Buildings and Improvements	4,370
Total	5,076
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	706
Building and Improvements	3,917
Total	4,623
Accumulated Depreciation and Amortization	$ (1,501)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Arden House [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 19,202
Initial Cost to Company
Land	2,250
Buildings and Improvements	23,816
Total	26,066
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,250
Building and Improvements	22,836
Total	25,086
Accumulated Depreciation and Amortization	$ (8,042)
Life on Which Depreciation in Latest Income Statement is Computed	28 years
Pope John Paul [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	13,702
Total	13,702
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	12,660
Total	12,660
Accumulated Depreciation and Amortization	$ (4,041)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Saint Camillus [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	12,528
Total	12,528
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	11,413
Total	11,413
Accumulated Depreciation and Amortization	$ (3,745)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Madison House [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,337
Buildings and Improvements	8,164
Total	12,501
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,337
Building and Improvements	7,715
Total	12,052
Accumulated Depreciation and Amortization	$ (2,320)
Life on Which Depreciation in Latest Income Statement is Computed	36 years
Willows (CT) [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,838
Buildings and Improvements	9,961
Total	11,799
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,838
Building and Improvements	9,130
Total	10,968
Accumulated Depreciation and Amortization	$ (3,073)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
The Reservoir [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,204
Buildings and Improvements	9,457
Total	10,661
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,204
Building and Improvements	9,093
Total	10,297
Accumulated Depreciation and Amortization	$ (2,784)
Life on Which Depreciation in Latest Income Statement is Computed	36 years
Glen Hill [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	918
Buildings and Improvements	7,017
Total	7,935
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	918
Building and Improvements	6,429
Total	7,347
Accumulated Depreciation and Amortization	$ (2,882)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Governor's House [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	5,750
Total	5,750
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	5,209
Total	5,209
Accumulated Depreciation and Amortization	$ (2,587)
Life on Which Depreciation in Latest Income Statement is Computed	20 years
Elms Haven [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 14,743
Initial Cost to Company
Land	3,717
Buildings and Improvements	18,473
Total	22,190
Cost Capitalized Subsequent to Acquisition	7
Gross Amount at which Carried at Close of Period
Land	3,717
Building and Improvements	17,914
Total	21,631
Accumulated Depreciation and Amortization	$ (5,903)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Sable [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,272
Buildings and Improvements	5,591
Total	6,863
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,272
Building and Improvements	5,422
Total	6,694
Accumulated Depreciation and Amortization	$ (1,987)
Life on Which Depreciation in Latest Income Statement is Computed	35 years
Carmicheal [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	1,741
Total	1,741
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	1,263
Total	1,263
Accumulated Depreciation and Amortization	$ (810)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Willows (CA) [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	137
Buildings and Improvements	1,426
Total	1,563
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	137
Building and Improvements	1,194
Total	1,331
Accumulated Depreciation and Amortization	$ (707)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Washington Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 9,383
Initial Cost to Company
Land	0
Buildings and Improvements	1,331
Total	1,331
Cost Capitalized Subsequent to Acquisition	7
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	1,146
Total	1,146
Accumulated Depreciation and Amortization	$ (580)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Lake Drive [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	160
Buildings and Improvements	549
Total	709
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	160
Building and Improvements	87
Total	247
Accumulated Depreciation and Amortization	$ (62)
Life on Which Depreciation in Latest Income Statement is Computed	10 years
Langdon Place of Dover [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,177
Initial Cost to Company
Land	801
Buildings and Improvements	10,036
Total	10,837
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	801
Building and Improvements	9,191
Total	9,992
Accumulated Depreciation and Amortization	$ (2,928)
Life on Which Depreciation in Latest Income Statement is Computed	42 years
Clipper Harbor [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	846
Buildings and Improvements	7,632
Total	8,478
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	846
Building and Improvements	6,964
Total	7,810
Accumulated Depreciation and Amortization	$ (2,803)
Life on Which Depreciation in Latest Income Statement is Computed	43 years
Mineral Springs [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 12,362
Initial Cost to Company
Land	417
Buildings and Improvements	5,352
Total	5,769
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	417
Building and Improvements	4,872
Total	5,289
Accumulated Depreciation and Amortization	$ (1,665)
Life on Which Depreciation in Latest Income Statement is Computed	43 years
Wolfeboro [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 10,413
Initial Cost to Company
Land	454
Buildings and Improvements	4,531
Total	4,985
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	454
Building and Improvements	4,153
Total	4,607
Accumulated Depreciation and Amortization	$ (1,345)
Life on Which Depreciation in Latest Income Statement is Computed	41 years
Langdon Place of Keene [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,737
Initial Cost to Company
Land	304
Buildings and Improvements	3,992
Total	4,296
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	304
Building and Improvements	3,591
Total	3,895
Accumulated Depreciation and Amortization	$ (1,383)
Life on Which Depreciation in Latest Income Statement is Computed	46 years
Edmondson Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	446
Buildings and Improvements	5,087
Total	5,533
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	446
Building and Improvements	4,563
Total	5,009
Accumulated Depreciation and Amortization	$ (1,487)
Life on Which Depreciation in Latest Income Statement is Computed	35 years
Heartland Villa [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	532
Buildings and Improvements	4,025
Total	4,557
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	532
Building and Improvements	3,660
Total	4,192
Accumulated Depreciation and Amortization	$ (1,142)
Life on Which Depreciation in Latest Income Statement is Computed	35 years
Meridian Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	840
Buildings and Improvements	8,342
Total	9,182
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	840
Building and Improvements	8,032
Total	8,872
Accumulated Depreciation and Amortization	$ (3,353)
Life on Which Depreciation in Latest Income Statement is Computed	39 years
Saint Joseph's [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	21,878
Total	21,878
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	20,801
Total	20,801
Accumulated Depreciation and Amortization	$ (8,597)
Life on Which Depreciation in Latest Income Statement is Computed	24 years
Broadmeadow Healthcare [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,650
Buildings and Improvements	21,730
Total	23,380
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,650
Building and Improvements	21,730
Total	23,380
Accumulated Depreciation and Amortization	$ (3,385)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Capitol Healthcare [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,940
Buildings and Improvements	15,500
Total	20,440
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,940
Building and Improvements	15,500
Total	20,440
Accumulated Depreciation and Amortization	$ (2,525)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Pike Creek Healthcare [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,460
Buildings and Improvements	25,240
Total	27,700
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,460
Building and Improvements	25,240
Total	27,700
Accumulated Depreciation and Amortization	$ (3,976)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Renaissance Healthcare [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,640
Buildings and Improvements	22,620
Total	24,260
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,640
Building and Improvements	22,620
Total	24,260
Accumulated Depreciation and Amortization	$ (3,633)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Clara Burke [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,527
Buildings and Improvements	12,453
Total	14,980
Cost Capitalized Subsequent to Acquisition	90
Gross Amount at which Carried at Close of Period
Land	2,527
Building and Improvements	12,543
Total	15,070
Accumulated Depreciation and Amortization	$ (1,853)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Warrington [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,617
Buildings and Improvements	11,662
Total	14,279
Cost Capitalized Subsequent to Acquisition	15
Gross Amount at which Carried at Close of Period
Land	2,617
Building and Improvements	11,677
Total	14,294
Accumulated Depreciation and Amortization	$ (1,588)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Ridgecrest [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	509
Buildings and Improvements	5,018
Total	5,527
Cost Capitalized Subsequent to Acquisition	580
Gross Amount at which Carried at Close of Period
Land	509
Building and Improvements	5,598
Total	6,107
Accumulated Depreciation and Amortization	$ (913)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Camden Care Center [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,235
Buildings and Improvements	5,777
Total	7,012
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,235
Building and Improvements	5,777
Total	7,012
Accumulated Depreciation and Amortization	$ (711)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Arbrook Plaza [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,783
Buildings and Improvements	14,219
Total	18,002
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,783
Building and Improvements	14,219
Total	18,002
Accumulated Depreciation and Amortization	$ (1,669)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Northgate Plaza [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,901
Buildings and Improvements	10,299
Total	15,200
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,901
Building and Improvements	10,299
Total	15,200
Accumulated Depreciation and Amortization	$ (1,245)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Gulf Pointe Plaza [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,005
Buildings and Improvements	6,628
Total	7,633
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,005
Building and Improvements	6,628
Total	7,633
Accumulated Depreciation and Amortization	$ (842)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Gateway Senior Living [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	6,368
Buildings and Improvements	29,919
Total	36,287
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	6,368
Building and Improvements	29,919
Total	36,287
Accumulated Depreciation and Amortization	$ (2,456)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Legacy [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	615
Buildings and Improvements	16,176
Total	16,791
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	615
Building and Improvements	16,176
Total	16,791
Accumulated Depreciation and Amortization	$ (1,457)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Pointe [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	615
Buildings and Improvements	2,943
Total	3,558
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	615
Building and Improvements	2,943
Total	3,558
Accumulated Depreciation and Amortization	$ (315)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Regency [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	246
Buildings and Improvements	6,206
Total	6,452
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	246
Building and Improvements	6,206
Total	6,452
Accumulated Depreciation and Amortization	$ (680)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Parkmoor Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	430
Buildings and Improvements	13,703
Total	14,133
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	430
Building and Improvements	13,703
Total	14,133
Accumulated Depreciation and Amortization	$ (1,281)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Onion Creek [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	871
Buildings and Improvements	12,843
Total	13,714
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	871
Building and Improvements	12,843
Total	13,714
Accumulated Depreciation and Amortization	$ (920)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Adams PARC [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,332
Buildings and Improvements	6,904
Total	8,236
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,332
Building and Improvements	6,904
Total	8,236
Accumulated Depreciation and Amortization	$ (470)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
PARCway [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,189
Buildings and Improvements	23,567
Total	25,756
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,189
Building and Improvements	23,567
Total	25,756
Accumulated Depreciation and Amortization	$ (1,428)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Brookhaven Extensive Care [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	869
Buildings and Improvements	5,236
Total	6,105
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	869
Building and Improvements	5,236
Total	6,105
Accumulated Depreciation and Amortization	$ (398)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
St. Thomas More Medical Complex [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	6,343
Buildings and Improvements	65,573
Total	71,916
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	6,343
Building and Improvements	65,573
Total	71,916
Accumulated Depreciation and Amortization	$ (2,962)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Bay Ridge Healthcare Center [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,548
Buildings and Improvements	40,773
Total	42,321
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,548
Building and Improvements	40,773
Total	42,321
Accumulated Depreciation and Amortization	$ (1,708)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
NMS Healthcare of Silver Spring [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	676
Buildings and Improvements	56,897
Total	57,573
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	676
Building and Improvements	56,897
Total	57,573
Accumulated Depreciation and Amortization	$ (2,349)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
NMS Healthcare of Hagerstown [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,475
Buildings and Improvements	56,237
Total	57,712
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,475
Building and Improvements	56,237
Total	57,712
Accumulated Depreciation and Amortization	$ (1,701)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
NMS Healthcare of Springbrook [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	963
Buildings and Improvements	48,085
Total	49,048
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	963
Building and Improvements	48,085
Total	49,048
Accumulated Depreciation and Amortization	$ (562)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 102,976
Initial Cost to Company
Land	110,076
Buildings and Improvements	963,581
Total	1,073,657
Cost Capitalized Subsequent to Acquisition	2,295
Gross Amount at which Carried at Close of Period
Land	110,076
Building and Improvements	932,678
Total	1,042,754
Accumulated Depreciation and Amortization	(190,038)
Monroe House [Member]
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	0
Buildings and Improvements	182
Total	182
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	43
Total	43
Accumulated Depreciation and Amortization	$ (33)
Life on Which Depreciation in Latest Income Statement is Computed	15 years
Forest Hills (ALF) [Member]
Initial Cost to Company
Land	$ 1,803
Buildings and Improvements	3,927
Total	5,730
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,803
Building and Improvements	3,775
Total	5,578
Accumulated Depreciation and Amortization	$ (1,618)
Life on Which Depreciation in Latest Income Statement is Computed	30 years
Forest Hills (ALF) [Member] | Mortgages [Member]
Gross Amount at which Carried at Close of Period
Mortgage loan	$ 12,500
Langdon Place of Exeter [Member]
Real Estate and Accumulated Depreciation
Encumbrances	3,363
Initial Cost to Company
Land	571
Buildings and Improvements	7,183
Total	7,754
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	571
Building and Improvements	6,479
Total	7,050
Accumulated Depreciation and Amortization	$ (2,230)
Life on Which Depreciation in Latest Income Statement is Computed	43 years
Langdon Place of Nashua [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 5,330
Initial Cost to Company
Land	0
Buildings and Improvements	5,654
Total	5,654
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	4,919
Total	4,919
Accumulated Depreciation and Amortization	$ (1,429)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Heritage Place [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	668
Buildings and Improvements	5,492
Total	6,160
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	668
Building and Improvements	5,116
Total	5,784
Accumulated Depreciation and Amortization	$ (1,369)
Life on Which Depreciation in Latest Income Statement is Computed	38 years
Glen Crest [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,356
Buildings and Improvements	6,666
Total	8,022
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,356
Building and Improvements	6,544
Total	7,900
Accumulated Depreciation and Amortization	$ (2,161)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Village at Northrise [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,432
Buildings and Improvements	6,003
Total	7,435
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,432
Building and Improvements	5,236
Total	6,668
Accumulated Depreciation and Amortization	$ (2,581)
Life on Which Depreciation in Latest Income Statement is Computed	29 years
Age Well Senior Living [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	256
Buildings and Improvements	2,262
Total	2,518
Cost Capitalized Subsequent to Acquisition	1,031
Gross Amount at which Carried at Close of Period
Land	256
Building and Improvements	3,293
Total	3,549
Accumulated Depreciation and Amortization	$ (966)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
New Dawn Memory Care Center [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,874
Buildings and Improvements	12,829
Total	15,703
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,874
Building and Improvements	12,829
Total	15,703
Accumulated Depreciation and Amortization	$ (1,477)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Independence Village at Frankenmuth [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	5,027
Buildings and Improvements	20,929
Total	25,956
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	5,027
Building and Improvements	20,929
Total	25,956
Accumulated Depreciation and Amortization	$ (2,604)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Gulfe Pointe Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	789
Buildings and Improvements	607
Total	1,396
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	789
Building and Improvements	607
Total	1,396
Accumulated Depreciation and Amortization	$ (121)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Aspen Ridge Retirement Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,024
Buildings and Improvements	5,467
Total	7,491
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,024
Building and Improvements	5,467
Total	7,491
Accumulated Depreciation and Amortization	$ (793)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Green Acres of Cadillac [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	217
Buildings and Improvements	3,000
Total	3,217
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	217
Building and Improvements	3,000
Total	3,217
Accumulated Depreciation and Amortization	$ (368)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Green Acres of Greenville [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	684
Buildings and Improvements	5,832
Total	6,516
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	684
Building and Improvements	5,832
Total	6,516
Accumulated Depreciation and Amortization	$ (712)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Green Acres of Manistee [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	952
Buildings and Improvements	2,578
Total	3,530
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	952
Building and Improvements	2,578
Total	3,530
Accumulated Depreciation and Amortization	$ (348)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Green Acres of Mason [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	198
Buildings and Improvements	4,131
Total	4,329
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	198
Building and Improvements	4,131
Total	4,329
Accumulated Depreciation and Amortization	$ (528)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Nottingham Place [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	744
Buildings and Improvements	1,745
Total	2,489
Cost Capitalized Subsequent to Acquisition	400
Gross Amount at which Carried at Close of Period
Land	744
Building and Improvements	2,145
Total	2,889
Accumulated Depreciation and Amortization	$ (241)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Royal View [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	307
Buildings and Improvements	2,477
Total	2,784
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	307
Building and Improvements	2,477
Total	2,784
Accumulated Depreciation and Amortization	$ (347)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Tawas Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	258
Buildings and Improvements	3,713
Total	3,971
Cost Capitalized Subsequent to Acquisition	45
Gross Amount at which Carried at Close of Period
Land	258
Building and Improvements	3,758
Total	4,016
Accumulated Depreciation and Amortization	$ (616)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Turning Brook [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	546
Buildings and Improvements	13,139
Total	13,685
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	546
Building and Improvements	13,139
Total	13,685
Accumulated Depreciation and Amortization	$ (1,443)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Stoney River Marshfield [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	574
Buildings and Improvements	8,733
Total	9,307
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	574
Building and Improvements	8,733
Total	9,307
Accumulated Depreciation and Amortization	$ (1,003)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Greenfield of Woodstock [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	597
Buildings and Improvements	5,465
Total	6,062
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	597
Building and Improvements	5,465
Total	6,062
Accumulated Depreciation and Amortization	$ (557)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Square [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	504
Buildings and Improvements	17,670
Total	18,174
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	504
Building and Improvements	17,670
Total	18,174
Accumulated Depreciation and Amortization	$ (1,476)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
The Meadows [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	217
Buildings and Improvements	9,906
Total	10,123
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	217
Building and Improvements	9,906
Total	10,123
Accumulated Depreciation and Amortization	$ (862)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Park Place [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 13,685
Initial Cost to Company
Land	2,300
Buildings and Improvements	21,115
Total	23,415
Cost Capitalized Subsequent to Acquisition	2,747
Gross Amount at which Carried at Close of Period
Land	2,300
Building and Improvements	23,862
Total	26,162
Accumulated Depreciation and Amortization	$ (1,906)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Parkview In Allen [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,190
Buildings and Improvements	45,767
Total	47,957
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,190
Building and Improvements	45,767
Total	47,957
Accumulated Depreciation and Amortization	$ (2,912)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
The Atrium at Gainesville [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,139
Buildings and Improvements	44,789
Total	46,928
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,139
Building and Improvements	44,789
Total	46,928
Accumulated Depreciation and Amortization	$ (2,999)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
The Chateau [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,760
Buildings and Improvements	44,397
Total	47,157
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,760
Building and Improvements	44,397
Total	47,157
Accumulated Depreciation and Amortization	$ (2,863)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Gardens At Wakefield Plantation [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,344
Buildings and Improvements	37,506
Total	39,850
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,344
Building and Improvements	37,506
Total	39,850
Accumulated Depreciation and Amortization	$ (2,345)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Las Brisas [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,992
Buildings and Improvements	30,909
Total	35,901
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,992
Building and Improvements	30,909
Total	35,901
Accumulated Depreciation and Amortization	$ (2,009)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Creekside Terrace [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,995
Buildings and Improvements	24,428
Total	27,423
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,995
Building and Improvements	24,428
Total	27,423
Accumulated Depreciation and Amortization	$ (1,619)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Colonial Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	805
Buildings and Improvements	26,498
Total	27,303
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	805
Building and Improvements	26,498
Total	27,303
Accumulated Depreciation and Amortization	$ (1,731)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Garden Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,325
Buildings and Improvements	20,510
Total	21,835
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,325
Building and Improvements	20,510
Total	21,835
Accumulated Depreciation and Amortization	$ (1,412)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Desert Rose [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	530
Buildings and Improvements	21,775
Total	22,305
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	530
Building and Improvements	21,775
Total	22,305
Accumulated Depreciation and Amortization	$ (1,438)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Windland South [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,996
Buildings and Improvements	19,368
Total	21,364
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,996
Building and Improvements	19,368
Total	21,364
Accumulated Depreciation and Amortization	$ (1,366)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Cedar Woods [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,403
Buildings and Improvements	18,821
Total	21,224
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,403
Building and Improvements	18,821
Total	21,224
Accumulated Depreciation and Amortization	$ (1,242)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Virginian [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,080
Buildings and Improvements	19,545
Total	20,625
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,080
Building and Improvements	19,545
Total	20,625
Accumulated Depreciation and Amortization	$ (1,308)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Monarch Estates [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,209
Buildings and Improvements	17,326
Total	20,535
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,209
Building and Improvements	17,326
Total	20,535
Accumulated Depreciation and Amortization	$ (1,191)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Village At The Falls [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,477
Buildings and Improvements	18,778
Total	20,255
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,477
Building and Improvements	18,778
Total	20,255
Accumulated Depreciation and Amortization	$ (1,288)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Holiday At The Atrium [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	978
Buildings and Improvements	18,257
Total	19,235
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	978
Building and Improvements	18,257
Total	19,235
Accumulated Depreciation and Amortization	$ (1,221)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Lake Ridge Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,152
Buildings and Improvements	17,523
Total	18,675
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,152
Building and Improvements	17,523
Total	18,675
Accumulated Depreciation and Amortization	$ (1,197)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Heritage Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,092
Buildings and Improvements	13,823
Total	17,915
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,092
Building and Improvements	13,823
Total	17,915
Accumulated Depreciation and Amortization	$ (979)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Madison Meadows [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,567
Buildings and Improvements	12,029
Total	14,596
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,567
Building and Improvements	12,029
Total	14,596
Accumulated Depreciation and Amortization	$ (873)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
South Wind Heights [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,782
Buildings and Improvements	11,244
Total	13,026
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,782
Building and Improvements	11,244
Total	13,026
Accumulated Depreciation and Amortization	$ (804)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Harrison Regent [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	794
Buildings and Improvements	10,873
Total	11,667
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	794
Building and Improvements	10,873
Total	11,667
Accumulated Depreciation and Amortization	$ (748)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Avalon MC - Boat Club [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	359
Buildings and Improvements	8,126
Total	8,485
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	359
Building and Improvements	8,126
Total	8,485
Accumulated Depreciation and Amortization	$ (524)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Avalon MC - 7200 [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	123
Buildings and Improvements	4,914
Total	5,037
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	123
Building and Improvements	4,914
Total	5,037
Accumulated Depreciation and Amortization	$ (318)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Avalon MC - 7204 [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	215
Buildings and Improvements	4,821
Total	5,036
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	215
Building and Improvements	4,822
Total	5,037
Accumulated Depreciation and Amortization	$ (314)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Avalon MC - 7140 [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	143
Buildings and Improvements	6,653
Total	6,796
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	143
Building and Improvements	6,653
Total	6,796
Accumulated Depreciation and Amortization	$ (420)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Delaney Creek Lodge [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,283
Buildings and Improvements	8,424
Total	9,707
Cost Capitalized Subsequent to Acquisition	35
Gross Amount at which Carried at Close of Period
Land	1,283
Building and Improvements	8,459
Total	9,742
Accumulated Depreciation and Amortization	$ (591)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Nature Coast Lodge [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,031
Buildings and Improvements	5,577
Total	6,608
Cost Capitalized Subsequent to Acquisition	46
Gross Amount at which Carried at Close of Period
Land	1,031
Building and Improvements	5,623
Total	6,654
Accumulated Depreciation and Amortization	$ (448)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
West Winds [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,688
Buildings and Improvements	9,098
Total	10,786
Cost Capitalized Subsequent to Acquisition	55
Gross Amount at which Carried at Close of Period
Land	1,688
Building and Improvements	9,153
Total	10,841
Accumulated Depreciation and Amortization	$ (701)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Capital Place [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,477
Buildings and Improvements	23,767
Total	26,244
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,477
Building and Improvements	23,767
Total	26,244
Accumulated Depreciation and Amortization	$ (1,554)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Tudor Heights [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	561
Buildings and Improvements	4,865
Total	5,426
Cost Capitalized Subsequent to Acquisition	1,139
Gross Amount at which Carried at Close of Period
Land	561
Building and Improvements	6,004
Total	6,565
Accumulated Depreciation and Amortization	$ (453)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
New Haven AL [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,174
Buildings and Improvements	6,298
Total	7,472
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,174
Building and Improvements	6,298
Total	7,472
Accumulated Depreciation and Amortization	$ (340)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Cherry Park [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 5,040
Initial Cost to Company
Land	763
Buildings and Improvements	6,771
Total	7,534
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	763
Building and Improvements	6,771
Total	7,534
Accumulated Depreciation and Amortization	$ (321)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Orchard Valley [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 7,000
Initial Cost to Company
Land	843
Buildings and Improvements	10,724
Total	11,567
Cost Capitalized Subsequent to Acquisition	(573)
Gross Amount at which Carried at Close of Period
Land	270
Building and Improvements	10,724
Total	10,994
Accumulated Depreciation and Amortization	$ (480)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
The Shores [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 5,258
Initial Cost to Company
Land	679
Buildings and Improvements	8,024
Total	8,703
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	679
Building and Improvements	8,024
Total	8,703
Accumulated Depreciation and Amortization	$ (382)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Kensington Court [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,360
Buildings and Improvements	16,855
Total	18,215
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,360
Building and Improvements	16,855
Total	18,215
Accumulated Depreciation and Amortization	$ (771)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Masonville Manor [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	960
Buildings and Improvements	19,056
Total	20,016
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	960
Building and Improvements	19,056
Total	20,016
Accumulated Depreciation and Amortization	$ (854)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Okanagan Chateau [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,321
Buildings and Improvements	8,308
Total	10,629
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,321
Building and Improvements	8,308
Total	10,629
Accumulated Depreciation and Amortization	$ (415)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Court at Laurelwood [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,823
Buildings and Improvements	22,135
Total	23,958
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,823
Building and Improvements	22,135
Total	23,958
Accumulated Depreciation and Amortization	$ (987)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Fairwoods Lodge [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,187
Buildings and Improvements	20,346
Total	21,533
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,187
Building and Improvements	20,346
Total	21,533
Accumulated Depreciation and Amortization	$ (908)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Birmingham Lodge [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	143
Buildings and Improvements	2,402
Total	2,545
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	143
Building and Improvements	2,402
Total	2,545
Accumulated Depreciation and Amortization	$ (163)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Life's Journey of Mattoon [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	812
Buildings and Improvements	6,796
Total	7,608
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	812
Building and Improvements	6,796
Total	7,608
Accumulated Depreciation and Amortization	$ (302)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Life's Journey of Pana [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	154
Buildings and Improvements	2,098
Total	2,252
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	154
Building and Improvements	2,098
Total	2,252
Accumulated Depreciation and Amortization	$ (105)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Life's Journey of Taylorville [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	267
Buildings and Improvements	5,201
Total	5,468
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	267
Building and Improvements	5,201
Total	5,468
Accumulated Depreciation and Amortization	$ (232)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Life's Journey Estates [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	134
Buildings and Improvements	659
Total	793
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	134
Building and Improvements	659
Total	793
Accumulated Depreciation and Amortization	$ (36)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Life's Journey of Paris [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	132
Buildings and Improvements	3,090
Total	3,222
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	132
Building and Improvements	3,090
Total	3,222
Accumulated Depreciation and Amortization	$ (124)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Ashley Pointe [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,559
Buildings and Improvements	9,059
Total	10,618
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,559
Building and Improvements	9,059
Total	10,618
Accumulated Depreciation and Amortization	$ (348)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Farmington Square Eugene [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,428
Buildings and Improvements	16,138
Total	17,566
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,428
Building and Improvements	16,138
Total	17,566
Accumulated Depreciation and Amortization	$ (549)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Farmington Square Tualatin [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	527
Buildings and Improvements	14,659
Total	15,186
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	527
Building and Improvements	14,659
Total	15,186
Accumulated Depreciation and Amortization	$ (502)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Farmington Square of Salem [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,074
Buildings and Improvements	19,421
Total	20,495
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,074
Building and Improvements	19,421
Total	20,495
Accumulated Depreciation and Amortization	$ (687)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Maison Senior Living [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,908
Buildings and Improvements	20,996
Total	24,904
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,908
Building and Improvements	20,996
Total	24,904
Accumulated Depreciation and Amortization	$ (678)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Colorado Springs [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,210
Buildings and Improvements	9,490
Total	10,700
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,210
Building and Improvements	9,490
Total	10,700
Accumulated Depreciation and Amortization	$ (312)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Sun City West [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	930
Buildings and Improvements	9,170
Total	10,100
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	930
Building and Improvements	9,170
Total	10,100
Accumulated Depreciation and Amortization	(135)
Poet's Walk at Fredericksburg [Member]
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	1,379
Buildings and Improvements	21,209
Total	22,588
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,379
Building and Improvements	21,209
Total	22,588
Accumulated Depreciation and Amortization	$ (310)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Poet's Walk at Chandler Oaks [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	679
Buildings and Improvements	13,642
Total	14,321
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	679
Building and Improvements	13,642
Total	14,321
Accumulated Depreciation and Amortization	$ (170)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
The Montecito Santa Fe [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,536
Buildings and Improvements	19,441
Total	21,977
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,536
Building and Improvements	19,441
Total	21,977
Accumulated Depreciation and Amortization	$ (145)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
The Golden Crest [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	292
Buildings and Improvements	6,889
Total	7,181
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	292
Building and Improvements	6,889
Total	7,181
Accumulated Depreciation and Amortization	$ (19)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Poet's Walk at Henderson [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,430
Buildings and Improvements	21,850
Total	23,280
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,430
Building and Improvements	21,850
Total	23,280
Accumulated Depreciation and Amortization	$ (52)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Kruse Village [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	476
Buildings and Improvements	11,912
Total	12,388
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	476
Building and Improvements	11,912
Total	12,388
Accumulated Depreciation and Amortization	$ (33)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 48,590
Initial Cost to Company
Land	106,519
Buildings and Improvements	1,081,415
Total	1,187,934
Cost Capitalized Subsequent to Acquisition	4,925
Gross Amount at which Carried at Close of Period
Land	105,946
Building and Improvements	1,082,005
Total	1,187,951
Accumulated Depreciation and Amortization	(82,131)
Texas Regional Medical Center [Member]
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,020
Buildings and Improvements	57,620
Total	61,640
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,020
Building and Improvements	57,620
Total	61,640
Accumulated Depreciation and Amortization	$ (10,387)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Acute Care Hospitals [Member]
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,020
Buildings and Improvements	57,620
Total	61,640
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,020
Building and Improvements	57,620
Total	61,640
Accumulated Depreciation and Amortization	(10,387)
Multi-property Indebtedness [Member]
Real Estate and Accumulated Depreciation
Encumbrances	12,072
Initial Cost to Company
Land	0
Buildings and Improvements	0
Total	0
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	0
Total	0
Accumulated Depreciation and Amortization	0
Real Estate [Member] | Mortgages [Member]
Gross Amount at which Carried at Close of Period
Collateral amount	$ 12,100

SCHEDULE IV MORTGAGE LOANS ON90

SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance at the beginning of the period	$ 241,038	$ 209,275	$ 162,870
Additions during period:
Draws	0	8,713	51,217
New mortgage loans	3,767	20,411	4,500
Interest income added to principal	690	2,639	1,781
Deductions during period:
Paydowns/Repayments	(206,469)	0	(11,093)
Balance at the end of the year	39,026	$ 241,038	$ 209,275
Mortgages [Member]
Mortgage Loans on Real Estate [Line Items]
Prior Liens	0
Principal Balance	38,231
Book Value	38,262
Loan Loss Allowance	(1,620)
Net Book Value	$ 36,642
Mortgages [Member] | Weston [Member]
Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	9.00%
Prior Liens	$ 0
Principal Balance	16,079
Book Value	$ 16,079
Mortgages [Member] | Ramsey [Member]
Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	9.00%
Prior Liens	$ 0
Principal Balance	13,876
Book Value	$ 13,887
Mortgages [Member] | Marshfield II [Member]
Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	9.00%
Prior Liens	$ 0
Principal Balance	5,209
Book Value	$ 5,222
Mortgages [Member] | Madeira [Member]
Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	10.00%
Prior Liens	$ 0
Principal Balance	3,067
Book Value	3,074
Construction Mortgages [Member]
Mortgage Loans on Real Estate [Line Items]
Prior Liens	0
Principal Balance	39,026
Book Value	$ 37,484
Construction Mortgages [Member] | McKinney [Member]
Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	8.00%
Prior Liens	$ 0
Principal Balance	795
Book Value	$ 842